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Gelsolin is a multifunctional actin-binding protein that is known to play 
a crucial role in cancer cell motility and invasion.  However, the mechanisms 
by which gelsolin promotes cancer cell invasion is poorly understood.  
Independent lines of studies have shown an association between the abnormal 
rise in Reactive Oxygen Species (ROS) levels with malignant growth and 
cancer cell invasion.  In this study we have identified a new role of gelsolin in 
modulating the intracellular ROS levels, particularly the superoxide (O2
-
) 
species, which significantly contributes to gelsolin-mediated invasion.  We 
show that HCT116 colon cancer cells that stably overexpress gelsolin have 
higher levels of O2
-
 as well as enhanced invasion when compared to the empty 
vector control and wild-type HCT116 cells.  Consistently, knockdown of 
endogenous gelsolin in two colon cancer cell lines HCT116 and RKO reduces 
the intracellular levels of O2
- 
and attenuates invasion.  Blockade of O2
-
generation with diphenyleneiodonium (DPI), an inhibitor of the O2
- 
producing 
enzyme-NADPH oxidase (Nox) potently reduces the invasive capacities of 
gelsolin-overexpressing cells.  Moreover, increasing the O2
- 
levels in gelsolin-
knockdown HCT116 cells by silencing the antioxidant enzyme Cu/Zn 
superoxide dismutase (Cu/Zn SOD) rescues invasion.  These results strongly 
suggest a reliance on O2
-
 for the gelsolin-mediated invasion process.  We have 
previously shown that gelsolin-overexpressing cells secrete higher levels of the 
matrix degrading enzyme — urokinase plasminogen activator (uPA), thus 
facilitating invasion.  Interestingly, treatment of gelsolin-overexpressing cells 
with DPI reduces uPA secretion providing evidence that uPA secretion by 
gelsolin-overexpressing cells is influenced by O2
-
.  In addition, we also show 
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that gelsolin overexpression suppresses the activity of Cu/Zn SOD, an 
antioxidant enzyme that scavenges O2
-
.  Gelsolin was found to co-
immunoprecipitate with Cu/Zn SOD, suggesting that gelsolin may form a 
complex with Cu/Zn SOD and inhibit its O2
- 
scavenging functions.  The 
impairment of Cu/Zn SOD activity provides a mechanistic explanation for the 
elevated amount of intracellular O2
-
 in gelsolin-overexpressing cells.  In 
summary, our findings demonstrate a new insight into the role of gelsolin in 
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CHAPTER 1  INTRODUCTION 
1.1 CANCER CELL INVASION 
1.1.1 Invasion-metastatic cascade 
Metastasis is one of the most life-threatening diseases which accounts 
for 90% of cancer death worldwide (Gupta & Massague, 2006; Mehlen & 
Puisieux, 2006; Weigelt et al., 2005).  The spread of tumour from the primary 
site to a distant region in the body is known as metastasis.  Metastasis is a 
multifactorial process that involves a complex and an intricate interaction 
between the tumour cells and the surrounding environment which consists of 
the stroma, extracellular matrix (ECM), lymph vessels and the vascular 
systems. 
The process of metastasis begins with detachment of tumour cells from 
the primary site and invasion through the nearby tissues.  Invading tumour 
cells secrete proteolytic enzymes that are able to degrade the ECM and break 
away from the basement membrane.  Degradation of ECM by proteases 
facilitates local invasion as well as migration of tumour cells out into the 
extracellular space.  The tumour cells travel along the surface of other cells 
and force their way into the nearby vessels (lymph or blood vessels).  Once the 
tumour cells reach the vessels, they degrade and invade through the epithelial 
lining of the blood vessels and infiltrate into the blood stream in a process 
called intravasation.  Inside the circulation, the tumour cells move along the 
endothelial cell lining until they reach a point where they firmly attach to the 
endothelial cell walls.  Once tumour cells strongly adhere to the endothelial 
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walls, they extravasate from the vessel to enter into the new tissue.  If the new 
environment is suitable, these neoplastic cells proliferate and form new 
colonies called the secondary tumours.  Secondary tumours often induce 
neoangiogenesis to ensure sufficient blood supply to the newly formed 
colonies (Chambers et al., 2002; Friedl & Wolf, 2003; Steeg, 2003; Talmadge 
& Fidler, 2010; Yilmaz & Christofori, 2009).  A schematic illustration of the 
invasion-metastatic cascade is shown in figure 1.1. 
Metastasis is a tough and inefficient process from the point of view of 
a tumour cell because metastasizing cells encounter a number of adversities 
during their journey to the new site (Chambers et al., 2002; Shibue & 
Weinberg, 2009; Valastyan & Weinberg, 2011).  Migrating tumour cells may 
die while invading into the constricted spaces into the blood vessel walls;  they 
may even succumb while in the blood circulation or be recognised and 
destroyed by the cells of the immune system.  A significant fraction of 
migrating tumour cells that successfully reach a new location may still perish 
if the new environment is not suitable.  Only the ones that survive throughout 
these adversities will proliferate to establish new colonies (Barbour & Gotley, 
2003; Chambers et al., 2002; Luzzi et al., 1998; Shibue & Weinberg, 2009; 








Figure 1.1. Schematic illustration of the invasion-metastatic cascade (a) in situ 
cancer cells outlined by an intact basement membrane.  (b) Cancer cells acquire 
invasive phenotype which is characterised by loss of cell-cell adhesion, altered cell–
extracellular matrix adherence, release of extracellular matrix-degrading proteases 
leading to fragmented basement and ECM, and increased motility (c) Cancer cells 
enter the lymphatic system and colonise at the lymph nodes, or (d) cancer cell directly 
enter the circulation system (e) Cancer cells that survive in the circulation travel to 
distant sites and attach to the endothelial walls and extravasate from the circulatory 
system (f) Formation of micrometatases at the secondary site which progresses from 
single cells and may remain dormant for years, to occult micrometastases or  





1.1.2 Molecular mechanisms of cancer cell invasion 
Cancer cell motility and invasion constitutes one of the most critical 
steps during the course of metastasis.  Cancer cell invasion involves a 
coordinated network of molecules that result in attachment to the matrix, 
degradation of the ECM, loss of intercellular adhesion, enhanced cell motility 
and resistance to death (Curran et al., 2004; Curran & Murray, 2000; Friedl & 
Alexander, 2011; Kassis et al., 2001; Leber & Efferth, 2009; Meyer & Hart, 
1998; Sahai, 2005; Yilmaz & Christofori, 2009).  During these processes a 
number of oncogenic factors are expressed in an orchestrated fashion allowing 
cells to acquire invasive and aggressive phenotype.  Amongst the oncogenic 
factors are the oncogenes such as Rac, Ras, and Src, (Angers-Loustau et al., 
2004; Campbell & Der, 2004; Guarino, 2010; Zhuge & Xu, 2001), 
dysregulated actin cytoskeleton (Yamaguchi & Condeelis, 2007; Yamaguchi 
et al., 2005; Yamaguchi et al., 2006; Yilmaz & Christofori, 2009), as well as 
chemically reactive molecules such as the Reactive Oxygen Species (ROS) 
(Alexandrova et al., 2006; Binker et al., 2009; Nishikawa & Hashida, 2006).  
Depending on the molecular complex they associate with, these oncogenic 
factors may elicit different responses depending on the stimuli, the 
environment and the type of tumour. 
1.1.3 Cancer cell-extracellular matrix (ECM) interaction and ECM 
degradation 
Successful invasion of tissues requires cell-ECM interaction and 
breakdown of the components of the ECM and basement membrane.  Integrin-
ECM interaction instigate intracellular signalling cascade that regulate gene 
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expression required for actin cytoskeletal reorganisation and cell adhesion 
leading to enhanced invasion.  To initiate cell adhesion, integrins assemble at 
the plasma membrane enabling cells to attach to the ECM at the focal 
adhesion point (Guan, 1997; Svineng et al., 2008).  Focal adhesion proteins, 
such as focal adhesion kinase (FAK), along with focal adaptor proteins — 
p130Cas and paxillin are important regulators of integrins (Ben Mahdi et al., 
2000; Price & Thompson, 2002).  FAK associates with other signalling 
proteins such as Src kinase to modulate integrin-mediated cell migration by 
phosphorylating p130Cas and paxillin (Price & Thompson, 2002).  Activated 
p130Cas and paxillin associates with other proteins involved in membrane 
ruffling, cell migration and invasion (Zhao & Guan, 2011). 
Once invasive tumour cells adhere to and interact with the ECM, they 
infiltrate the surrounding ECM.  The major constituents of the ECM are 
collagen, laminin and fibronectin that can be degraded by specific proteases.  
Of the most prominent proteases associated with cancer are the urokinase 
plasminogen activator (uPA) system and the matrix metalloproteinases 
(MMPs) (Brooks et al., 2010; Meyer & Hart, 1998).  Through their 
degradative actions, these proteases remodel the ECM, paving the way for 
invading cells to migrate and promote tumour cell invasion and metastasis 
(Baldassarre et al., 2006; Yilmaz & Christofori, 2009).  A schematic summary 






Figure 1.2. Cell-ECM interaction and ECM degradation.  During cell adhesion, 
intracellular signalling molecules such as the focal adhesion kinase (FAK), Src, p130 
Cas and paxillin associate with each other to activate integrin assembly at the plasma 
membrane.  Activated integrins attach to the ECM at the focal adhesion point.  
Integrin-ECM interaction also triggers signalling cascade that is involved in cell 
invasion and migration.  Once cancer cells are firmly adhered to ECM, they release 
proteolytic enzymes such as MMPs and uPA that degrade components of the ECM 
thereby facilitating cancer cell invasion. 
 
Urokinase plasminogen activator (uPA) system 
Tumour cells secrete the serine protease uPA as a soluble protein that 
binds to its specific cell surface receptor, the uPA receptor (uPAR).  Binding 
of uPA to uPAR converts plasminogen to active plasmin, which can then 
degrade components of the basement membrane and ECM through its 
proteolytic activity (Brooks et al., 2010; Duffy, 2004; Lijnen, 2001; Meyer & 
Hart, 1998; Syrovets & Simmet, 2004).  Besides activation of plasmin, uPA 
can also induce the activation of other proteases involved in cancer cell 
invasion, such as the MMPs, highlighting the pivotal role of uPA in promoting 
cancer cell invasion (Legrand et al., 2001; Taniguchi et al., 1998; Zhao et al., 
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2008).  Increased levels of uPA have been implicated to correlate with 
invasive and aggressive phenotypes in tumours (Bauer et al., 2005; Pyke et al., 
1991; Zhao et al., 2008).  In line with this, increased expression and activation 
of uPA was shown to enhance invasion (Zhang et al., 2011) whilst 
downregulation of uPA reduced the invasive abilities of tumour cells 
(Mohanam et al., 2002; Zhang et al., 2011). 
uPA expression is regulated by activation of the mitogen-activated 
protein kinase (MAPK) pathway and downstream activation of transcription 
factors including Nuclear Factor-kappa B (NF-κB), Activator Protein-2α  (AP-
2α) and Specificity protein 1 (Sp1) (Kim et al., 2007b; Lee et al., 2009; Tobar 
et al., 2010b).  ROS have also been shown to indirectly activate the 
uPA/uPAR system via activation of the MAPK pathway. 
Matrix metalloproteinases 
MMPs are a large family of endopeptidases that degrade a variety of 
substrates in the ECM.  The different MMPs are categorised according to their 
specific substrates as collagenases, gelatinases, stromelysins and membrane-
type MMPs (Lukaszewicz-Zając et al., 2011).  MMPs are first secreted as 
zymogens and the inactive pro-MMPs are activated by cleavage of the pro-
peptide domain.  MMPs can also be activated by serine proteases such as uPA, 
other active MMPs or by ROS oxidation (Nelson & Melendez, 2004; 
Rajagopalan et al., 1996).  The tissue inhibitors of metalloproteinases (TIMPs) 
are the endogenous inhibitors of MMPs.  Often in invasive cancer cells, high 
amount of MMP activities are observed as opposed to lower activities of 
TIMPs (Curran et al., 2004; Lukaszewicz-Zając et al., 2011). 
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1.1.4 Loss of cell-to-cell adhesion  
In several cancer types, the onset of tumour malignancy is often 
marked by dissolution of cell-to-cell contacts that results in cell scattering 
(Thiery, 2002).  Cell scattering is induced when cell to cell adhesion 
molecules are deregulated which cause morphological changes to the cell.  
The alteration in cell shape closely resembles the switch observed during 
epithelial-mesenchymal transition (EMT) where epithelial cells lose their 
characteristics such as tight cell-cell adhesion and acquire a fibroblastic-like 
spindle-shaped morphology (Thiery, 2002) (figure 1.3).  One of the hallmarks 
of EMT is the loss of cell-to-cell adhesion molecule E-cadherin with a 
concomitant increase in the expression of the mesenchymal marker N-
cadherin, a process called the cadherin switch (Yilmaz & Christofori, 2009).  
Loss of epithelial markers (laminin 1, ZO-1, desmoplakin, cytokeratin, and 
collagen IV) and activation of mesenchymal markers (alpha-smooth muscle 
actin (α-SMA), vimentin) have also been observed during EMT-like changes.  
In most cases, loss of E-cadherin is a result of activation of transcriptional 
repressors of E-cadherin such as Snail, Slug, Zeb1, SIP1, E47 and Twist.  
These EMT-related features are associated with aggressive behaviour leading 
to the progression of invasion and the metastasis of many cancer types 
(Barnett et al., 2011; Baum et al., 2008; Thiery, 2002; Thiery, 2003; Thiery & 
Sleeman, 2006).  It is however important to note that cancer cells can also 




Figure 1.3.  Acquisition of EMT-like phenotypes during cancer cell migration 
and invasion.  The onset of EMT is characterised by the partial or complete loss of 
cell to cell adhesion molecules and induction of meshenchymal markers.  These 
changes also involve cytoskeletal reorganisation leading to alteration in cell shape. 
 
1.1.5 Actin cytoskeleton and cancer cell invasion 
Although various factors are involved, regulation of the actin 
cytoskeleton is one of the most crucial determinants of cancer cell invasion.  
Many of the steps in cancer cell invasion depend on the structural changes and 
cell motility aspects which are driven by actin cytoskeletal dynamics.  
Changes in cell shape, particularly formation of actin rich protrusions such as 
lamellipodia, filopodia, invadopodia and podosomes have been illustrated 
during cell movement and invasion (Ridley, 2011).  Activation of the small 
GTPases such as Rho, Rac and Cdc42 are responsible for transmitting signals 
to actin-binding proteins for the formation of actin-rich plasma membrane 
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protrusions necessary for migration and invasion (Kozma et al., 1995; Nobes 
& Hall, 1995a; Nobes & Hall, 1995b; Nobes & Hall, 1999).  Formation of 
these protrusive structures is a highly dynamic process tightly regulated by a 
network of actin-binding proteins.  Key actin-binding proteins associated with 
the formation of protrusive structures include the Wiskott–Aldrich Syndrome 
Protein (WASP) family of proteins, the Arp2/3 complex, cofilin, cortactin, 
gelsolin and members of the gelsolin superfamily of proteins (Chellaiah et al., 
1998; Chellaiah et al., 2000; Jones et al., 2002; Yamaguchi & Condeelis, 
2007; Yilmaz & Christofori, 2009). 
Lamellipodia are flat, sheet-like membrane protrusions formed at the 
leading edge of migrating cells (Friedl & Gilmour, 2009; Yap et al., 2005).  
Lateral branching of actin filaments and actin assembly in lamellipodia 
requires generation of free barbed ends of actin filaments.  These functions are 
carried out by Arp2/3 complex, N-WASP, gelsolin and cofilin.  Lamellipodia 
are known to generate the force required for cell migration.  Formation of 
lamellipodia requires interaction of the cell with the ECM via cell surface 
receptors such as the integrins.  A thin, rod-like projection composed of 
bundled, cross-linked actin filaments originate from the edge of lamellipodia.  
This projection is called the filopodium.  Filopodia are believed to act as 
sensors for lamellipodia to detect chemoattractants or nutrients released from 
blood vessels.  Metastatic cells are rich in filopodia-like structures which 
correlate with their invasiveness.  However, the exact mechanisms underlying 
filopodia formation is not clearly understood.  Lamellipodia and filopodia are 
mostly associated with cell movement on a 2-dimensional (2-D) surface 
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(Chellaiah et al., 2000; Yamaguchi & Condeelis, 2007; Yilmaz & Christofori, 
2009). 
Invadopodia and podosomes are actin-rich ventral membrane 
protrusions associated with cancer cell invasion and metastasis.  They are 
coupled with proteolytic cores that enable them to degrade the ECM.  
Secretion of proteases such as Membrane type 1-matrix metalloproteinase 
(MT1-MMP) by invadopodia provides advantage for degradation and 
migration in a dense rigid 3-dimensional (3-D) ECM environment (Chen, 
1989; Ridley, 2011; Weaver, 2006).  Formation of invadopodia and 
podosomes involves recruitment of a network of molecules including actin and 
actin regulatory proteins (cofilin, fascin, cortactin, WASP, gelsolin), signalling 
proteins (Rac1, Src), proteases (Membrane-type MMP-1) and the ROS-
producing enzyme NADPH oxidase (Nox) (Chellaiah, 2006; Clark & Weaver, 
2008; Clark et al., 2007; Gianni et al., 2010a; Li et al., 2010; Machesky & 
Insall, 1998; Machesky & Li, 2010; Yamaguchi et al., 2005; Yu et al., 2012).  
Recently ROS have also been suggested to promote invadopodia formation 
(Diaz & Courtneidge, 2012; Diaz et al., 2009; Gianni et al., 2010a; Gianni et 
al., 2010b).  Cell migration and invasion driven by actin-rich protrusions on a 







Figure 1.4.  Actin-rich membrane protrusion-mediated cell migrations in 
different environment. Lamellipodia and filopodia are formed at the leading edge of 
migrating cells on a 2-D substrate.  Invadopodia and podosomes are formed at the 
invading front on the ventral side of the cell.  Invadopodia and podosomes are 
equipped with the ability to degrade the ECM which allows cells to enter and migrate 
through the 3-D ECM environment.  Migration and invasion via membrane 
protrusions are directed by regulation of the actin cytoskeletal dynamics.  Cancer 
cells express high levels of proteins involved in the formation of actin-rich 
protrusions associated with increased migratory and invasive potential.  Arrows 







Gelsolin is a 82 kilodalton (kDa) multi-functional protein well known 
for its actin-binding property.  Gelsolin is the founding member of the gelsolin 
superfamily of actin binding proteins which consist of six other members 
namely — capG, villin, supervillin, adseverin, advillin and flightless 1.  All 
members of the gelsolin superfamily contain three or six homologous repeats 
of the gelsolin-like domains with binding sites for actin.  Gelsolin is the best 
characterised actin-regulatory protein in this family (Silacci et al., 2004).  
Gelsolin regulates actin dynamics by severing, capping and nucleating actin 
filaments (Burtnick et al., 1997), thereby playing important roles in actin 
cytoskeletal organisation, cell migration, invasion, morphogenesis and 
apoptosis (Arora & McCulloch, 1996). 
Three naturally occurring isoforms of gelsolin have been identified to 
date.  These consist of two cytoplsmic forms (cytoplasmic gelsolin and 
gelsolin-3) and plasma gelsolin (Kwiatkowski et al., 1986; Vouyiouklis & 
Brophy, 1997; Yin et al., 1984).  Cytoplasmic and plasma gelsolin are splice 
variants of the same gene.  Plasma gelsolin contains an extra 25 amino acid at 
the N-terminus which serves as a signal peptide for secretion (Kwiatkowski et 
al., 1986).  Gelsolin-3 varies from cytoplasmic gelsolin in that it contains an 
additional 11 amino acid at the N-terminus (Vouyiouklis & Brophy, 1997). 
Cytoplasmic gelsolin is the most abundant form of intracellular 
gelsolin with its functions being implicated in many cellular processes 
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including cell migration and invasion, apoptosis, platelet formation and 
development (Silacci et al., 2004; Spinardi & Witke, 2007).  Although 
cytoplasmic and plasma gelsolin differ in terms of localisation, they share a 
common principal function of regulating actin severing.  In fact, gelsolin is 
one of the most potent and well characterised actin severing proteins identified 
to date.  Plasma gelsolin plays an important function in scavenging actin 
debris from the circulation released during apoptosis or necrotic cell death.  
Mutated plasma gelsolin is one of the causes of amyloidosis, a disease induced 
by protein aggregation (Li et al., 2012; Maury, 1991).  Gelsolin-3 is found in 
the cytoplasm of oligodendrocytes in the brain, lungs, and testis.  Gelsolin-3 is 
known to be associated with myelin formation and central nervous system 
(CNS) formation (Silacci et al., 2004; Vouyiouklis & Brophy, 1997). 
1.2.2 Interaction between gelsolin and actin — structure to function 
relation 
The regulation of actin cytoskeletal dynamics is central for the 
maintenance of cell rigidity, locomotion and cellular homeostasis.  Actin-
binding proteins such as gelsolin are crucial in regulating the actin cytoskeletal 
dynamics.  Gelsolin is activated by an intracellular rise in calcium (Ca
2+
) 
concentration and negatively regulated by binding with polyphosphoinositide 
4,5-bisphosphate (PIP2) (Janmey & Stossel, 1987; Yin & Stossel, 1979; Yin & 
Stossel, 1980; Yin et al., 1980).  The actin-regulatory activity of gelsolin is 
attributable to its structural and domain rearrangement.  Gelsolin consists of 
six domains which are arranged as two tandem homologous halves, each 
containing a 3-fold segmental repeats (Kwiatkowski et al., 1986) (figure 1.5).  
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Domains G1-G3 constitute the N-terminal half, while domains G4-G6 make 
up the C-terminal half.  The N (G1-3) and C (G4-6)-terminals are connected 
by a linker that contains cleavage site for caspase-3.  Isolated N-half has been 
shown to sever actin in the absence of Ca
2+
 activation.  However, Ca
2+
 is 
essential for activation of full length gelsolin that involves a fine cooperation 
between the N-and C-terminal halves (Burtnick et al., 1997; Burtnick et al., 
2004). 
Protein crystallography studies suggested that each domain in gelsolin 
possesses calcium binding site allowing the recriumtment of up to six Ca
2+
ions 
(Burtnick et al., 1997; Choe et al., 2002; McLaughlin et al., 1993; Pope et al., 
1995).  However, due to the relatively lower concentration of Ca
2+
 inside the 
cell, it has been proposed that binding of two to three Ca
2+
 ions may be 
sufficient to induce the intracellular actin-severing ability of gelsolin (Burtnick 
et al., 1997). 
 
Figure 1.5.  Gelsolin structure to function domains.  Gelsolin consists of six 
domains, G1-G6.  Gelsolin is regulated by Ca
2+
 (green squares) and PIP2 (blue ovals) 
binding.  The isolated domain G1 contains severing activity, while domains G1-3 
possess the capping activity.  Studies have identified three actin-binding sites (red 
ovals), six Ca
2+
 binding sites, one PIP2 binding site and a caspase-3 cleavage site 
(blue arrow).  Figure is adapted and modified from Spinardi and Witke, 2007; and 
Sun et al., 1999. 
16 
 
At resting stage, gelsolin forms a compact closed structure that opens 
upon Ca
2+
 activation, allowing gelsolin to bind to actin filament (figure 1.6).  
The domain G6 of the C-terminus contains a short helix tail that latches back 
to G2 of the N-terminus that blocks the actin binding region of the N-half, this 
model is known as the ―tail latch hypothesis‖ (Burtnick et al., 2004; Choe et 
al., 2002).  However, Ca
2+ 
binding induces a conformational change that opens 
up gelsolin and releases the G6 tail bound to the N-half, exposing the actin 
binding regions on the N-half of G2.  This domain rearrangement can then 
direct the binding and positioning of gelsolin to actin to induce severing and 
subsequently cap the fast growing end.  Capping makes severing very 
effective because it prevents annealing of the filament.  Furthermore, severing 
creates a number of polymerisation-competent ends that act as sites for actin 
polymerisation once gelsolin is released from the barbed ends (Sun et al., 
1999).  Polymerisation resumes when PIP2 interacts with and detaches gelsolin 
from the barbed end of the actin filament (Janmey & Stossel, 1987).  
Uncapping of actin leads to rapid reassembly of actin without a lag time and 
enhancing actin polymerisation.  Thus, gelsolin modulates actin filament 
assembly and disassembly which constitutes an important part in the dynamic 
regulation of the actin cytoskeleton.  In addition, it has been suggested that 
gelsolin can promote actin nucleation by binding to two actin monomers to 






Figure 1.6.  Schematic diagram showing gelsolin binding, severing and capping 
of an actin filament.  Gelsolin forms a compact closed structure at resting stage.  
Upon Ca
2+ 
trigger, gelsolin opens up and binds to and severs actin filament.  After 
severing, gelsolin caps the fast growing end and prevent it from polymerisation.  
However, when PIP2 binds to gelsolin, it induces a conformational change and 
releases gelsolin from actin.  Figure is adapted and modified from Sun et al., 1999. 
 
1.2.3 The role of gelsolin in cell motility: evidence from in vivo studies 
Studies using gelsolin null animals have established the importance of 
gelsolin in motility, survival and several other fundamental cellular processes 
(Azuma et al., 1998; Endres et al., 1999; Lu et al., 1997; Witke et al., 1995).  
Gelsolin-null fibroblasts showed reduced cell motility and increased actin 
stress fibers, a phenotype related to defective actin cytoskeletal remodelling 
(Azuma et al., 1998).  Gelsolin has been shown to function as a downstream 
effector of Rac, a regulator of membrane ruffle formation.  Rac 
overexpression has been observed as a compensatory mechanism for the loss 
of gelsolin.  Translocation of Rac is required for the formation of membrane 
ruffles and membrane protrusions.  Although Rac translocates to the 
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membrane in response to epidermal growth factor (EGF), cell motility, 
membrane ruffle and lamellipodia formation are impaired in the absence of 
gelsolin suggesting that Rac requires gelsolin to carry out its function in cell 
motility (Azuma et al., 1998).  Gelsolin knockout animals also showed defects 
associated with reduced chemotaxis, wound healing, blood clotting, and 
impaired neurite retraction (Lu et al., 1997; Maniatis et al., 2009; Oikonomou 
et al., 2009; Witke et al., 1995). 
In addition, evidence from animal models also demonstrates the 
importance of gelsolin in survival.  Gelsolin-knockout mouse in a pure strain 
background died during birth or shortly after birth indicating the importance of 
gelsolin for survival (Kwiatkowski, 1999).  However, gelsolin-null animals in 
a mixed background survive without major phonotypic effects which suggests 
the presence of compensatory mechanisms for survival. 
1.2.4 Gelsolin-mitochondrial association 
In addition to its localisation in the cytosol, gelsolin has been detected 
in an isolated mitochondrial fraction (Koya et al., 2000; Kusano et al., 2000).  
By interacting with the mitochondria, gelsolin can function as a negative 
regulator of apoptosis.  Overexpression of full length gelsolin has been shown 
to confer anti-apoptotic properties by blocking cytochrome c release from the 
mitochondria and preventing mitochondrial membrane potential loss.  Gelsolin 
also physically binds to voltage dependant anion channel (VDAC), thereby 
blocking VDAC activity as well as its subsequent downstream activities.  
Besides interacting with mitochondrial components, gelsolin in complex with 
PIP2 was also found to inhibit apoptosis by inhibition of caspase-3 and -9 
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activities (Azuma et al., 2000; Klampfer et al., 2005; Kusano et al., 2000; 
Ohtsu et al., 1997).  The exact mechanism by which gelsolin translocates to 
the mitochondria and how it regulates mitochondrial apoptotic pathways are 
not well understood.  Gelsolin has also been shown to have a neuroprotective 
role against Alzheimer’s disease by enhancing the mitochondrial activity 
(Antequera et al., 2009).  Overexpression of gelsolin enhances the activity of 
complex IV of the mitochondrial electron transport chain (ETC) leading to a 
reduction in nitric oxide and reduced cell death.  On the other hand, due to the 
presence of the caspase-3 celavage site, gelsolin also serves as an effector 
molecule for caspase-3 mediated apoptosis.  The N-terminal half of gelsolin 
loses the Ca
2+
 regulatory component acquiring an unregulated actin-severing 
capacity.  Uncontrolled actin severing disrupts the integrity of the actin 
cytoskeleton, thus facilitating the apoptotic cell death signalling cascade 
(Geng et al., 1998; Kothakota et al., 1997). 
1.2.5 Gelsolin in cancer 
The role of gelsolin in cancer has been long been a topic of debate.  
Gelsolin has often been regarded as a tumour suppressor due to its 
downregulation in several cancer whilst overexpression of gelsolin leading to 
aggressive behaviours is also observed in a number of studies (Li et al., 2012). 
Tumour-suppressive functions of gelsolin 
Gelsolin is found to be downregulated during the carcinogenesis of 
breast (Asch et al., 1996; Winston et al., 2001), colon (Gay et al., 2008), 
stomach (Moriya et al., 1994), bladder (Tanaka et al., 1995), prostate (Lee et 
al., 1999b), lung (Dosaka-Akita et al., 1998) as well as in transformed human 
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fibroblast and epithelial cells (Vandekerckhove et al., 1990).  Studies have 
suggested that epigenetic regulations may play a role in the loss of gelsolin in 
breast cancer (Mielnicki et al., 1999).  The mRNA transcript of gelsolin was 
found to be downregulated in breast cancer carcinoma.  The downregulation of 
gelsolin could be due to transcriptional repression whereby activating 
transcription factor 1 (ATF-1) repressed gelsolin promoter by binding to 
gelsolin negative regulatory element site (Dong et al., 2002).  Consistent with 
this, the transcription factor Sp1 has also been implicated to play a role in 
downregulating the expression of gelsolin in human bladder cancer cells 
(Haga et al., 2004).  Transcriptional repressors such as histone deactelyase 1 
(HDAC-1) and DNA methylatransferases have been suggested to participate 
in silencing gelsolin expression in certain types of cancer including breast 
(Mielnicki et al., 1999), cervix (Han et al., 2000), gastric (Kim et al., 2004), 
and urinary bladder (Haga et al., 2004).  In line with these findings, 
upregulation of gelsolin expression has been observed in several human cancer 
cells after treatment with HDAC inhibitors (Hoshikawa et al., 1994; Mielnicki 
et al., 1999; Noske et al., 2005). 
Post-translational modification of gelsolin protein has also been found 
to downregulate gelsolin protein levels in pancreatic cancer cells (Ni et al., 
2008).  Gelsolin undergoes ubiquitin-mediated proteosomal degradation 
leading to decreased gelsolin levels.  Interestingly, when pancreatic cancer 
cells were treated with proteosome inhibitor lactacycti, it induces gelsolin 
expression.  Moreover, analyses of human pancreatic tissues show high 
correlation between high gelsolin poly-ubiquitination and lower gelsolin 
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expression.  Thus, this study shows that proteosomal degradation accounts for 
the loss of gelsolin in human pancreatic cancer (Ni et al., 2008). 
Although no major chromosome rearrangement or mutations were 
observed in the studies conducted Asch et al.., (Asch et al., 1996), point 
mutation at codon 321 of gelsolin has been identified in the Ras-transformed 
NIH3T3 cells (Mullauer et al., 1993).  This mutation occurred due to the 
replacement of cytosine by alanine, leading to a single amino acid substitution 
of proline to histidine referred to as the gelsolin variant His321.  Gelsolin 
His321 variant is found in domain G3 of the N-half region of gelsolin.  As the 
N-half is important for actin severing, it is conceivable that this point mutation 
may cause impaired actin severing and contributes to tumour suppression. 
An important point to note is that in gelsolin-null mouse, loss of 
gelsolin itself does not lead to tumour formation.  Therefore, the tumour 
suppressive role of gelsolin may result from other upstream factors that 
regulate gelsolin such as epigenetic alterations, post translational 
modifications and mutations in the gelsolin gene (Spinardi & Witke, 2007). 
Tumour-promoting functions of gelsolin 
Although gelsolin has been implicated to be a tumour suppressor, a 
significant amount of studies have also suggested the tumour-promoting 
functions of gelsolin.  In the clinical set up, high gelsolin expression has been 
linked to bigger tumour size, invasive phenotype and poor patient outcome.  
Moreover, the expression of gelsolin in cancer has been proposed to display a 
biphasic expression pattern where gelsolin was found to be downregulated at 
the premalignant stage and upregulated at the more aggressive and malignant 
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stage (Gay et al., 2008; Rao et al., 2002; Shieh et al., 2006; Shieh et al., 1999; 
Thompson et al., 2007; Thor et al., 2001).  In oral squamous cell carcinoma, 
high gelsolin expression in patients correlates with metastatic disease (Shieh et 
al., 2006).  Consistent with this, gelsolin expression was found to be low in 
the primary colon adenocarcinoma (Gay et al., 2008) whereas gelsolin 
expression was observed to be high at the invasive front of liver metastases 
(Zhuo et al., 2012).  In a subset of breast cancer gelsolin expression was found 
to be associated with the overexpression and activation of the receptor tyrosine 
kinases epidermal growth factor receptor (EGFR) and erbB-2 and this 
association was further correlated to aggressive phenotype (Thor et al., 2001).  
Gelsolin has also been found to be highly expressed in cervical cancer tissue 
when compared with the adjacent normal tissue (Liao et al., 2011). 
Gelsolin in cancer cell invasion 
It has been established that changes in gelsolin levels have profound 
effects on cell motility.  In vitro and in vivo experiments have shown that 
overexpression of gelsolin enhanced cell migration and invasion whilst loss of 
gelsolin resulted in decreased motility and invasion (Azuma et al., 1998; 
Cunningham et al., 1991; De Corte et al., 2002; Van den Abbeele et al., 
2007).  Because gelsolin is an actin regulatory protein, a number of gelsolin-
mediated motility is linked to its function in modulating actin cytoskeletal 
dynamics (Litwin et al., 2009; Litwin et al., 2012; Radwanska et al., 2012).  In 
line with this, a recent study suggests the involvement of gelsolin in enhancing 
cancer cell migration and invasion in the colon adenocarcinoma cell line 
LS180 (Litwin et al., 2012).  Here, the authors show that increased gelsolin 
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expression leads to its translocation to the membrane.  Once at the membrane, 
gelsolin associates with the actin cytoskeleton, leading to a decrease in the 
actin filament to monomeric actin ratio, which could result in the increased 
migratory ability observed (Litwin et al., 2012).  Another member of the 
gelsolin superfamily, supervillin is also known to play a role in invasion.  
However it has been observed that the supervillin exhibits its pro-invasive 
function in a gelsolin-dependent manner (Crowley et al., 2009) which further 
evidences the centrality of gelsolin in invasion. 
As noted earlier, motile cells acquire structural changes such as 
lamellipodia and invadopodia (Ridley, 2011).  Gelsolin has been shown to 
play an important role in the EGF-induced cell migration by participating in 
the formation of lamellipodia (Chou et al., 2002).  The involvment of gelsolin 
in other forms of protrusions such as podosomes have been evidenced.  
Indeed, gelsolin has been shown to be crucial for podosome formation in 
osteoclasts, whereby deficiency of gelsolin inhibits podosomes formation 
(Chellaiah et al., 2000).   Invadopodia and podosomes are structurally related 
membrane protrusions that have been implicated in enhancing the invasion 
process by secretion of proteases (Chen, 1989; Ridley, 2011).  It is therefore 
tempting to speculate that gelsolin at the invading front may participate in 
proteolysis.  We have previously shown that gelsolin overexpression leads to 
the increased production and secretion of uPA thereby promoting invasion in 
colon cancer cells (Zhuo et al., 2012).  However, the mechanism by which 
gelsolin contributes to protease secretion is unclear. 
24 
 
1.2.6 Gelsolin interacts with signalling proteins  
Gelsolin has been documented to associate with several molecules 
involved in signal transduction pathway that favours cell migration and 
invasion.  The small GTPases, Ras and Rac are important mediators of cell 
motility that have been linked with gelsolin during migratory signalling 
events.  Invasion mediated by gelsolin rely on the upstream signalling events 
triggered by Ras that acts through the Phosphatidylinositide 3-kinases (PI3K) 
– Rac pathway (De Corte et al., 2002).  Gelsolin-mediated membrane ruffling 
and regulation of collagen phagocytosis is also influenced by signalling 
pathways triggered in response to extracellular stimuli such as the EGF (Arora 
et al., 2004; Azuma et al., 1998; Chou et al., 2002).  Moreover, gelsolin has 
also been shown to play a role in enhancing cell migration following erbB-
2/EGFR activation (Chen et al., 1996).  EGF enhances PIP2 hydrolysis by 
Phospholipase C γ (PLCγ), releasing gelsolin from its bound state to 
participate in actin cytoskeletal rearrangement.  Gelsolin is also involved in 
lipid metabolism and lipid signalling via its interactions with phospholipids 
such as Phospholipase C γ1 (PLCγ1) and phospholipase D (PLD) (Banno et 
al., 1992; Chellaiah et al., 1998; Chellaiah & Hruska, 1996; Finkelstein et al., 
2010). 
Formation of a focal contact point is a crucial step during cell 
adhesion.  Gelsolin has been found to form complexes with several focal 
adhesion proteins including the oncogenic Src, PI3K, p130Cas, focal adhesion 
kinase (FAK), vinculin, talin, paxillin and integrin αv β3.  As mentioned 
earlier, gelsolin participates in the formation of podosomes and podosomes are 
known to play important roles during cell adhesion.  Through its interaction 
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with focal adhesions proteins, gelsolin is involved in the remodelling of the 
actin cytoskeleton and podosome formation.  At the focal adhesion site, 
gelsolin has been shown to associate with the protein tyrosine phosphatase 
(PTP)-proline-glutamic acid-serine-threonine amino acid sequences (PEST), 
PTP-PEST.  As PTP-PEST is a negative regulator of receptor tyrosine kinase 
(RTK), (Chellaiah et al., 2001), association between gelsolin and PTP-PEST 
may result in activation of signalling pathways downstream of RTK. 
The dynamic nature of gelsolin shows its potential to interact with 
various other proteins that are important in fundamental cellular processes.  
Understanding the mechanisms of how gelsolin interact with these proteins as 
well as exploring other interacting partners of gelsolin may provide a better 
insight into how gelsolin promotes cancer cell migration and invasion. 
 
Figure 1.7. Gelsolin interacts with signalling molecules that favour cell migration 
and invasion.  Gelsolin is a downstream effector of the Ras-Rac PI3K pathway and 
also respond to EGF trigger.  Gelsolin is also found to form complexes with focal 
adhesion proteins that mediate the actin-rich podosome formation.  Figure is adapted 
and modified from Chellaiah et al.,2001 and Li et al., 2012. 
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1.3 REACTIVE OXYGEN SPECIES 
1.3.1 Introduction 
Reactive oxygen species are formed when molecular oxygen is 
incompletely reduced during cellular enzymatic reactions or during aerobic 
respiration.  In aerobic cells, ROS are mainly produced as a by-product of 
metabolic reactions (D'Autréaux & Toledano, 2007; Halliwell, 1996; Novo & 
Parola, 2008).  ROS comprise of several species that are either free radicals or 
non radicals as shown in Table 1. 




)  Hydrogen peroxide (H2O2) 
Hydroxyl (
.
OH) Hypochlorous acid (HOCl) 
Peroxyl (RO2.) Ozone (O3) 
Alkoxy (RO
.
) Singlet oxygen (
1Δg) 
Hydroperoxyl (HO2.)  
 
Table 1.1 Types of reactive oxygen species. Adapted from Halliwell, 1996.  
1.3.2 Sources of ROS 
As noted earlier, cellular ROS are generated by enzymatic or by non-
enzymatic reactions.  One of the principal enzymes that produces ROS is the 
nicotinamide adenine dinucleotide phosphate-oxidase, NADPH oxidase (Nox).  
Phagocytic or non-phagocytic Nox are membrane bound enzymes that 
generates ROS using cytosolic nicotinamide adenine dinucleotide phosphate 
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(NADPH) as an electron donor. Nox is a multi-complex protein that consists 
of membrane subunits (gp91phox and p22phox) and cytosolic proteins 
(p47phox, p67phox, p40phox).  Nox also consists of regulatory subunits such 
as small guanosine triphosphate (GTP)-binding protein Rac 1 and 2 
(Moldovan et al., 2006; Pervaiz & Clement, 2007). Other enzymatic sources 
include xanthine oxidases (XO), cyclooxygenases (COX), and lipoxygenases 
(LOX) (Gloire et al., 2006). 
Another important source of ROS is the mitochondrial ETC.  The ETC 
comprise of a number of four protein complexes (I-IV) in which a number of 
oxidation-reduction reactions take place.  ROS are mainly generated from 
complex I and III of the ETC.  Free electrons transferred across the ETC from 
complex I to IV is used in the reduction of O2 to water.  However, during the 
course of electron transfer, O2
-
are generated when electrons leak and react 
with ambient O2 (Cadenas & Davies, 2000).  O2
-
 is then converted to H2O2 by 
manganese superoxide dismutase (Mn SOD) in the mitochondria and by 
copper zinc superoxide dismutase (Cu/Zn SOD) in the cytosol (Fridovich, 
1995).  Subsequent reactions lead to the formation of other types of ROS. 
1.3.3 The antioxidant system 
Redox balance is necessary to maintain cellular homeostasis.  Because 
abnormal increase in intracellular ROS levels can impede the normal 
functioning of the cell, cells are equipped with antioxidant defense systems to 
eliminate excess ROS.  In mammalian cells, the antioxidant system include 
enzymatic (glutathione peroxidase, catalase, Cu/Zn SOD, Mn SOD, 
thioredoxin peroxidase and glutaredoxin) and non-enzymatic systems 
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(glutathione, carotenoids, vitamins C and E, and flavonoids) (Halliwell, 1996) 
as shown in Table 1.2.  After O2
- 
conversion to H2O2 by SODs, H2O2 is further 
detoxified to water by catalase, glutathione and thioredoxin peroxidases 
(Fridovich, 1978; Fridovich, 1995). 
Enzymatic antioxidant defense system  
Cu/Zn SOD (Copper Zinc SOD)       2 O2
- + 2 H+                H2O2 + O2 
Mn SOD (Manganese SOD)             2 O2
- + 2 H+                H2O2 + O2 
Glutathione peroxidase                     2GSH + H2O2               GSSG + 2H2O 
Catalase                                             2H2O2                            2H2O + O2 
Thioredoxin (Trx) peroxidase         Trx(SH)2 + H2O2              TrxS2 + 2H2O 
Non-Enzymatic antioxidant defense system  
Glutathione (GSH) – main thiol antioxidant and redox buffer of the cells 
Carotenoids 
α - tocopherol (Vitamin E) 
Ascorbic acid (Vitamin A) 
Flavoniods 
 
Table 1.2 Enzymatic and non-enzymatic antioxidant systems.  Compiled from 
Halliwell, 1996 and Sies, 1997. 
1.3.4 ROS – antioxidant imbalance and implications in cancer 
Under physiological conditions, cells maintain a fine balance between 
ROS levels and efficient antioxidant systems.  However, in pathological 
conditions including cancer, disturbance in the balance between ROS 
generation and antioxidant activities are often observed leading to a state of 
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oxidative stress (Halliwell, 2006; Sies, 1997).  Increased oxidative stress 
conditions have been observed in most cancer cells when compared to their 
normal cell counterparts (Kumar et al., 2008; Lee et al., 1999a; Szatrowski & 
Nathan, 1991).  Depending on the level of oxidative stress, cancer cells are 
differentially regulated.  At a milder sub-lethal conditions of oxidative stress, 
signalling pathways that offer growth proliferation, migration and invasion 
advantages are activated.  However, heightened oxidative stress levels fuels 
the cell death signalling pathways (Benhar et al., 2002; Gloire et al., 2006; 
Kang & Pervaiz, 2012; Mellier & Pervaiz, 2012; Nishikawa, 2008). 
Downregulation of the three major antioxidants Cu/Zn SOD, Mn SOD 
and catalase was detected in prostate cancer (Bostwick et al., 2000), whereas 
overexpression of Cu/Zn SOD, Mn SOD and catalase has been shown to 
inhibit growth and reduce aggressive behaviours in breast cancer cells 
(Glorieux et al., 2011; Weydert et al., 2006).  Studies using animal models 
have shown the importance of antioxidants during cancer development.  Mn 
SOD null animals die shortly after birth due to severe oxidant insult (Li et al., 
1995; Melov et al., 2001).  Although, heterozygous animals with 50% normal 
Mn SOD and a Cu/Zn SOD knockout mice could survive, these animals were 
susceptible to increased rates of liver cancer, lymphomas, adenocarcinomas 




1.3.5 ROS and cancer cell invasion 
ROS have been well known to participate in signalling mechanisms 
that lead to cancer cell migration, invasion and EMT by activating the MAPK 
pathway (Cannito et al., 2010; Wu, 2006a).  Intracellular ROS levels may rise 
due to aberrant mitochondrial action, impaired antioxidant activities or 
activation of cell surface receptors by growth factors (such as the receptor 
tyrosine kinase, RTK).  Binding of integrin to the ECM has also been shown 
to cause a mild oxidative burst by activation of LOX (Chiarugi et al., 2003; 
Taddei et al., 2007; Werner & Werb, 2002).  It is not well understood how 
activation of growth factor receptors lead to increased ROS levels.  This could 
likely be through activation of signalling molecules such as Rac, key regulator 
of non-phagocytic Nox enzymes (Brown & Griendling, 2009).  Signalling 
pathways that trigger ROS generation and the activation of downstream 
molecules leading to cancer cell migration, invasion and EMT are represented 
in figure 1.8. 
Protein kinase C (PKCs), an important activator of the MAPK pathway 
and the negative regulator of RTKs - the protein tyrosine phosphatases (PTPs) 
are two important signalling molecules targeted by ROS (Wu, 2006; Wu et al., 
2006).  The critical cysteine residues present in both PKCs and PTPs renders 
them susceptible to oxidative modification by ROS.  Oxidative modification 
of PKC activates the kinase whereas PTP is inactivated by ROS oxidation 
(Boivin et al., 2010; den Hertog et al., 2008; Salmeen & Barford, 2005).  
ROS-activated MAPK pathway can trigger the downstream transcriptional 
activation of AP-1, Ets-1, Snail, HIF-1α and NF-κB.  Activation of these 
transcriptional factors induces EMT-like features such as loss of cell polarity 
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and cell-to-cell contact that facilitate cancer cell dissemination as well as 
cancer cell invasion (Tochhawng et al., 2013).  In addition, activation of redox 
sensitive transcription factors also elevates the expression of the ECM-
degrading proteases, uPA and MMPs, thus enhancing cancer cell invasion 
(Kim et al., 2007b; Nelson & Melendez, 2004; Tobar et al., 2010b).  ROS 
have been shown to upregulate several MMPs and uPA in a number of cancer 
cells (Binker et al., 2009; Chiu et al., 2010; Khoi et al., 2012a; Kim et al., 
2007a; Pelicano et al., 2009). 
ROS have also been implicated in the enzymatic activation of MMPs 
via oxidative modification of the cysteine residue in the MMP molecule 
(Nelson & Melendez, 2004; Saari et al., 1992); however, whether ROS also 
regulate the enzymatic activity of uPA is not known.  In addition to increased 
gene transcription, ROS also aids in the stability of uPA and uPAR mRNAs 
(Tran et al., 2003a).  ROS have been shown to enhance the interaction 
between the uPA/uPAR mRNAs and the mRNA-stabilising Hu family of 
RNA-binding proteins (HuR) indicating the role of ROS in the post-
transcriptional control of uPA and uPAR.  Although the downstream targets 
and pathways of the ROS-mediated cancer cell invasion have been identified, 




Figure 1.8. Schematic diagram of ROS-triggered signalling pathways leading to 
cell migration and invasion.  Intracellular ROS may be generated from several 
sources including mitochondria, Nox and LOX as a result of interactions between 
growth factors - platelet-derived growth factor (PDGF)/ Vascular endothelial growth 
factor (VEGF) and cell surf ace receptors such as RTK and integrin assembly.  The 
ROS produced can activate the MAPK signalling cascade and NF-κB pathways 
leading to activation of target genes such as uPAs and MMPs.  Figure adapted and 




1.3.6 The actin cytoskeleton and ROS 
Evidence from several lines of studies have illustrated the relationship 
between the actin cytoskeleton and ROS.  ROS have often been implicated in 
the regulation of cellular processes that involve the actin cytoskelal dynamics 
leading to enhanced migration and invasion (San Martin & Griendling, 2010; 
Tochhawng et al., 2013).  Increased O2
-
 have been shown to stimulate Rac1 
activity resulting in enhanced actin polymerisation.  Accordingly, when O2
-
 
was scavenged by the antioxidants, diphenyleneiodonium (DPI) and MnTM 
PyP (manganese (III) tetrakis (1-methyl-4-pyridyl) porphyrin) growth of actin 
filament was abrogated (Moldovan et al., 1999).  These data suggest the 
participation of ROS in actin cytoskeletal dynamics. 
ROS have been shown to play a role during the formation of actin rich 
cell protrusions (Diaz & Courtneidge, 2012; Kim et al., 2009).  Actin-rich 
protrusions including lamellipodia, filopodia and invadopodia are induced by 
signalling molecules such as Rac, Rho and cdc42 (Kozma et al., 1995; Nobes 
& Hall, 1995a; Nobes & Hall, 1995b; Nobes & Hall, 1999).  Rac1 regulates 
Nox activity to generate ROS (Cheng et al., 2006; Miyano et al., 2006), 
demonstrating a possible regulation of actin cytoskeleton by ROS.  The actin 
binding protein cofilin is an actin depolymerising factor that plays an 
important role during lamellipodia formation (Lai et al., 2008; Yap et al., 
2005).  ROS have been suggested to activate cofilin during lamellipodia 
formation by stimulating the upstream regulators of cofilin, SSH and Slingshot 
1L (SSHL1) proteins (Kim et al., 2011; Kim et al., 2009).  ROS have also 
been found to be an important component of invadopodia (Diaz et al., 2009; 
Gianni et al., 2010a).  As mentioned earlier, Nox participates in invadopodia-
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induced cancer cell invasion in which ROS have been shown to play a critical 
role.  Tyrosine phosphorylation of two Src substrates, tyrosine kinase 
substrates 4 and 5 (Tks4 and Tks5) regulate the Nox-induced ROS production.  
The ROS generated in turn modulate Src activation, suggesting the existence 
of a positive feedback mechanism which regulates invadopodial formation 
(Diaz et al., 2009; Gianni et al., 2010a). 
ROS have been shown to directly oxidise monomeric (G-actin) as well 
as polymerized (F-actin) (DalleDonne et al., 1995; DalleDonne et al., 1999).  
Induction of ROS from integrin assembly has been shown to oxidise actin 
resulting in actin glutathionylation.  The resulting oxidised actin leads to cell 
spreading via regulating the actin-mysoin contractility (Fiaschi et al., 2006).  
Recently, a multidomain redox enzyme Molecule Interacting with CasL 
(Mical) has also been implicated in oxidising actin filaments leading to 
reduced actin polymerization (Giridharan et al., 2012; Hung et al., 2011). 
Although studies have shown the ROS regulation of actin cytoskeleton, 
other studies have also evidenced that actin assembly may be required for the 
generation of ROS.  Actin assembly has been shown to be required for O2
-
 
generation in eosinophils (Suzuki et al., 2003).  Nox activation requires the 
recruitment and assembly of its cytosolic components to the plasma 
membrane.  Actin-binding proteins such as cortactin (Usatyuk et al., 2007), 
WAVE1 (Wu et al., 2003) and moesin, a member of the ezrin/radixin/moesin 
(ERM) family (Zhan et al., 2004) have been shown to mediate the membrane 
translocation of the cytosolic component of Nox, p47 phox.  In addition, actin 
cytoskeleton was shown to stabilise Nox protein complex at the plasma 
membrane by acting as a scaffold (Granfeldt & Dahlgren, 2001).  The 
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involvement of actin and actin-associated proteins in ROS generation is 
largely understudied to date.  As ROS and the actin cytoskeleton and its 
associated proteins play important roles in cell migration and invasion, 
understanding the interaction between them would provide better insights into 




1.4 PURPOSE AND OBJECTIVES OF THE STUDY 
Actin cytoskeletal proteins including gelsolin are known to regulate 
cancer cell invasion (Azuma et al., 1998; Cunningham et al., 1991; De Corte 
et al., 2002; Van den Abbeele et al., 2007).  However, the mechanisms by 
which gelsolin promotes invasion have been poorly demonstrated.  
Interestingly, independent lines of studies have provided evidence that cancer 
cells generate increased levels of ROS as compared to their normal cell 
counterparts.  It has been shown that the increase in ROS levels observed in 
cancer cells could transform cells to become more malignant and possess 
invasive phenotypes (Kumar et al., 2008; Lee et al., 1999a; Szatrowski & 
Nathan, 1991).  Because ROS act as a second messenger in relaying signals 
and can interact with a number of other signalling molecules, ROS have been 
shown to promote tumourigenesis by amplification of tumour promoting 
signals (Wu, 2006b).  Amongst the many molecules that ROS interacts with, 
ROS have been shown to directly oxidise actin that in turn contributes to cell 
spreading, for instance, by increasing the acto-myosin contractility (Fiaschi et 
al., 2006).  On the other hand, evidence also suggests the requirement of actin 
assembly for ROS generation (Suzuki et al., 2003).  It is therefore conceivable 
that actin or actin-binding proteins such as gelsolin be involved in ROS 
generation and contributes to cancer cell invasion. In an attempt to dissect the 
mechanisms by which gelsolin promotes cancer cell invasion, we propose that 
gelsolin may be an important factor that modulates intracellular ROS levels 




The aims of this project are: 
1. To investigate whether gelsolin modulates intracellular ROS levels. 
2. To investigate if gelsolin promotes cancer cell invasion by 
modulating ROS levels in cancer cells. 
3. To determine if modulation of ROS levels by gelsolin influences 
extracellular matrix-degrading elements that promote invasion. 
4. To dissect the mechanisms by which gelsolin modulates 





















CHAPTER 2  MATERIALS AND METHODS 
2.1 MATERIALS  
2.1.1. Chemicals and Reagents  
All chemicals and reagents were obtained from the following sources: 
Abcam 
 Mouse monoclonal anti-gelsolin (ab11081) 
AIT Biotechnologies 
Table 2.1. Real-time PCR primers 
Nox1 forward 5'tatgaagtggctgtgctggt3' 
  reverse 3'gaggttgtggtctgcacactg5' 
Nox2 forward 5'tgttcagctatgaggtggtga3' 
  reverse 3'tcagattggtggcgttattg5' 
Nox4 forward 5'gctggaggcattggagtaac3' 
  reverse 3'accaacggaaggactggata5' 
Nox5 forward 5'actatctggctgcacattcg3' 
  reverse 3'acactcctcgacagcctctt5' 
Gapdh forward 5'tcaagaaggtggtgaagcag3' 
  reverse 3'tcgctgttgaagtcagagga5' 
 
Amresco 




Applied Biosystems  
 Taqman PCR primers for Cu/Zn SOD (Hs00533490_m1), Mn SOD 
(Hs00167309_m1), Glulatredoxin 2 (Hs00375015_m1), Catalase 
(Hs00156308_m1), Antioxidant Protein 1 (Hs00187841_m1) and 
GAPDH (Hs99999905_m1) 
BD Biosciences 
 Mouse Monoclonal anti-MnSOD (611580), BD Matrigel basement 
membrabe matrix (354234) 
BDH  
 Sucrose (10274), Mannitol (29148) 
Bioworld 
 Dithiothreitol (DTT) (40400120) 
Biorad 
 Biorad protein assay dye reagent (500-0006), Coomassie brilliant blue 
dye (161-0400) 
Calbiochem 
 Amiloride Hydrochloride (2016-88-8) 
Cell signalling technologies 




Enzo life Sciences 
 SOD activity assay kit (ADI-900-157) 
Fisher 
 Glycine (G/0800/60) 
Gibco 
 Geneticin G418 (10131-027), Opti-MEM (31985) 
Hyclone 
 Fetal bovine serum (SV30160.03) 
Invitrogen/ Molecular probes 
 CM – H2DCFDA (5-(and-6) - chloromethyl-2’,7’ – dichlorodihydro-
fluorescein diacetate acetyl ester) (C6827), Mitosox Red probe 
(M36008), Amplex® Red Hydrogen Peroxide/Peroxidase Assay Kit 
(A22188), Lipofectamine RNAiMAX transfection reagent (13778150), 
Lipofectamine 2000 (11668-019) 
Merck 
 Glycerol, Potassium hydroxide (KOH) (UN1813) 
Olink Biosciences 
 In situ Proximity Ligation Assay kit 
PAA Laboratories 




 siRNA against Cu/Zn SOD (SI02623481) 
QREC 
 Potassium chloride (KCl) (7447407) 
R&D Systems 
 uPA ELISA kit (DY1310) 
Roche 
 Cell proliferation ELISA, BrdU kit (colorimetric) (11647229001), 
Complete Protease inhibitor cocktail tablets (05-872-988-001), 
Phosphatase inhibitor cocktail (04-906-837-001) 
Santa Cruz Biotechnologies 
 Rabbit polyclonal anti-copper chaperone for Cu/Zn SOD (sc-20141), 
Mouse monoclonal anti-GAPDH (sc-32233), Goat anti-rabbit IgG 
conjugated with HRP (sc-2004), Goat anti-mouse IgG conjugated with 
HRP (sc-2005), Protein A/G Plus Agarose Beads (sc-2003) 
Sigma Aldrich 
 Mouse monoclonal anti-β-actin (A2228), Diethylthiocarbamate (DDC) 
(71481), Dimethylsulfoxide (DMSO) (D2650), Diphenyleneiodonium 
chloride (DPI) (D2926), Bis-N-methylacridinium (Lucigenin) 
(M8010), Somatic ATP releasing reagent (FLSAR), Triton X-100, 
McCoy’s 5A modified medium (M4892), RPMI 1640 (R4130), 
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Dulbecco’s Modified Eagle’s Medium (D1152), Sodium deoxycholate 
(D6750), Sodium bicarbonate (NaHCO3) (S6297), Bovine serum 
albumin (A9418), Trypan blue dye (72-57-1), Pipes (P6757), 
Ammonium per sulfate (A3678), Crystal violet (C3886) 
Thermo Scientific 
 Super signal, West Dura, extended duration substrate (34076), 
stripping buffer (21059) 
Vivantis 
 Tris-Base (PR0612), 10X PBS (PB0344) 
1
st
 Base  
 siRNA against gelsolin, biotechnology grade water (Buf1180), Tris-
HCl (B10-1500), 10% SDS (Buf 2051) 
2.1.2 Cell lines  
HCT116, DLD-1, Caco-2 and RKO are human colon cancer cell lines 







2.2.1 Cell culture 
HCT116 was cultured in McCoy’s 5A modified medium (Sigma-
Aldrich); DLD-1 was cultured in RPMI 1640 (R4130, Sigma-Aldrich) and 
RKO was cultured in Dulbecco’s Modified Eagle’s Medium (Sigma-Aldrich).  
All media were supplemented with 10% fetal bovine serum (FBS) (Hyclone).  
Stable HCT116 cell lines overexpressing gelsolin C1 and C8 as well as empty 
vector control cells were grown in McCoy’s 5A medium with 500μg/mL 
Geneticin G418 (Gibco).  All cell lines were maintained at 37
o
C in a 
humidified incubator supplemented with 5% CO2. 
2.2.2 DNA transfection 
Stable transfection 
Stable cell lines overexpressing gelsolin have previously been derived 
from HCT116 cells in our laboratory (Zhuo et al., 2012).  Briefly, gelsolin 
cDNA was inserted into a plasmid encoding enhanced green fluorescence 
protein (EGFP) as well as Kanamycin resistance genes.  The plasmids were 
then transfected to HCT116 cells and subjected to antibiotic Genecitin (G418) 
selection.  Vector control cells were prepared by transfecting a plasmid 




2.2.3 siRNA Transfection 
The following siRNA duplex oligoribonucleotide were used for silencing 
target gene expressions: 
 siRNA gelsolin – target sequence  
AAACGUCCAAUCUUGUUGGAGCAGG (Invitrogen)  
 siRNA Cu/Zn SOD –target sequence  
CCATGCAGGTCCTCACTTTA (Qiagen) 
10nM of stealth siRNA duplex oligoribonucleotide were used to silence 
gelsolin and Cu/Zn SOD.  The siRNA complex was prepared by combining 
the desired amount of siRNA with Lipofectamine RNAiMAX transfection 
reagent (Invitrogen) in Opti-MEM reduced serum media (Gibco).  The siRNA 
complex was incubated for 20 minutes at room temperature before 
transfection.  The siRNA complex was then added to the cells in a drop-wise 
manner and incubated for four hours at 37ºC.  After the incubation period, 
transfection media were removed and replaced with complete media 
supplemented with 10% FBS.  Non-targeting siRNA control with medium GC 
content (Invitrogen) was used as a negative control for gelsolin and All star 
negative control siRNA (Qiagen) was used as control for Cu/Zn SOD. 
2.2.4 ROS measurements 
2.2.4.1  Lucigenin Assay 
Total intracellular superoxide (O2
-
) was measured using the 
chemiluminescence-based lucigenin method as described (Clement & 
Stamenkovic, 1996).  Briefly, cells were cultured in complete media under 
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normal growth conditions.  Cells were then harvested and cell pellets were 
lysed with 420µL of ATP-releasing agent.  400µL of lysate was immediately 
transferred to a glass tube chemiluminescence was monitored using a Berthold 
Sirius Luminometer.  Data were described as Relative Light 
Units/second/milligram of protein (RLU/s/mg protein).  The remaining 20µL 
lysate was used for Bradford Protein assay and used for normalizing RLU 
reading. 
2.2.4.2  Mitosox Red staining 
Mitochondrial O2
-
 was detected using Mitosox red, a fluorescent probe 
targeted to the mitochondria and highly susceptible to oxidation by O2
-
.  Cells 
were stained with Mitosox Red probe with a final concentration of 5µM at 
37°C for 30 minutes.  Excess dye was washed off with 1X PBS.  Cell pellet 
was then resuspended in serum free media and measurement was immediately 
carried out with flow cytometry at PE-Texas Red (510nm excitation) channel.  
Data were analysed using the Summit software 4.3. 
2.2.4.3  CM-H2DCFDA staining 
General ROS were assessed using CM-H2DCFDA probe.  Cells were 
stained with CM-H2DCFDA probe with a final concentration of 10µM at 37ºC 
for 30 minutes.  Excess dye was washed off with 1X PBS.  Cell pellet was 
then resuspended in serum free media and measurement was immediately 
carried out with flow cytometry at FL-1 (488nm excitation) channel.  Data 
were analysed using the Cell Quest Pro software. 
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2.2.4.4  Amplex Red 
Cells were harvested and whole cell lyatse was prepared using Triton 
X-100-based lysis buffer.  20µL of cell lysate was dispensed in a well of 96-
well plate (black plate) and Amplex Red reagent mix was added to the 
samples.  Fluorometric reading was immediately determined using Varioskan 
fluorometric reader.  Data was normalized to protein concentration. 
2.2.5 Trypan Blue Exclusion 
4x10
5 
Cells were seeded in a 12-well plate with or without without 
5µM Diphenyleneiodonium (DPI) in medium containing 1% FBS for 24 
hours.  Cells were detached from the wells and appropriate dilutions were 
made for cell counting.  The Trypan Blue dye and the diluted cell suspension 
was then with mixed in equal ratio. 10µL of this mixture was loaded onto a 
haemocytometer and the number of cells that did not take up the dye were 
counted. 
2.2.6 Matrigel Invasion Assay 
Matrigel invasion assay was performed using the BD Matrigel 
Basement Membrane Matrix (BD Biosciences).  Matrigel was thawed on ice 
overnight and cells for invasion were serum starved overnight in serum free 
media.  40µL of diluted matrigel (0.33mg/mL, diluted in chilled serum free 
media) was coated on 8μm pore size 6.5 mm diameter transwell filter 
membrane (Corning Costar).  The matrigel was allowed to polymerise at 37
o
C 
for 2 hours. 2 x 10
5
 cells with or without 5µM DPI were seeded on the upper 
chamber of the transwell on top of the matrigel layer.  Complete media 
containing 10% FBS was added to the lower chamber as a chemoattractant.  
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24 hours after incubation at 37
o
C, cells on the upper chamber were removed 
by cotton swabs while cells that have invaded through the matrigel and come 
out on the under-side of the membrane were fixed with 70% ethanol for 20 
minutes at room temperature and stained with 0.2% crystal violet for 30 
minutes at room temperature for visualisation.  Invaded cells were captured 
using Canon powershot A640 camera at 20X magnification for counting and 
2.5X magnification was used to represent the distribution of invaded cells in 
the entire well.  10 representative fields were captured per membrane and the 
numbers of invaded cells were manually counted and quantified using 
Metamorph or ImageJ softwares. 
2.2.7 Zymographic Assay 
Enzymatic activities of secreted uPA were determined by fibrin-
plasminogen zymography.  Cells were grown in serum-free medium with or 
without DPI for the desired time-points.  The conditioned media were 
normalised using cellular lysate and then combined with non-reducing 5X 
sample loading buffer (0.2M Tris-HCL pH 6.8, 30% Glycerol, 10% SDS and 
0.05% Bromophenol blue) and loaded onto 12% SDS-PAGE gel containing 
730µg/mL of human fibrinogen (Sigma-aldrich) and 20µg/mL human 
plasminogen (Sigma-aldrich).  After electrophoresis, gels were rinsed with 
distilled water twice and washed twice with chilled wash buffer (2.5% Triton 
X-100 and 50mM Tris-HCl pH 8.0) for 25 minutes with agitation.  The gels 
were then incubation at 37
o
C with incubation buffer (0.1M glycine buffer, pH 
8.0) for 16 hours with gentle agitation.  The gels were stained with Coomassie 
blue (0.05% Coomassie dye, 40% methanol, 10% acetic acid) for 2 hours at 
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room temperature, and destained with de-staining solution (30% Methanol and 
10% acetic acid) for 2 hours.  Areas of lysis appear as zones of clearance 
against the Coomassie blue-stained background.  Gels were placed on top of a 
light box and gel pictures were captured.  Gel pictures were further processed 
using Adobe Photoshop CS6. 
2.2.8 Bio-Rad Protein Assay 
Protein concentration was determined using the Bio-Rad Protein dye 
reagent, using Bovine serum albumin (BSA) (sigma) as the standard.  One part 
of the dye reagent was diluted with four parts of water and filtered.  10µL of 
protein sample diluted at 10-30X were incubated with 200µL of diluted dye 
reagents in a 96-well plate at room temperature for 5 minutes.  Absorbance 
was measured at 595nm using an ELISA plate reader. 
2.2.9 Superoxide dismutase (SOD) activity Assay 
SOD activity was measured using the calorimetric based SOD activity 




) is generated by the oxidation of xanthine by xanthine 
oxidase.  O2
-
 can reduce the tetrazolium salt WST-1 to WST-1 formazon, 
which gives a coloured product that is detectable at 450nm.  SOD in the 
sample dismutased O2
-
 generated, thereby reducing the conversion rate of 
WST-1 to WST-1-formazan.  Therefore, reduction of WST-1-formazan is a 
measure of SOD activity in the samples where the coluoration observed is 






 cells were washed with 1X PBS. Cells were detached by gentle 
trypsinization and transferred to a 15mL falcon tube and centrifuged at 1500 
rpm for 5 minutes.  Supernatants were discarded and cell pellets were washed 
with 1mL of ice-cold 1X PBS and transferred to 1.5mL Axygen microtubes on 
ice.  Cells were again centrifuged and supernatant was discarded.   Cells were 
suspended in 100 μL of cold 1X Cell Extraction Buffer (Triton x-100, SOD 
buffer, and protease inhibitor).  Cell suspensions were incubated on ice for 30 
minutes with periodic vortexing (every 10 minutes).  The disrupted cell 
suspensions were micro centrifuged at 10,000g for 10 minutes at 4ºC to 
remove insoluble material.  The supernatants were recovered in a fresh tube 
pre-chilled on ice.  Protein concentration of the cleared cell lysate was 
determined using Bradford Protein assay.  Cell lysates were either stored in 
small aliquotes at -80ºC or immediately used for assaying SOD activity.  20 
µg protein was used for per well which was diluted with distilled water to 
make up to a volume of 25μL.  Each sample was pipetted in triplicate to a 
clear bottom 96-well plate.  SOD standards from 0 Unit (buffer alone) to 20 
Units were prepared by diluting purified SOD protein in SOD buffer, and 
25μL of each standard unit was pipette in duplicate to the bottom of the well.  
150μL of Master Mix (WST-1 and Xanthine oxidase) was pipetted into each 
well using a multichannel pipette.  The reaction was then initiated by adding 
25μL of 1x Xanthine Solution to all the wells using a multichannel pipet.  The 
plate was immediately transferred to a microtiter plate reader and absorbance 




2.2.10 Western Blotting 
2.2.10.1  Whole cell lysate preparation 
Cells were harvested by gentle trypsinisation.  Cell were washed once 
with chilled 1X PBS and pelleted followed by lysis with 1X 
radioimmunoprecipitation assay (RIPA) buffer (50mL Tris-HCL pH 8.0, 
150mM NaCl, 0.5% Sodium deoxycholate and 1% NP-40) supplemented with 
protease inhibitors (Roche Complete protease inhibitor cocktail).  Lysis was 
carried out by gently rocking the tubes at 4ºC for 30 minutes and 
microcentrifuged at 14,000g for 12 minutes at 4ºC to remove insoluble 
material.  The supernatants were recovered in a fresh tube pre-chilled on ice.  
Cell lysates were aliquoted and stored at -20ºC.  Protein concentration was 
determined using Bradford Protein Assay.  Equal amount of samples were 
loaded into each well for Western blot analysis.  Housekeeping protein, β– 
actin or GAPDH were used to assess equal loading. 
2.2.10.2  Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE)  
SDS-PAGE gel electrophoresis was carried out using the Bio-Rad 
Powerpack system.  The resolving gels used in the study (10, 12 and 15%) 
were prepared with 1.5M Tris HCl, pH 8.8, 10% SDS, 30% bis - acrylamide, 
and were polymerised by adding ammonium persulphate (APS) (the source of 
free radical) and  N, N, N’, N’- tetramethyl – ethylenediamine (TEMED) (the 
catalyst that catalyses the decomposition of the persulphate ion to generate 
free radical).  A 4% stacking gel was used and was prepared with 1.0M Tris – 
HCl, pH 6.8, 10% SDS (w/v), 30% bis - acrylamide and polymerised with 
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APD and TEMED.  For routine protein gel electrophoresis, protein samples 
were mixed with ¼ parts of 5X SDS sample loading buffer and were heated at 
95ºC for 5 min before loading into the gels.  For non-reducing gel 
electrophoresis (Zymography), protein samples were mixed with SDS sample 
loading buffer without the reducing agent.  Protein samples were heated at 
95°C for 5 minutes before loading into the gel.  Electrophoresis was carried 
out as described above. 
SDS – PAGE resolved proteins were transferred onto activated 
polyvinylidene difluoride (PVDF) membrane (dipped in 100% methanol for 
15 seconds followed by incubation in distilled water for 2 minutes with 
agitation at room temperature.  Electroblotting was conducted using the Bio-
Rad Powerpac system at 350mA for 1 hour at 4ºC.  
2.2.10.3 Immunodetection 
After transfer, PVDF membrane was incubated with blocking buffer, 
5% w/v milk (Blocking grade milk, Bio-Rad) in 1X TBST (20mM Tris – HCl, 
pH 7.6, 137mM NaCl, 0.1% Tween 20) for 1 hour at room temperature.  After 
blocking, the membrane was incubated with the relevant primary antibodies 
(diluted in 5% milk w/v in 1X TBST or 5% BSA w/v in 1X TBST) and 
incubated overnight at 4ºC with gentle shaking.  Unbound primary antibodies 
were washed off with 1X TBST (repeated 3 times, 7 minutes each with 
vigorous shaking).  The membrane was incubated further with the respective 
horse radish peroxidase conjugated secondary antibodies in 5% milk with 
gentle shaking for 1 hour at room temperature.  Unbound secondary antibodies 
were again washed off with 1x TBST (repeated 3 times, 7 minutes each with 
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vigorous shaking).  The resulting immunocomplexes formed were detected 
using chemiluminescence substrate (Thermo Scientific, West Dura, Super 
signal extended duration substrate).  For re-probing of the same membrane for 
different proteins, the membrane was incubated with stripping buffer for 5 
minutes at room temperature.  Membranes were rinsed once with 1X PBST for 
5 minutes with agitation at room temperature.  Stripped membranes were re-
probed with the respective primary and secondary antibodies as mentioned. 
2.2.11 Immunoprecipitation 
Cells were harvested from 70-80% confluent 10cm plates.  Plates were 
washed with chilled 1X PBS for 3 times, and cells were lysed on the plate 
using 80µL of modified RIPA buffer (5M Nacl, 1M Tris-HCL, pH 8.0, 0.5M 
EDTA, 1% Triton X-100, 0.1% Sodium deoxycholate and protease inhibitors).  
Cells were then detached from the plate by gently scraping and detached cells 
were then transferred to a pre-chilled 1.5mL eppendorf tubes.  Lysis was 
carried out by incubating the tube on a 360º rotator at 4ºC for 30 mins and the 
cleared lysate was obtained by centrifugation at 10,000g at 4ºC for 10 minutes.  
500µg of the protein lysate was then subjected to pre-clearing.  
Pre-clearing 
500µg of lysate was mixed with 20µL of beads (Protein A/G PLUS 
Agarose Beads, Santa cruz ) in a 1.5mL eppendorf tube.  The volume was 
adjusted to 150µL with the modified RIPA buffer and incubated on a 360° 
rotator at 4°C for 1 hour.  Pre-cleared lysate was then obtained by spinning 
down at 10,000g at 4ºC for 10 minutes.  The supernatant that contains the pre-
cleared lysate was retained and mixed with 20µL of beads that have been 
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conjugated with 2µg of primary antibodies (Gelsolin or Cu/Zn SOD) or 2µg of 
Mouse IgG control antibody (used as a negative control). 
Beads-antibody conjugation 
20µL of beads was mixed with 2µg of primary antibodies and volume 
was made up to 150µL with RIPA buffer and incubated on a rocker at 4°C for 
4 hours.  Beads conjugated with antibody were obtained by spinning down 
10,000g at 4ºC for 10 minutes. 
The pre-cleared lysate and the antibody conjugated to the beads were 
combined in a 1.5mL epperdorf tube.  The final volume was adjusted to 
500µL with the modified RIPA buffer and the mixture was incubated on a 
360° rotator at 4°C overnight.  The pulled down material was then washed for 
four times using the modified RIPA buffer.  After the final wash, the beads 
containing the pulled down material was boiled with sample loading buffer 
and spun down at 10,000g for 2 minutes.  The supernatant was loaded onto a 
SDS-PAGE gel. 
2.2.12 Isolation of intact mitochondria and cytosolic fraction 
Cells were grown to 70% confluence in two 10cms tissue culture 
dishes to obtained approximately 25x106 cells.  The dishes were washed twice 
with 10mL of cold 1xPBS.  150µL of Mitochondrial extraction buffer 
(200mM mannitol, 68mM sucrose, 50mM Pipes-KOH (pH 7.4), 50mM KCl, 
5mM EGTA, 2mM MgCl2 and1mM dithiothreitol), containing protease 
inhibitors (protease inhibitor cocktail, ROCHE) and was added to the dishes 
and cells were detached by scraping.  The detached cells were transferred to 
1.5mL Axygen tubes and incubated on ice for 20 minutes.  After incubation, 
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the cells were homogenized with a dounce homogenizer and passaged for 30 – 
40 strokes followed by centrifugation at 300 g for 10 minutes at 4ºC. The 
supernatant was transferred to a fresh 1.5mL Axygen tubes and centrifuged at 
12000g for 30 min at 4ºC. The pellet contains the intact mitochondrial 
fraction. The supernatant was again centrifuged at 25,000g for 45 minutes to 
obtain a clear supernatant which contains the cytosolic fraction. 
2.2.13 Sandwiched Enzyme-linked immunosorbent assay (ELISA) 
Cells were plated at a density of 3 x 10
5 
well in complete media in a 12 
well-plate format.  Cells were serum starved using serum free media with or 
without 5µM DPI for the desired time-points.  Conditioned media as well as 
cell lysates were harvested and stored at -20
o
C until analysis by ELISA. 
Amount of supernatants to be used for ELISA analysis was quantified by 
using an inverse ratio from the intracellular protein concentration (determined 
from the harvested lysate using Bradford Protein Assay).  ELISA was 
performed following standard sandwiched ELISA methods using the uPA 
DuoSet ELISA kit (R&D Systems).  A day before the experiment, ELISA 
plates were coated 100µL capture antibody, plates were sealed and incubated 
overnight.  Next day, wells were washed thoroughly (3-5 times) with 400µL 
of wash buffer, followed by blocking the plates with 300 µL Reagent Diluent 
(R&D Systems) for 1 hour at room temperature.  Wells were washed 3 times 
with 1X wash buffer (0.05% PBST).  100µL of samples were dispensed to the 
wells and incubated for 2 hours at room temperature.  Washing step was 
repeated for three more times.  100µL of a working dilution of Streptavidin-
HRP was added to each well; plates were covered and incubated for 20 
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minutes at room temperature.  This was followed by adding 100µL of 
substrate solution and again incubated for 20 minutes at room temperature.  
The reaction was stopped by adding 50µL of stop solution.  The optical 
density of each well was measured immediately, using ASYS UVM 340 
microplate reader at 450nm, using 570nm as reference wavelength. 
2.2.14 Real-time PCR 
2.2.14.1  RNA Extraction 
Total RNA was isolated from cells using RNeasy Mini Kit (Qiagen) 
following the manufacturer’s instructions.  Samples were lysed and 
homogenised by passing through a 20-gauge needle for twenty times.  Ethanol 
was added in a 1:1 ratio to provide ideal binding conditions before the lysates 
were loaded onto the silica membrane column.  The column was washed a few 
times using washing buffer to remove contaminants.  RNA was then eluted in 
30-50μl of RNase-free water.  Eluted RNA was treated with DNase to avoid 
DNA contamination.  The RNA concentration and quality was determined 




2.2.14.2 cDNA synthesis 
RNA samples were converted to cDNA for Real-time PCR 
applications.  6µg of total RNA was converted to cDNA per 20μL reaction 
using ImProm-II Reverse Transcription System reagents (Promega).  
Oligo(dT) primer (2μg RNA in 1μL Oligo (dt)) was added to RNA in 
nuclease-free water.  The reaction mix was heated at 70
o
C for 5 minutes for 
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target RNA and primer combination.  This reaction mix was immediately 
chilled on ice for 5 minutes before adding reverse transcription reaction mix 
(ImProm-II5X Reaction Buffer, 3mM MgCl2, 0.5mM dNTP Mix, 20 units of 
Recombinant RNasein Ribonuclease Inhibitor and ImProm-II Reverse 
Transcriptase).  The reaction mix was then incubated at 25
o
C for 5 minutes, 
42
o
C for 50 minutes for annealing and extension step respectively.  A no-
template (RNA) control was included.  The cDNAs were stored at -20
o
C until 
Real-time PCR analysis. 
2.2.14.3 Real-Time PCR 
Real-time PCR was performed using two platforms. 
1. ABI 7500 Fast Real-time PCR system: Real-time PCR carried out on 
the ABI 7500 Fast Real-time PCR system.  cDNA was added to a 
custom Taqman Gene Expression Assay comprising a primer and 
Taqman probe, and combined with Taqman Universal PCR Master 
Mix (ABI) according to manufacturer’s instructions.  The thermal 
cycling conditions were as follows: one cycle at 95
o
C for 10 minutes, 
followed by 40 cycles of denaturation at 95
o
C for 15 seconds and 
annealing extension at 60
o
C for 1 minute.  The primers used include 
Cu/Zn SOD, (Hs00533490_m1), Mn SOD (Hs00167309_m1), 
Glulatredoxin 2 (Hs00375015_m1), Catalase (Hs00156308_m1), 
Antioxidant Protein 1 (Hs00187841_m1) and GAPDH 
(Hs99999905_m1) was included as internal control. 
2. Roche- LightCycler 480 system: cDNAs was diluted with nuclease 
free water (1:3) and combined with LightCycler 480 SYBR Green 
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Master Mix.  The thermal cycling conditions were as follows: one 
cycle at 95
o
C for 15 minutes, followed by 40 cycles of denaturation at 
95
o
C for 30 seconds and annealing extension at 60
o
C for 30 seconds.  
Realtime PCR primers for Nox1, Nox2, Nox4, Nox5 and GAPDH 
were designed using Primer3 software (for sequence, refer to Table 
2.1).  All primers used here are obtained from AIT biotechnologies.  
2.2.15 In situ Proximity Ligation Assay 
In situ Proximity Ligation Assay was performed using the 563 Duolink 
detection kit (OLINK, Uppsala, Sweden) according to manufacturer’s 
instructions.  Briefly, 1 x 10
5
 cells were grown on a 12-cm coverslip for 24-36 
hours.  Cells were fixed with 4% parafolrmaldehyde for 20 mins followed by 
blocking using 5% BSA for 1 hour at room temperature.  Cells were then 
incubated with primiary antibodies against gelsolin (1:200 dilution) and Cu/Zn 
SOD (1:400 dilution) at 4°C overnight.  Primary antibodies were washed for 
2x using the wash buffer A (provided in the kit).  The cells were incubated 
with the PLA probes (secondary antibodies linked to oligonucleotides) at 37°C 
for 1 hour.  PLA probes were washed off using wash buffer A for 2x.  The 
oligonucleotides were then ligated using the ligation reaction mixture at 37°C 
for 30 minutes.  After washing off the excess ligation mixture, ligated product 
was amplified using the red fluorescent amplification reagent at 37°C for 100 
minutes.  Cells were washed with Wash buffer B (provided in the kit) for 3x 
and the coverslip was mounted onto a glass slide using mounting media 
(provided in the kit) containing DAPI to counterstain the nuclei.  Images were 
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captured using).  Images were captured using Olympus DP72 microscope and 
cellSens software at 60x magnification. 
2.2.16 Microscopy 
Cell counting and images for Invasion assay were obtained using Carl 
Zeiss Axiovert 40 CFL - Inverted Microscope and images were processed 
Image J and Adobe photoshop CS6.  Visualisation and images for the In situ 
Proximity Ligation Assay were processed using Olympus DP72 microscope 
and cellSens software. 
2.2.17 Statistical analysis 
All statistical analyses were performed using a two tailed Student’s t-
test.  Differences between sample means were considered statistically 




















CHAPTER 3  GELSOLIN PROMOTES COLON CANCER 
CELL INVASION VIA MODULATING INTRACELLULAR 




Increased gelsolin expression in tissues positively correlates with 
invasive phenotype in many cancer types (Gay et al., 2008; Rao et al., 2002; 
Shieh et al., 2006; Shieh et al., 1999; Thompson et al., 2007; Thor et al., 
2001).  This correlation has been confirmed by several investigators using 
both cell lines and animal models.  Many of the studies on the roles of gelsolin 
in cell migration and invasion have been linked to its calcium-regulated 
functions in actin dynamics, for instance, transfection of gelsolin in the colon 
cancer cell line LS180 resulted in increased migration by enhancing actin 
filament turnover (Litwin et al., 2012).  Downregulation of gelsolin was 
shown to counteract the invasive phenotypes of the breast cancer cell MDA-
MB 231 as well as the cervical cancer cell line Hela (Van den Abbeele et al., 
2007).  However, the mechanisms by which gelsolin promotes cancer cell 
invasion is not fully understood. 
ROS play important roles as second messengers in migratory and 
invasive signalling pathways.  When generated in response to growth factor 
stimulation of cancer cells, ROS have been shown to trigger migration and 
invasion signalling pathways (Wu, 2006a).  ROS are involved the activation of 
MAPK pathway and  transcriptional activation of genes involved in invasion 
such as MMPs and uPAs (Tochhawng et al., 2013).  ROS have also been 
suggested to directly interact and activate MMP via oxidation in nutrophils 
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(Saari et al., 1992).  Increased levels and activation of these proteases enhance 
invasion by digesting the ECM and paves the way for invading cells.  In this 
way, ROS play an important role in facilitating the invasive process 
(Tochhawng et al., 2013). 
Although a number of studies have shown the downstream targets of 
ROS in invasion, the upstream regulators of ROS in cancer cell invasion is 
incompletely understood.  Furthermore, how different molecules coordinate 
and interact with each to promote cancer cell invasion is still unclear.  
Therefore, it is necessary to delineate ROS regulation as well as its 
downstream targets.  In this study we propose that gelsolin may act as an 
upstream molecule that modulates intracellular redox status and thereby 




To investigate the mechanisms by which gelsolin promotes invasion, we have 
the following objectives: 
1. To determine whether gelsolin expression modulates ROS levels, and 
to identify the dominant ROS species involved. 
2. To demonstrate if ROS contributes to gelsolin-induced cell invasion. 
3. To determine whether alteration of the intracellular redox state by 
gelsolin contributes to upregulation of extracellular matrix-degrading 
enzymes. 
Study model 
The study was conducted using a gain-of-function model by gelsolin 
overexpression, as well as loss-of-function model using siRNA-mediated 
knockdown of gelsolin.  Our laboratory has previously derived stable clones 
that overexpress gelsolin from the colorectal cancer cell line HCT116 (Zhuo et 
al., 2012).  Two gelsolin-overexpressing stable clones, namely C1 and C8 
were compared against the empty vector control and wild-type HCT116 cells.  
Loss-of-function studies were performed using siRNA-mediated knockdown 
of endogenous gelsolin in the colorectal cancer cell lines HCT116, RKO, 
Caco-2 and DLD-1.  Gelsolin siRNA-treated cells were compared with the 









In order to characterise the ROS species modulated by gelsolin 
expression, the levels of total intracellular O2
-
 were first assessed using the 
chemiluminescence-based Lucigenin assay (as described under materials & 
methods).  Two gelsolin-overexpressing HCT116 clones C1 and C8 were 
compared with the empty vector control and wild-type HCT116 cells.  
Overexpression of gelsolin was confirmed by western blot as shown in figure 
3.1A.  Under normal growth conditions in complete media (McCoy 5A with 
10% FBS), total O2
-
 levels were elevated by three-fold in gelsolin-
overexpression C1 and C8 cells when compared to the empty vector control 
and wild-type HCT116 cells (Fig.3.1B).  We also investigated the role of 
endogenous gelsolin in modulating O2
-
 levels by siRNA-mediated knockdown 
of gelsolin in HCT116 and RKO cells.  Knockdown of gelsolin is evident from 
the western blot as shown in figure 3.1C.  When gelsolin was silenced, the 
intracellular O2
-
 levels also dropped significantly (Fig.3.1D).  These data 







Figure 3.1A&B. Gelsolin overexpression increases total intracellular superoxide 
(O2
-
) levels.  (A) Western blot showing overexpression of gelsolin.  (B) Gelsolin 
overexpression increases total intracellular O2
-
 levels in HCT116 cells: Total 
intracellular O2
-
 levels was measured by the chemiluminescent-based lucigenin assay. 
Gelsolin-overexpressing cells show significantly higher levels of O2
-
 compared to the 
vector control and wild-type HCT116 cells.  Data shown are mean ± SD of at least 
three independent experiments.  *p-value <0.05 (Two tailed Student’s t- test). 
 
























































Figure 3.1C&D. Gelsolin knockdown decreases total intracellular superoxide 
(O2
-
) levels.  (C) Western blot showing gelsolin knockdown in HCT116 and RKO 
cells.  (D) siRNA knockdown of gelsolin in HCT116 and RKO cells results in 
decreased levels of O2
-
.  Data shown are mean ± SD of at least three independent 














































As mitochondria are the major sources of ROS in the cell, the 
contribution of mitochondrial O2
-
 to the increase in total intracellular O2
-
 
levels following gelsolin overexpression was analysed.  Mitosox red dye was 
used to detect intra-mitochondrial O2
-
.  Cells were treated with Mitosox red 
probe, and mitochondrial O2
-
 levels were measured by flow cytometry.  
Gelsolin overexpressing cells C1 and C8 were found to exhibit higher 
mitochondrial O2
-
 levels when compared to the empty vector control and wild-
type HCT116 cells (Fig. 3.2A).  This is observed by a strong intensity of 
Mitosox red dye indicated by the shift in the histogram to the right.  Consistent 
with this observation, knockdown of endogenous gelsolin in wild-type 
HCT116 and RKO cells reduced O2
-
 levels as indicated by the shift in the 
histogram to the left (Fig. 3.2B&C).  The efficiency of gelsolin knockdown in 
HCT116 and RKO cells were analysed by Western blot (Fig. 3.2D).  Thus, from our 







Figure 3.2A.  Overexpression of gelsolin expression elevates mitochondrial 
superoxide (O2
-
) levels.  (A) Overexpression of gelsolin showed higher 
mitochondrial O2
- 
levels as compared to the empty vector control and wild-type 
HCT116 cells.  Upper panel, histogram showing intensity of Mitosox Red dye 
measured using the PE-Texas Red log channel (shift towards right indicates 
higher intensity).  Lower panel, bar charts showing mean fluorescence intensity 
of Mitosox red dye.  Data shown are mean ± SD of at least three independent 







Figure 3.2B-D.  Knockdown of gelsolin reduces mitochondrial superoxide 
(O2
-
) levels.  Gelsolin was knocked down in HCT116 and RKO cells and 
mitochondrial O2
-
 was measured by Mitosox red dye measured on a PE-Texas 
Red log scale.  Left panel, histogram showing mitosox red staining in HCT116 
and RKO following geloslin knockdown.  Knockdown of gelsolin results in 
reduced O2
.-
 levels shown by a lower intensity of mitosox staining measured 
using the PE-Texas Red log channel (indicated by the left shift in the histogram).  
Right panel, bar charts showing mean fluorescence intensity of Mitosox Red 
dye.  (D) Western blot analysis confirms the efficiency of gelsolin knockdown in 
HCT116 and RKO cells.  Data shown are mean ± SD of at least three 
independent experiments.  *p-value <0.05 (Two tailed Student’s t- test). 












































































3.3.3 Gelsolin expression does not affect the levels of other ROS species 
(H2O2, 
.
OH and HOCl)  
As ROS consist of several species, we investigated whether gelsolin 
influence the intracellular levels of other species of ROS such as H2O2,
.
OH 
and HOCl.  An 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein 
diacetate, acetyl ester (CM-H2DCFDA) oxidation assay was performed to 
examine if other ROS species are altered by gelsolin.  Several ROS including 
H2O2,
.
OH and HOCl can cause CM-H2DCFDA oxidation (Myhre et al., 2003; 
Royall & Ischiropoulos, 1993; Scott et al., 1988; Zhu et al., 1994).  Gelsolin 
was silenced in different colon cancer cell lines including HCT116, RKO, 
DLD-1 and Caco-2 followed by CM-H2DCFDA staining and green 
fluorescent intensity at FL-1 channel was assessed by flow cytometry.  We 
observed no significant change in CM-H2DCFDA intensity when gelsolin was 
silenced in these cell lines compared with the respective control siRNAs (Fig. 
3.3A & B). 
In addition, the Amplex Red hydrogen peroxide assay was used to 
detect H2O2 levels in gelsolin-overexpressing cells.  The Amplex Red reagent 
reacts with H2O2 in a 1:1 stoichiometry.  The resulting oxidation product, red 
fluorescent resorfin was assayed fluorometrically.  As shown in figure 3.3C, 
no difference was observed in H2O2 levels when gelsolin expression was 
increased.  These data suggest that gelsolin overexpression specifically 
modulates O2
-







Figure 3.3A&B.  Gelsolin knockdown does not affect the levels of other ROS 
(H2O2,
.
OH and HOCl).  (A) Gelsolin was knocked down in HCT116, Caco-2, DLD-
1 and RKO colorectal cancer cell lines and ROS levels were compared between 
gelsolin knockdown cells and control siRNA-treated cells using CM-H2DCFDA 
probe.  Histogram showing the intensity of CM-H2DCFDA staining measured at FL-1 
channel.  (B) Western blots showing the efficiency of gelsolin knockdown in 












Figure 3.3C. Overexpression of gelsolin expression does not alter H2O2 levels. 
Amplex Red was used to assess H2O2 levels in gelsolin-overexpressing cells.  Bar 
charts showing the relative fluorimetric reading of the Amplex Red dye.  Data shown 








































3.3.4 Gelsolin overexpression promotes invasion of HCT116 cells 
To evaluate the role of increased gelsolin expression in cancer cell 
invasion, transwell invasion assay was performed.  Gelsolin-overexpressing 
cells as well as empty vector control and wild-type HCT116 cells were 
allowed to invade through a matrigel matrix and 10% FBS containing media 
was used as a chemoattractant.  Briefly, cells were suspended in serum-free 
media and seeded on the upper chamber.  Cells were then allowed to invade 
for 24 hours towards the lower chamber that contains media with 10% FBS.  
Invaded cells were then fixed with 70% ethanol and stained with crystal violet 
and counted using Metamorph software.  Gelsolin-overexpressing C1 and C8 
cells were found to have enhanced invasion capacity when compared to the 
empty vector and wild-type HCT116 cells (Fig. 3.4A).  Consistent with this, 
gelsolin knockdown results in a significant decrease in invasion of HCT116 
cells (Fig. 3.4B).  The efficiency of gelsolin knockdown in HCT116 cells were 




Figure 3.4A. Gelsolin overexpression enhances cell invasion.  Cells with gelsolin 
overexpression (C1 & C8) have higher invasive capabilities when compared to the 
empty vector control and wild-type HCT116 cells.  Upper panel, representative 
pictures of invaded cells are shown (2.5X magnification of the entire well).  Lower 
panel, bar charts showing the quantification of  invaded cell numbers.  Data shown 
are mean ± SD of at least three independent experiments.  *p-value <0.05 (Two tailed 
Student’s t- test). 
 
 




























Figure 3.4B&C. Gelsolin knockdown reduces invasion of HCT116 cells.  
Gelsolin knockdown cells have lower invasive capacities compared to the control 
siRNA–treated cells.  Upper panel, representative pictures of invaded cells are 
shown (2.5X magnification of the entire well).  Lower panel, bar charts showing 
the quantification of invaded cell numbers.  (C) Western blot showing gelsolin 
knockdown in HCT116 and RKO cells.  Data shown are mean ± SD of at least 
three independent experiments.  *p-value <0.05 (Two tailed Student’s t- test).  
 




























3.3.5  DPI treatment blocks O2
-
 production and attenuates invasion in 
gelsolin-overexpressing cells 
Diphenyleneiodonium (DPI) is a potent inhibitor of the O2
-
 producing 
enzyme NADPH oxidase (Nox) (Robertson et al., 1990).  In order to 
investigate whether O2
-
 induced by gelsolin is required for gelsolin-mediated 
invasion, gelsolin-overexpressing cells were treated with 5µM of DPI.  DPI 
treatment significantly lowers the O2
-
 levels of gelsolin-overexpressing C1 and 
C8 as well as empty vector control and wild-type HCT116 cells.  However, C1 
and C8 were more sensitive to DPI treatment and the reduction of O2
-
 in C1 
and C8 were brought down to a level comparable to that of the empty vector 
control cells (Fig. 3.5A).  The role of O2
-
 in gelsolin-mediated invasion was 
further assessed using a transwell invasion assay performed under similar 
conditions of DPI treatment.  Consistent with the reduction in O2
- 
levels, the 
invasive capacities of gelsolin-overexpressing cells significantly dropped 
following DPI treatment (Fig. 3.5B).  To ensure that the reduction in invasion 
observed after DPI treatment is not due reduction in cell viability, we 
performed a cell viability assay using the Trpan Blue Excluson.  We confirm 
that treatment of cells with 5µM DPI for 24 hours has minimal effect on cell 
viability (Fig. 3.5C).  These data therefore indicate that O2
-
 is important in 
invasion and it may be an important molecule downstream of gelsolin that 








Figure 3.5A. DPI treatment reduces O2
- 
levels.  Treatment of cells with 5µM DPI 
significantly lowered O2
- 
levels.  Data shown are mean ± SD of at least three 
independent experiments.  *p-value <0.05 (Two tailed Student’s t- test). 
 










































Figure 3.5B. DPI treatment reduces invasion.  Treatment of cells with 5µM DPI 
significantly lowered the invasive capacities of gelsolin overexpressing C1 & C8 cells.  
Upper panel, representative pictures of invaded cells with or without DPI treatments 
are shown (2.5X magnification of the entire well).  Lower panel, bar charts showing 
the quantification of invaded cell numbers.  Data shown are mean ± SD of at least 
three independent experiments.  *p-value <0.05 (Two tailed Student’s t- test). 
 
 





























































Figure 3.5C. DPI has minimal effect on HCT116 cell viability.  To confirm the 
effect of DPI on gelsolin-induced cell invasion, gelsolin-overexpressing cells 
were treated with 5µM DPI for 24h and cell viability was assessed using the 
Trypan Blue Exclusion cell counting method.  No significant difference in cell 
viability was observed between control group and DPI treated cells.  Data shown 
are mean ± SD of at least three independent experiments.  
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 levels by knockdown of Cu/Zn SOD rescues 
invasion in gelsolin-depleted HCT116 cells 
As shown earlier knockdown of gelsolin reduces both O2
-
 levels (refer 
to Fig. 3.1B) and invasion (refer to Fig. 3.4B).  To confirm the requirement of 
O2
-
 downstream of gelsolin for invasion, a rescue experiment was performed 
to increase O2
-
 levels in gelsolin-knockdown cells.  The antioxidant enzyme 
Cu/Zn SOD that catalyses the conversion of O2
-
 to H2O2 was silenced in 
gelsolin-depleted HCT116.  Silencing of Cu/Zn SOD abrogated the conversion 
of O2
-
 to H2O2 thus leading to increased accumulation of O2
-
 even in the 
absence of gelsolin.  Knockdown of gelsolin and Cu/Zn SOD is evident from 
the western blots as shown in figure 3.6A.  Knockdown of gelsolin results in 
decreased levels of O2
-
, however, knockdown of Cu/Zn SOD restores O2
-
 in 
gelsolin-depleted cells (Fig 3.6B).  Similarly, knockdown of gelsolin results in 
decreased invasion, however, simultaneous knockdown of Cu/Zn SOD 
together with gelsolin completely restores invasion in gelsolin-depleted cells 
(Fig. 3.6C).  These data show the requirement of O2
-
 in gelsolin-induced 





Figure 3.6A&B. Increasing O2
-
 levels by knockdown of Cu/Zn SOD rescues 
invasion in gelsolin depleted HCT116 cells.  (A) Western blot showing 
knockdown of gelsolin and Cu/Zn SOD.  (B) Simultaneous knockdown of 
gelsolin and Cu/ZnSOD significantly increases O2
- 
levels in gelsolin-depleted 
cells.  Data shown are mean ± SD of at least three independent experiments.  *p-

























































Figure 3.6C. Increasing O2
-
 levels by knockdown of Cu/Zn SOD rescues 
invasion in gelsolin-depleted HCT116 cells.  Simultaneous knockdown of 
gelsolin and Cu/ZnSOD significantly rescues the invasive capacity of gelsolin-
depleted cells by increasing O2
- 
levels.  Data shown are mean ± SD of at least 







































3.3.7 Gelsolin expression modulates urokinase plasminogen activator  
            (uPA) secretion and activity 
uPA is an extracellular serine protease that can activate the proenzyme 
plasminogen to active plasmin in the extracellular environment (Brooks et al., 
2010).  Active plasmin can efficiently digest the ECM, thus facilitating cell 
invasion.  uPA secretion was assessed using a double-sandwiched ELISA and 
the readings were normalised to protein concentrations.  Cells were grown in 
serum-free media for 16 hours and the conditioned media were used to detect 
uPA secretion by ELISA.  Figure 3.7A showed that uPA secretion is higher in 
gelsolin-overexpressing C1 and C8 cells when compared to the empty vector 
control and wild-type HCT116 cells — consistent with our previously 
published data (Zhuo et al., 2012).  In addition, when endogenous gelsolin was 
knocked down in several colon cancer cell lines including HCT116, Caco-2 
and DLD-1 (Fig. 3.7B), reduced uPA secretion was observed (Fig. 3.7C).  
These data indicate that gelsolin modulates uPA secretion in these cells. 
To understand the functional relevance of gelsolin-induced uPA 
secretion, a SDS-gel based enzymatic activity test was performed using 
zymography.  Conditioned media mentioned above were loaded onto a SDS-
PAGE gel containing uPA substrates (plasminogen and fibrinogen) and the gel 
was electrophoresed.  The clear zone of lysis observed in gelsolin-
overexpressing C1 and C8 cells were more pronounced when compared to the 
empty vector control and wild-type HCT116, indicating higher uPA activities 
conferred by gelsolin overexpression (Fig. 3.7D).  Consistently, silencing of 
gelsolin in the gelsolin-overexpressing C1 cells and other colon cancer cell 
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lines including HCT116, DLD-1 and Caco-2 resulted in significant reduction 
of the proteolytic activity of uPA (Fig. 3.7E&F).  Taken together, our data 
indicate that gelsolin modulates uPA secretion as well as the proteolytic 
activity of uPA on the degradation of the extracellular matrix. 
 
 
Figure 3.7A. Gelsolin overexpression induces uPA secretion.  uPA secretion was 
assessed using double sandwiched ELISA.  Overexpression of gelsolin in C1 and C8 
cells augmented the secretion of uPA when compared to the empty vector control and 
wild-type HCT116 cells.  Data shown are mean ± SD of at least three independent 
experiments.  *p-value <0.05 (Two tailed Student’s t-test). 
































Figure 3.7B. Gelsolin knockdown decreases uPA secretion.  (B) Knockdown of 
endogenous gelsolin in different colon cancer cell lines HCT116, Caco-2 and DLD-1 
significantly reduced uPA secretion when compared to their respective control 
siRNAs.  Data shown are mean ± SD of at least three independent experiments.  *p-


































Figure 3.7C-E. Gelsolin expression modulates uPA activity.  (C) uPA activity was 
determined by zymographic analysis using conditioned media from cells cultured in 
serum-free media for 16 hours.  Gelsolin-overexpressing C1 have significantly higher 
uPA activity when compared to the empty vector control and wild-type HCT116 
cells, as shown by the clear zone of lysis.  (D) Western blot showing gelsolin 
knockdown in gelsolin-overexpressing C1, wild-type HCT116, Caco-2 and DLD-1 
cells.  (E) uPA activity was determined by zymographic analysis using conditioned 
media from gelsolin knockdown cells cultured in serum-free media for 3 hours.  
Knockdown of gelsolin in C1, HCT116, DLD-1 and Caco-2 showed decreased uPA 










3.3.8 DPI inhibits gelsolin-induced uPA secretion  
ROS have been implicated to play a role in cancer cell invasion by 
modulating the secretion and activities of ECM-degrading enzymes including 
uPA.  To investigate whether O2
-
 participate in enhancing uPA secretion 
induced by gelsolin, cells were serum-starved with 5µM DPI or 50µM 
Amiloride for 8 hours and the conditioned media were used to detect uPA by 
ELISA.  Control cells were also serum starved without treatment for 8 hours 
and the conditioned media was used for detecting uPA by ELISA.  Amiloride, 
an inhibitor of uPA was used as a positive control for efficiency of uPA 
inhibition.  Amiloride has been shown to modulate uPA at the gene 
transcriptional level and post transcriptional level including blockade of 
secretion and activity (Vassalli & Belin, 1987; Wang et al., 1995),.  Treatment 
of cells with DPI significantly inhibited uPA secretion in gelsolin-
overexpressing C1 and C8 cells when compared to the empty vector control 
and wild-type HCT116.  Furthermore, the level of inhibition of uPA secretion 
by DPI in C1 and C8 cells were found to be comparable to the level of 
inhibition displayed by Amiloride, indicating an efficient inhibitory action by 
DPI treatment (Fig. 3.8).  This data suggests that O2
-
 plays a role in the 





Figure 3.8. Gelsolin-induced uPA secretion is modulated by intracellular O2
-
 
levels.  Cells were serum starved with or without 5µM DPI for 8 hours and the 
conditioned media were used to detect uPA by ELISA.  Amiloride (Am), an inhibitor 
of uPA was used as a positive control.  Treatment of cells with 5µM DPI significantly 
inhibited uPA secretion in gelsolin-overexpressing C1 and C8 cells whereas 5µM 
DPI treatment did not show inhibitory effect of uPA secretion in the empty vector 
control and wild-type HCT116.  Secreted uPA levels were normalised to protein 
concentration.  Data shown here is a representative of at least three independent 
experiments. 
  































In this study we have demonstrated a novel role of gelsolin as a pro-
oxidant molecule whose expression positively correlates with the intracellular 
levels of ROS particularly the O2
-
 species.  We found that overexpression of 
gelsolin increases intracellular O2
- 
levels. Consistently, when gelsolin 
expression was silenced with siRNA targeted against gelsolin, a reduction in 
O2
- 
levels was observed.  As noted earlier in section 1.3.1, ROS consist of 
several other species including H2O2,
.
OH, HOCl etc., we assessed whether 
gelsolin expression could influence other ROS species besides O2
- 
.  We found 
that neither overexpression nor knockdown of gelsolin alters the levels of 
other species of ROS such as H2O2.  Our results therefore indicate that gelsolin 
expression specifically modulates the total intracellular levels of O2
-
. 
Since mitochondria are one of the major sources of O2
-
 in the cell, we 
investigated whether mitochondrial O2
-
 is affected by gelsolin expression.  Our 
data showed that gelsolin overexpression increases mitochondrial O2
-
 levels by 




to the increase in total 
intracellular O2
-
.  This increase in mitochondrial O2
- 
could be a result of 
increased mitochondrial activity.  Gelsolin overexpression has been implicated 
to modulate mitochondrial activity by increasing mitochondrial complex IV 
activity (Antequera et al., 2009).  However, mitochondrial O2
-
 is likely to play 
a minor contribution in gelsolin’s effects on O2
-
 production, as gelsolin 
overexpression in HCT116 induced a 3-fold increase in the total intracellular 
O2
-
 levels.  This observation indicates that other extra-mitochondrial sources 
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of ROS including increased activities of the O2
- 
producing enzymes such as 
Nox, or impaired activities of antioxidant enzymes such as the Cu/Zn SOD 





 is required for gelsolin-mediated cancer cell invasion 
We and others have previously shown that gelsolin is important during 
cancer cell invasion (De Corte et al., 2002; Van den Abbeele et al., 2007; 
Zhuo et al., 2012), and our data here also supports the role of gelsolin in 
promoting invasion.  In addition, we show that gelsolin-induced invasion 
requires intracellular O2
-
.  High levels of gelsolin results in increased O2
-
 and 
invasion.  The increase in invasion induced by gelsolin could be attenuated by 
lowering the levels of O2
-
.  These data suggest that one of the mechanisms by 
which gelsolin enhances invasion is by increasing O2
-
 levels.  Consistent with 
this observation, knockdown of gelsolin reduces both O2
-
 levels and invasion.  
The invasive capacities of HCT116 cells were rescued when O2
-
 levels were 
increased in gelsolin-knockdown cells, consistent with an essential role for O2
-
 
downstream of gelsolin in cancer cell invasion.  Taken together, these set of 
data indicate a reliance on O2
-
 by gelsolin during the process of cancer cell 
invasion. 
Mounting evidence has documented the role of ROS in promoting 
cancer cell invasion through enhancing ECM degradation.  ROS have been 
shown to regulate ECM-degrading proteases such as the uPAs and the MMPs.  
Elevated levels of uPA and its receptor uPAR as well as MMPs are often 
observed in various cancer types, correlating with increased ROS levels and 
invasive phenotypes.  The roles of ROS in upregulating uPAs and MMPs have 
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been mostly attributed to the involvement of ROS in triggering the MAPK 
pathways leading to activation of transcription factors that control the 
expression of uPAs and MMPs (Binker et al., 2009; Chiu et al., 2010; Khoi et 
al., 2012a; Kim et al., 2007a; Nelson & Melendez, 2004; Pelicano et al., 
2009).  Besides transcriptional regulation, ROS have also been known to have 
the ability to induce the activation of MMPs (Saari et al., 1992).  However, 
whether this is true for uPA activity has not been documented.  ROS induced 
by triggers such as Helicobacter pylori infection and nicotine treatment have 
also been shown to stimulate increased uPA and uPAR levels (Khoi et al., 
2012b; Kim et al., 2007b).  Furthermore, when cancer cells were treated with 
antioxidants, the effects of nicotine on uPAR expression were reversed, 
supporting the involvement of ROS in regulating uPA and uPAR expression.  
ROS induced by transforming growth factor beta (TGF-β) was also shown to 
upregulate uPA leading to enhanced cancer cell invasion (Tobar et al., 2010a). 
We have reported that overexpression of gelsolin upregulated the 
mRNA level, secretion level as well as enzymatic activities of uPA (Fig. 3.7) 
(Zhuo et al., 2012).  To determine whether O2
-
 is involved in the induction of 
uPA in gelsolin-mediated invasion, gelsolin-overexpressing cells were treated 
with DPI.  Treatment of gelsolin-overexpressing cells with DPI significantly 
attenuated the secretion of uPA, suggesting the role of O2
-
 in enhancing uPA 
secretion.  Thus, our result have suggested uPA as a downstream effector of 
O2
-
 in gelsolin-medaited invasion.  More importantly, our study provides a 
mechanistic insight into the regulation of uPA by gelsolin. 
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In most of the studies, H2O2 have been implicated in the gene 
regulation of uPA and uPAR via oxidation-induced activation of transcription 
factors such as NF-κB and AP-1.  Although less is known about the role of O2
-
 
in the regulation of uPA gene expression, O2
-
 has been shown to be crucial for 
the oxidation-mediated activation of the transcription factor HIF-1α (Wang et 
al., 2004) and NF-kB (Marumo et al., 1997).  Therefore, it is plausible that O2
- 
may participate in the upregulation of uPA gene expression following gelsolin 
overexpression. 
Besides transcriptional regulation, ROS are also known to be involved 
in post-transcriptional as well as post-translational regulation of the ECM-
degrading proteins.  As noted earlier, (section 1.3.4) H2O2 has also been 
shown to stabilise the mRNAs of uPA and uPAR by facilitating the binding 
between uPA/uPAR mRNAs and the mRNA-stabilising Hu family of RNA-
binding proteins (HuR) (Tran et al., 2003b).  In addition, H2O2, HOCl and 
.
OH 
activate MMPs through oxidation of the cysteine residue in the catalytic 
domain (Saari et al., 1992).  O2
-
 also has the potential to modify proteins, for 
example, O2
-
 stimulates PKC activity through thiol modification and alteration 
of zinc levels (Knapp & Klann, 2000).  Thus, the role of O2
-
 in activating uPA 
cannot be excluded.  Conceivably, O2
- 
induced by gelsolin could serve as an 
important determinant in the activation of ECM-degrading proteases such as 
uPA at the invasive edge. 
In summary, our study has revealed a new mechanism by which 
gelsolin promotes cancer cell invasion.  Gelsolin increases the intracellular 
levels of O2
-
, which acts to enhance invasion by facilitating extracellular 





















CHAPTER 4  GELSOLIN MODULATES INTRACELLULAR 
LEVELS OF SUPEROXIDE (O2
-
) SPECIES BY 
SUPPRESSING THE ACTIVITY OF THE ANTIOXIDANT 
COPPER/ZINC SUPEROXIDE DISMUTASE (CU/ZN SOD) 
4.1 BACKGROUND 
Defects in the antioxidant system or upregulation of ROS-generating 
enzymes such as Nox can lead to increase in the intracellular levels of ROS.  
Antioxidants play important roles in maintaining the cellular redox 
homeostasis.  Abnormal fluctuations in the antioxidant system results in 
disturbance in the ROS-antioxidant balance which can lead to pathological 
conditions such as cancer.  The antioxidant systems consist of the SODs, 
catalase, glutathione, thioredoxins, glutaredoxins and antioxidant protein-1 
(ATOX-1) (Halliwell, 2006; Sies, 1997).  As excess ROS inside the cells can 
have harmful effects, the antioxidants play key roles in scavenging excess 
ROS by converting them to less harmful products.  The efficiency of 
antioxidants is enhanced by their target specificity, for example, SODs 
scavenge O2
- 
by dismutating them to H2O2 (Fridovich, 1978; Fridovich, 1995).  
H2O2 in turn is reduced to water by the action of catalase or other antioxidants.  
Defective functions of antioxidants thus result in accumulation of ROS in 
cells. 
In most cases, O2
- 
is the precursor ROS species; since SODs are the 
only enzymes responsible in eliminating O2
-
, they are often regarded as the 
first line in the antioxidant scavenging (Alscher et al., 2002; Van Raamsdonk 
& Hekimi, 2012).  Although the enzymatic functions of the two isoforms of 
SODs, the cytosolic Cu/Zn SOD and mitochondrial Mn SOD are similar, their 
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site of action is restricted to their cellular localisation.  Whilst Cu/Zn SOD is 
responsible for eliminating O2
- 
in the cytosol, Mn SOD scavenges O2
-
 in the 
mitochondria (Halliwell, 2007). 
In the previous chapter (chapter 3), we have shown that gelsolin 
overexpression correlates with an increase in the intracellular levels O2
- 
species of ROS.  Since defective antioxidants can result in accumulation of 
intracellular ROS levels, we hypothesize that gelsolin may affect the 
expression and activities of antioxidants.  We therefore assessed the mRNA 
expression of a panel of antioxidant genes and determined the activities of 
SODs. 
As the enzymatic regulation of Cu/Zn SOD depends on the 
metallochaperone, Copper chaperone for superoxide dismutase (CCS), we also 
examined the protein expression levels of CCS.  CCS donates copper to Cu/Zn 
SOD as well as aids in the dimerisation of Cu/Zn SOD molecules (Banci et al., 
2012; Banci et al., 2002; Furukawa et al., 2004).  Cu/Zn SOD activity can also 
be increased by increased gene and protein expression of Cu/Zn SOD.  Gene 
expression of Cu/Zn SOD is regulated by activation of its upstream 
transcription factors such as AP-1, NF-kB and Sp1, Nuclear Factor E2-Related 
Factor2 and Early Growth Response-1 (Milani et al., 2011). 
Because NADPH oxidases (Nox) are the major ROS-producing 
enzymes in the mammalian cells, the mRNA levels of Nox were assessed to 
evaluate if gelsolin have effect on them and use it as a means to increase ROS 




To investigate the mechanisms by which gelsolin induces increases in O2
-
 , the 
following objectives were addressed: 
1. Determine if gelsolin influences the expression of antioxidant genes. 
2. Investigate the effect of gelsolin on the protein expression and the 
enzymatic activities of SODs. 










4.3.1 Gelsolin overexpression suppresses the mRNA levels of antioxidant 
genes 
To investigate whether gelsolin expression affects the gene expression 
of antioxidant genes, real-time PCR was employed to determine the mRNA 
levels of antioxidant genes including Cu/Zn SOD, Mn SOD, catalase, 
Glutaredoxin-2 (Glrx-2) and ATOX-1.  Overexpression of gelsolin resulted in 
a reduction of the mRNA levels of the above-mentioned antioxidants.  
Gelsolin-overexpressing C1 and C8 have significantly lower gene expression 
levels of Cu/Zn SOD, Catalase and Glrx-2 when compared to the empty vector 
control and wild-type HCT116 cells (Fig. 4.1).  This data suggests that 






Figure 4.1. Gelsolin overexpression downregulates mRNA levels of antioxidant 
genes.  Gelsolin-overexpressing cells shows significantly lower levels of Cu/Zn SOD, 
Catalase and Glrx-2 mRNA levels when compared to the vector control and wild-type 
HCT116 cells.  Data shown are mean ± SD of at least three independent experiments. 
*p-value <0.05 (Two tailed Student’s t-test). 
  

































4.3.2 Gelsolin does not affect the protein expression of Cu/Zn SOD and 
Mn SOD 
In order to determine the underlying mechanisms by which gelsolin 
overexpression increases O2
-
 levels, we assessed the protein levels of SODs as 
O2
-
 is a specific target of SODs.  Moreover, gelsolin-overexpression also 
showed reduced mRNA levels of Cu/Zn SOD and Mn SOD.  Therefore, to 
investigate if the gene expression levels correlate to the protein expression 
levels, the protein levels of Cu/Zn SOD and Mn SOD were analysed by 
Western blot (Fig. 4.2).  Differences in protein levels of Cu/Zn SOD and Mn 
SOD were not evident when compared between gelsolin-overexpressing C1 
and C8 and empty vector control or wild-type HCT116 cells.  Similarly, 
knockdown of gelsolin in HCT116 cells did not affect the protein expression 
of Cu/Zn SOD and Mn SOD when compared to the control siRNA-treated 
cells.  These data show that although mRNA expression of Cu/Zn SOD and 





Figure 4.2A-D. Gelsolin expression does not affect the protein expression of 
Cu/Zn SOD and Mn SOD.  (A) Cu/Zn SOD levels were not affected when gelsolin 
expression was altered.  Comparison was made between gelsolin-overexpressing C1 
&C8 cells with the empty vector control and HCT116 cells.  (B) No change in Cu/Zn 
SOD levels were observed between siRNA knockdown of gelsolin when compared to 
siRNA control.  (C) No significant change in Mn SOD levels were observed between 
gelsolin-overexpressing C1 and C8 cells when compared to empty vector control and 
HCT116 cells.  (D) No significant change in Mn SOD levels were observed between 
siRNA knockdown of gelsolin when compared to siRNA control.  β-actin and 
GAPDH were used as internal loading controls.  The Western blots shown here are 













4.3.3 Gelsolin suppresses total SOD activity 
The enzymatic activity of SOD was investigated in gelsolin-
overexpressing HCT116 cell lines.  Using total cell lysate, we determined the 
combined enzymatic activities of Cu/Zn SOD and Mn SOD (referred to as 
total SOD) using the SOD activity kit from Enzo.  Gelsolin-overexpressing C1 
and C8 cells were found to have lower total SOD activities compared to the 
empty vector control and wild-type HCT116 cells (Fig. 4.3A).  Consistent 
with this observation, knockdown of endogenous gelsolin in wild-type 
HCT116 and RKO cells results in higher total SOD activity as compared to 
their control siRNA-treated counterparts (Fig. 4.3B).  These data suggest that 
although the protein levels of SODs were not altered by gelsolin expression, 







Figure 4.3A&B. Gelsolin expression modulates total SOD activity in HCT116 
and RKO cells.  Total intracellular superoxide dismutase (SOD) activity was 
analysed using total cell lysate.  (A) Overexpression of gelsolin in C1 and C8 results 
in significantly lower SOD activities when compared to the empty vector control and 
wild-type HCT116 cells.  (B) Knockdown of endogenous gelsolin in HCT116 and 
RKO cells results in increased total SOD activity.  Data shown are mean ± SD of at 








































































4.3.4 Gelsolin suppresses Cu/Zn SOD activity 
In order to identify the specific SOD isoform affected by gelsolin, sub-
cellular fractionation was performed to separate the cytosol and the 
mitochondria.  Cu/Zn SOD and Mn SOD activities were assayed from the 
respective fractions.  The validity of our fractionation was confirmed by the 
presence of Cu/Zn SOD and GAPDH in the cytosol and MnSOD and VDAC 
in the mitochondrial fractions, whilst β-actin was used as the internal loading 
controls for both fractions (Fig. 4.4A).  Our result shows that gelsolin-
overexpressing C1 and C8 cells have reduced Cu/Zn SOD activity (Fig 4.4B) 
when compared to empty vector control and wild-type HCT116 cells, whereas 
the activity of Mn SOD was minimally affected by gelsolin expression (Fig. 
4.4C).  This result suggests that Cu/Zn SOD is likely the isoform targeted by 
gelsolin. 
Diethyldithiocarbamate (DDC) is a potent chelator of metals (iron or 
copper) by interacting with free and protein bound metal.  DDC has been 
widely used as an agent to inhibit Cu/Zn SOD activity and increase 
intracellular O2
-
 levels in cells (Didion et al., 2001; Heikkila et al., 1976).  In 
this study, DDC was used as a positive control to determine the efficiency of 
Cu/Zn SOD inhibition observed in gelsolin-overexpressing cells.  Gelsolin-
overexpressing C1 cells and the empty vector control cells were both treated 
with 1mM DDC for an hour.  Treatment with DDC significantly reduces total 
SOD activities in both C1 and the empty vector control cells (Fig. 4.4D).  
Reduction in total SOD activities was reflected by a significant increase in O2
-
 
levels in both C1 and vector control cells (Fig. 4.4E).  Furthermore when cells 
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treated with 1mM DDC were subjected to sub-cellular fractionation,  Cu/Zn 
SOD activity was significantly abrogated in C1 and vector control cells 
whereas Mn SOD activity was minimally affcted (Fig. 4.4F).  The Mn SOD 
activity levels were comparable between C1 and vector control cells with or 
without DDC treatment.  Therefore, these data indicate that the approach used 
is suitable for detection of the specific isoform of SOD following sub-cellular 
fractions.  Our findings here support our observations in figures 4.4B&C that 
gelsolin overexpression suppresses Cu/Zn SOD activity but not Mn SOD. 
Accordingly, siRNA-mediated silencing of gelsolin in HCT116 and C1 
cells significantly increased Cu/Zn SOD activity whilst Mn SOD was 
nominally affected (Fig. 4.4G-K).  Taken together, these data indicate that 






Figure 4.4A. Subcellular fractionation of cytosol and mitochondria in gelsolin-
overexpressing cells.  Cytoslic and mitochondrial fraction were isolated in gelsolin-
overexpressing C1 and C8 as well as the empty vector and wild-type HCT116 cells.  
Fractionation was confirmed by the presence of Mn SOD and VDAC in the 
mitochondira and Cu/Zn SOD and GAPDH in the cytosol.  β-actin was used as the 
internal loading control. 
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Figure 4.4B&C.  Overexpression of gelsolin suppresses Cu/Zn SOD activity in 
HCT116 cells.  (B) Cu/Zn SOD activity was measured from the cytosolic extract.  
Gelsolin overexpression results in suppression of Cu/Zn SOD activity when 
compared to the empty vector control and wild-type HCT116 cells.  (C) Intact 
mitochondria were isolated and Mn SOD activity was determined.  No significant 
change in MnSOD activity was observed upon gelsolin overexpression.  Data shown 






































































Figure 4.4D&E. DDC inhibits total SOD activity.  Gelsolin-overexpressing C1 and 
empty vector control cells were both treated with 1mM of DDC for 1 hour.  (D)  
Total SOD activities were reduced in both C1 and in the empty vector control cells 
following DDC treatment.  (E) Concomitant with the drop in total SOD activity, 
1mM DDC treatment results in increased O2
-
 levels.  Data shown here is 










































































Figure 4.4F. DDC inhibits Cu/Zn SOD activity.  Cells were treated with 1mM 
DDC for 1 hour and the cytosol and mitochondria was fractionated.  Cu/Zn SOD and 
Mn SOD activites were assayed in from the respective fractions.  Cu/Zn SOD 
activities were dramatically reduced following DDC treatment whilst Mn SOD 
activity was minimally affected.  Data shown here is a representative of two 
independent experiments.  
































Figure 4.4G.  Subcellular fractionation of cytosol and mitochondria in gelsolin 
knockdown cells.  Gelsolin was silenced in HCT116 and C1 cells and cytosolic and 
mitochondrial fractions were isolated.  Fractionation was confirmed by the presence 
of Mn SOD and VDAC in the mitochondria and Cu/Zn SOD and GAPDH in the 







Figure 4.4H&I. Knockdown of gelsolin increases Cu/Zn SOD activity in HCT116 
and C1 cells.  Cu/Zn SOD activity was measured from the cytosolic extract in 
gelsolin knockdown HCT116 and C1 cells.  Elevated Cu/Zn SOD activity was 
observed when gelsolin was knocked down in HCT116 and C1.  Data shown are 

















































































Figure 4.4J&K.  Knockdown of gelsolin does not affect Mn SOD activity in 
HCT116 and C1 cells.  Mn SOD activity was measured from the mitochondrial 
extract in gelsolin knockdown HCT116 and C1 cells.  Mn SOD activity remains 
unchanged when gelsolin was knocked down in HCT116 and C1.  Data shown are 






































































4.3.5 Gelsolin does not affect protein expression of copper chaperone for  
            Cu/Zn SOD (CCS) 
CCS is a chaperone protein that physically interacts with Cu/Zn SOD 
and donates copper to it.  CCS is the most potent regulator of Cu/Zn SOD 
activity.  CCS facilitates Cu/Zn SOD dimerisation and also helps in 
maintaining its structural integrity that is required for efficient enzymatic 
action (Banci et al., 2012; Banci et al., 2002; Furukawa et al., 2004).  In an 
attempt to investigate the mechanisms by which gelsolin suppresses Cu/Zn 
SOD activity, we assessed the protein levels of CCS in both gelsolin-
overexpressing as well as gelsolin knockdown cells.  Our results showed that 
the protein levels of CCS remained unaltered when gelsolin expression was 
modulated either by overexpression or siRNA knockdown (Fig. 4.5A & B).  
These data indicate that gelsolin does not interfere with the protein levels of 












Figure 4.5A&B. Gelsolin expression does not affect protein expression of CCS.  
(A) The levels of CCS protein expression levels were found to be comparable 
between gelsolin-overexpressing C1 and C8 cells when compared to empty vector 
control and HCT116 cells.  (B) Knockdown of gelsolin in C1 cells did not alter the 
protein expression levels of CCS as compared to the control siRNA and a no siRNA 
































4.3.6 Gelsolin co-immunoprecipitates with Cu/Zn SOD 
To determine how gelsolin suppresses the enzymatic activity of Cu/Zn 
SOD, we investigated whether these two proteins can interact with each other.  
Endogenous Cu/Zn SOD was immunoprecipitated from the lysates of the 
gelsolin-overexpressing C1 cell line.  The presence of gelsolin in the 
immunoprecipitate was detected by western blot (Fig. 4.6).  A strong band of 
gelsolin in the Cu/Zn SOD lane was observed whereas no band was seen in the 








Figure 4.6 Gelsolin co-immunoprecipitates with Cu/Zn SOD.  Endogenous Cu/Zn 
SOD was immunoprecipitated from lysates of C1 cells using Cu/Zn SOD antibody.  
Mouse IgG was used as negative control and lysates (input) were analysed for the 
expression of Cu/Zn SOD and gelsolin.  Upper panel left: Blot showing the pulled 
down material, Cu/Zn SOD along with the IgG heavy chain (Hc) and IgG light chain 
(Lc).  Upper panel right: Gelsolin was pulled down along with Cu/Zn SOD and the 
detected band is shown here.  Lower panel: Blot showing the expression of gelsolin 





4.3.7 Gelsolin and Cu/Zn SOD lie in close proximity to each other 
By employing the in situ Proximity Ligation Assay (PLA), we 
demonstrated the association between gelsolin and Cu/Zn SOD in the wild-
type HCT116 cells.  Cells were incubated with antibodies against gelsolin and 
Cu/Zn SOD and detection of red fluorescent signals indicates that these two 
proteins lie close to each other (Fig 4.7).  The cells were also counterstained 
with DAPI to locate the nuclei.  Negative controls such as isotype antibody 
and single antibody-treatment controls were included to confirm the 
specificity of the assay.  No red fluorescent signals were detected in our 







Figure 4.7 Gelsolin and Cu/Zn SOD lie in close proximity to each other.  
Proximity ligation assay was performed in HCT116 cells.  PLA signals in red 
fluorescence were detected when cells were treated with both gelsolin and 
Cu/Zn SOD antibodies.  PLA signals were not detected in isotype control cells 
as well as in single antibody-treated cells.  Images were captured using 
Olympus DP72 microscope and cellSens software at 60x.  Scale bar represent 









4.3.8 Gelsolin expression modulates the mRNA levels of Nox  
In an attempt to explore other mechanisms by which gelsolin leads to 
increased O2
-
, the gene expression levels of a panel of Nox isoforms were 
evaluated.  As noted earlier NADPH oxidases (Nox) are the major ROS-
producing enzymes in the mammalian cells.  Five Nox isoforms (Nox1, Nox2, 
Nox3, Nox4, and Nox5) and two related enzymes Duox1 and Duox 2 have 
been identified to date (Katsuyama et al., 2012).  Here, Nox1, Nox2, Nox4 
and Nox5 gene expression were screened as these are the isoforms that have 
been mostly implicated in cancer (Kamata, 2009).  Out of the different 
isoforms of Nox screened, Nox 4 was undetectable in our study model.  
Overexpression of gelsolin increased the mRNA levels of Nox1 and Nox5, 
whilst Nox2 mRNA level was minimally affected (Fig. 4.8A).  In accordance 
with this, knockdown of gelsolin in the gelsolin-overexpressing C1 cells 
reduced the mRNA levels of Nox1 and Nox5 but did not affect Nox2 (Fig. 
4.8B).  These data therefore suggest that gelsolin may be involved in 










Figure 4.8A&B Gelsolin expression affects mRNA levels of Nox.  
(A) Overexpression of gelsolin in C1 and C8 leads to a significant increase in the 
gene expression of Nox1 and Nox5 when compared to the empty vector control and 
wild-type HCT116 cells.  (B) Knockdown of gelsolin in C1 results in the 
downregulation of Nox1 and Nox5 when compared to the control siRNA.  Data 
shown are mean ± SD of at least three independent experiments.  *p-value <0.05 




































































4.4.1 Gelsolin suppresses the activity of Cu/Zn SOD 
SODs are directly responsible for the catalytic conversion of O2
-
 to 
H2O2, thereby balancing the intracellular pool of O2
-
.  Therefore, 
downregulation of SOD will lead to increase in O2
-
 levels.  To understand the 
mechanisms by which gelsolin modulates O2
-
 levels, the mRNA and protein 
levels as well as SOD activities were determined.  Although the mRNA level 
of Cu/Zn SOD was found to be reduced by gelsolin overexpression, the 
protein level remains unchanged.  However, when the enzymatic activities of 
SODs were assayed, it was found that SOD activities were significantly 
attenuated following gelsolin overexpression. 
Sub-cellular fractionation that separates the cytoplasm from intact 
mitochondria allowed us to determine which isoform of SOD is a target of 
gelsolin.  SOD activity analysis from the cytoplasm shows a significantly 
reduced activity of SOD in gelsolin-overexpressing cells whereas no 
significant change in SOD activity was observed in the mitochondrial fraction.  
These data indicate that cytoplasmic Cu/Zn SOD is the specific target of 
gelsolin. 
Several post-translational regulations are required to activate Cu/Zn 
SOD. Dimerisation of Cu/Zn SOD as well as efficient copper insertion is 
required for the enzymatic activation of this enzyme.  Structural integrity is 
maintained by insertion of zinc ions, however, zinc can be replaced by other 
metal ions without affecting Cu/Zn SOD activity (Spagnolo et al., 2004).  
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CCS is the most well known activator of the Cu/Zn SOD – by donating copper 
to Cu/Zn SOD, and also facilitates dimer formation, resulting in a catalytically 
active form of Cu/Zn SOD (Furukawa et al., 2004).   We assessed the protein 
expression levels of CCS following modulation of gelsolin expression to test 
whether gelsolin influences the protein expression of CCS to regulate Cu/Zn 
SOD.  Our results show that protein expression of CCS was not altered by 
gelsolin expression.  Therefore the suppression of Cu/Zn SOD activity by 
gelsolin could be via other channels other than modulation of CCS protein 
levels. 
Glutaredoxins are antioxidants that catalyse the thiol-disulfide 
interchange reactions.  Glutaredoxins (Glrx) are present in two forms in 
animals, Glrx-1 (cytosolic) and Glrx-2 (mitochondrial) (Ferri et al., 2010; 
Gladyshev et al., 2001).   The mRNA levels of Glrx-2 was significantly 
reduced by gelsolin overexpression.  Studies have suggested a link between 
glutaredoxins and Cu/Zn SOD.  Glrx-2 has been implicated in the copper 
activation pathway that leads to Cu/Zn SOD stability (Carroll et al., 2006). A 
mutant form of Cu/Zn SOD has been found to aggregate in the mitochondria 
leading to the pathogenesis of the motor neuron disorder, amyotrophic lateral 
sclerosis (ALS) (Milani et al., 2011).  Glrx-2 has been shown to prevent the 
aggregation of mutant Cu/Zn SOD in the mitochondria and abrogates its 
toxicity (Ferri et al., 2010).  Therefore, downregulation of Glrx-2 by gelsolin 
overexpression may contribute to reduced Cu/Zn SOD activity, since Glrx-2 
appears to possess a certain degree of regulatory potential over Cu/Zn SOD. 
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4.4.2 Gelsolin associates with Cu/Zn SOD 
Gelsolin has been shown to interact and bind with several proteins 
including PI3K, c-Src (Chellaiah et al., 1998), p53 (An et al., 2011) and 
VDAC (Qiao & McMillan, 2007).  Therefore, we sought to test if gelsolin 
interacts with Cu/Zn SOD through protein-protein interaction.  Our results 
interestingly show that gelsolin could co-immunoprecipitate with Cu/Zn SOD 
which indicates that gelsolin and Cu/Zn SOD are binding partners.  In 
addition, in situ PLA analysis shows gelsolin and Cu/Zn SOD lie close to each 
other in the cell.  However, whether gelsolin and Cu/Zn SOD directly 
associates with each other is unclear and would require further investigation.  
Cu/Zn SOD has been shown to associate with actin and other cytoskeletal 
proteins (Zhang et al., 2007).  Cu/Zn SOD weakly interacts with actin and 
mutation in Cu/Zn SOD enhanced this actin-binding capacity in 
neuroblastoma cells (Takamiya et al., 2005). Recently, Cu/Zn SOD was also 
shown to co-localise with actin filaments which could be disrupted by 
phosphorylation of Cu/Zn SOD (Hjornevik et al., 2012).  Due to the close 
association of both gelsolin and Cu/Zn SOD with actin, it is also plausible that 
gelsolin may interact with Cu/Zn SOD through actin. 
Preliminary findings from in silico experiments suggest that gelsolin 
and Cu/Zn SOD may directly bind to each other (unpublished data provided 
by Dr Pugalenthi G, supplementary figures in Appendix 1).  Moreover, 
molecular dynamics simulation that mimics physiological condition shows 
that gelsolin-Cu/Zn SOD complex is stable.  Additionally, this study also 
120 
 
suggests that the C-terminal region of gelsolin may be important for binding to 
Cu/Zn SOD. 
Whether gelsolin and Cu/Zn SOD are direct binding partners will 
require further investigations, however, it is possible that the interaction 
between gelsolin and Cu/Zn SOD leads to the loss of Cu/Zn SOD activity.  
Indeed, gelsolin has the potential to suppress the activities of other proteins, 
for example, interaction between gelsolin and p53 leads to inactivation of p53 
in hepatocarcinoma cells (An et al., 2011).  Therefore the binding to gelsolin 
potentially have a inhibitory effect on Cu/Zn SOD activity, perhaps, by 
interfering with proper insertion of copper or disrupting dimerisation of Cu/Zn 
SOD. 
4.4.3 Gelsolin affects the mRNA levels of Nox isoforms 
In addition to defective antioxidants observed following gelsolin 
overexpression, we also studied the effect of gelsolin on the ROS-producing 
enzyme compex, the NADPH oxidases (Nox).  We observe that Nox1, Nox2 
and Nox5 genes are expressed in HCT116 and its derivative cell lines.  
Moreover, our result shows that gelsolin expression significantly upregulates 
the mRNA levels of both Nox1 and Nox5.  Transcription factors including 
Signal Transducer and Activator of Transcription-1 (STAT-1), AP-1 and Sp1 
have been suggested to regulate the transcription of Nox1 and binding of 
STAT-5 to Nox5 promoter region has been shown to induce Nox5 expression.  
Gelsolin may be involved in the transcriptional regulation of Nox1 and Nox5 
as gelsolin and other members of the gelsolin family such as flightless 1 and 
supervillin have been implicated as atranscriptional co-regulators.  Gelsolin 
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has been found to interact with the androgen receptor in prostate cancer cells 
and enhances its activity (Nishimura et al., 2003).  Furthermore 
immunohistochemistry analysis of gelsolin has also detected the presence of 
gelsolin in the nucleus in pancreatic cancer tissues (Thompson et al., 2007).  
However little is known on how gelsolin translocates to the nucleus and how it 
acts as a transcriptional co-regulator opening an avenue for future 
investigation. 
Thus far, we have revealed potential mechanisms by which gelsolin 
mediates its pro-oxidant nature.  We show that gelsolin expression negatively 
correlates with the mRNA expression of antioxidants as well as suppressing 
the activity of the antioxidant Cu/Zn SOD.  Gelsolin expression also correlates 
with an increase in the mRNA levels of the ROS-producing Nox enzymes.  
More significantly, we found a novel interaction between gelsolin and Cu/Zn 
SOD that seemingly result in the inactivation of Cu/Zn SOD activity leading 























CHAPTER 5  GENERAL DISCUSSION, CONCLUSION 
AND FUTURE WORK 
5.1 GENERAL DISCUSSION 
The actin cytoskeleton and its regulatory proteins influence cancer cell 
invasion.  Invasive cells are characterised by formation of actin-rich 
membrane protrusions that facilitate invasion by attachment to and 
degradation of ECM as well as generating force required for cell movement.  
Gelsolin is one of the most prominent actin-binding proteins that has been 
widely implicated in promoting cancer cell invasion.  The in-depth 
mechanisms by which gelsolin carries out invasive behaviour however remain 
poorly demonstrated. 
The role of gelsolin in cancer itself has been an open question.  
Because gelsolin has been found to be downregulated in several cancers it is 
considered as a tumour suppressor (Li et al., 2012).  Downregulation of 
gelsolin appears to be a result of transcriptional repression of gelsolin (Dong et 
al., 2002; Mielnicki et al., 1999).  Loss of function due to mutations also 
contributes to the tumour suppressive role of gelsolin (Mullauer et al., 1993).  
On the other hand, accumulating evidence supports the idea that gelsolin 
significantly contributes to tumour aggressiveness mainly in two areas — by 
its abilities to enhance invasion and resistance to apoptosis.  Gelsolin has been 
shown to be a downstream effector of Ras in the Rac-mediated invasion 
pathway (De Corte et al., 2002).  We have also recently shown that gelsolin 
promotes cancer cell invasion by elevating uPA levels as well as uPA 
secretion (Zhuo et al., 2012).  In this study we explore other potential 
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mechanisms by which gelsolin mediates invasion, such as through modulating 
intracellular ROS levels. 
5.1.1 Gelsolin as a pro-oxidant molecule 
Our results show that gelsolin expression modulates the intracellular 
levels of O2
-
.  Overespression of gelsolin results in increased levels of O2
-
 
whereas knockdown of endogenous gelsolin decreases O2
- 
levels.  However, it 
has been shown that gelsolin expression was heightened when PC12 rat 
medulla cells were treated with H2O2, and gelsolin has been suggested to have 
an antioxidant property (Chauhan et al., 2008; Ji et al., 2008).  Since our 
findings clearly point gelsolin as a pro-oxidant molecule, the induction of 
gelsolin expression by H2O2 is likely a result of an adaptive response to 
oxidative stress.  Indeed, gelsolin expression has been shown to be 
upregulated by hypoxic stress (Greijer et al., 2005) and genotoxic stress 
caused by 5- fluorouracil (5-FU) (Klampfer et al., 2005).  Thus, our study has 
demonstrated a novel pro-oxidant role of gelsolin, and importantly, we show 
that the increase in O2
-
 confers invasive phenotypes in cancer cells. 
5.1.2 Gelsolin mediates invasion in an O2
-
 dependent manner 
ROS have been shown to actively participate in the progression of 
cancer disease and promotes cancer cell invasion.  By virtue of their ability to 
modify proteins, DNA and lipids, and on the basis of how much ROS is 
produced, ROS regulates cancer in various aspects. For example, mild 
increase in ROS levels favour growth, proliferation and invasion whereas high 
levels of ROS are toxic to the cells (Benhar et al., 2002; Gloire et al., 2006; 
124 
 
Nishikawa, 2008).  Here, we show that the oxidative stress environment 
created by gelsolin is not toxic to cells but rather confers invasive phenotype.  
Gelsolin overexpression increased O2
-
 levels and enhanced cancer cell 
invasion.  The invasive abilities of gelsolin-overexpressing cells could be 
attenuated by DPI treatment.  Thus, our data corroborates the importance of 
O2
-
 in gelsolin-mediated invasion. 
Accumulating evidence have reported that ROS can upregulate MMPs 
and uPA expression (Binker et al., 2009; Chiu et al., 2010; Khoi et al., 2012a; 
Kim et al., 2007a; Pelicano et al., 2009).  In line with this, we found that 
gelsolin overexpression upregulates uPA secretion which could be lowered by 
DPI treatment.  Importantly, we have shown that uPA is critical in gelsolin-
mediated invasion (Zhuo et al., 2012).  Therefore, gelsolin-induced O2
-
 
probably plays a significant role in the upregulation of uPA and thereby 
promotes invasion.  In addition, whilst most studies have shown H2O2 as the 
dominant species involved in regulation of these proteases, our findings 
suggest an important role of O2
-
 in modulating uPA secretion and invasion.  
The mechanisms by which O2
-
 modulates uPA secretion however requires 
further studies. 
5.1.3  Gelsolin suppresses Cu/Zn SOD activity possibly by interacting 
with it 
Antioxidants play protective roles against cancer progression.  One 
such antioxidant is the Cu/Zn SOD.  Downregulation of Cu/Zn SOD is 
associated with malignant phenotypes in cancer.  Indeed loss of Cu/Zn SOD in 
animals leads to increased risk of liver cancer development (Elchuri et al., 
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2005; Van Remmen et al., 2003).  Our study has shown that gelsolin 
suppresses Cu/Zn SOD activity resulting in elevated levels of intracellular O2
-
 
pool.  Interestingly, our co-immunoprecipitation study reveals that gelsolin 
can form a complex with Cu/Zn SOD.  Therefore, it is possible that binding of 
gelsolin to Cu/Zn SOD interferes with Cu/Zn SOD activity leading to increase 
O2
-
. Although in silico analysis performed by Pugalenthi et al.., (unpublished 
data, personal communication) suggests that gelsolin binds directly to Cu/Zn 
SOD, more experimental evidences are required to substantiate the direct 
interaction.of gelsolin and Cu/Zn SOD. 
5.1.4 Gelsolin increases mRNA levels of Nox 
Besides the loss of Cu/Zn SOD, we sought to determine if ROS-
generating sources were influenced by gelsolin.  As Nox enzymes are the 
major O2
-
 generating source, we assessed the mRNA expressions of Nox.  We 
found that gelsolin-overexpression positively correlates with Nox1 and Nox 5 
mRNA levels.  Gelsolin has been implicated as a transcriptional co-regulator, 
supporting the potential role of gelsolin in the transcriptional control of these 
Noxes.  An important note to consider, however, is that Nox activity is highly 
dependent on its interactions with several cytosolic subunits (Katsuyama et al., 
2012).  Interestingly, actin and other actin-associated proteins have been 
shown to be involved in Nox assembly and stabilisation of Nox complex at the 
plasma membrane.  Therefore it is possible that gelsolin may also be involved 




Figure 5.1 Schematic illustration showing the summary of the key findings 
presented in this thesis. Overexpression of gelsolin suppresses Cu/Zn SOD activity, 
thereby increasing O2
-
 levels in the cell.  The mRNA levels of Nox genes were also 
found to be upregulated by gelsolin overexpression which may contribute to 
increased O2
-
 levels.  O2
-
 induced by gelsolin participates in uPA secretion resulting 
in enhanced cancer cell invasion.  
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5.2 CONCLUSION AND CLINICAL IMPLICATION 
In this study, we have delineated a novel role of gelsolin in creating a 
pro-oxidant milieu that favours cancer cell invasion.  The pro-oxidant nature 
of gelsolin triggers proteases such as uPA to degrade the ECM which 
facilitates the process of cancer cell invasion.  We further demonstrate a novel 
interaction between gelsolin and the antioxidant Cu/Zn SOD and this 
interaction possibly renders Cu/Zn SOD inactive, leading to the increase in O2
-
 
levels.  Disruption of the gelsolin-Cu/Zn SOD complex that restores Cu/Zn 
SOD activity will bring down the intracellular ROS levels and could at least in 
part attenuate the progression of cancer cell invasion.  Therefore, a better 
understanding of the interaction between gelsolin and Cu/Zn SOD is required.  
Targeting the gelsolin-Cu/Zn SOD complex will aid in lowering the 





5.3 FUTURE WORK 
Key areas of interest for future investigations are: 
 To elucidate whether gelsolin and Cu/Zn SOD are direct binding 
partners and to identify the binding region: Our findings have 
provided evidence that gelsolin suppresses Cu/Zn SOD activity, 
however, the mechanisms remain unclear.  We show that gelsolin co-
immunoprecipitates with Cu/Zn SOD and preliminary findings using in 
silico analysis suggest that the C-terminal half of gelsolin may be 
involved in this interaction (Appendix I, supplementary figure 1).  Our 
study can be extended to determine the nature of gelsolin-Cu/Zn SOD 
interaction.  Furthermore gelsolin mutant constructs, such as C-
terminal truncate or domain deletion mutants can be employed to 
determine the region of gelsolin important in the binding and 
regulation of Cu/Zn SOD. 
 To study the role of gelsolin and O2
-
 in invadopodia: Formation of 
invadopodia is an important mechanism by which cancer cells promote 
invasion.  Actin cytoskeleton and its regulatory protein are important 
in invadopodia.  The role of gelsolin and O2
-
 can be explored which 
may provide a mechanistic insight into the role of gelsolin-induced 
invasion. 
 Role of gelsolin-induced O2
-
 in uPA regulation: Although we have 
shown that O2
-
 is involved in upregulating uPA secretion, the 
mechanism is not known.  This study can be extended by assessing 
whether uPA transcription is influenced by O2
-
 induced by gelsolin.  
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Moreover, it would also be interesting to study if O2
- 
is involved in the 
activation step of uPA.  Understanding the mechanisms by which O2
-
 
participates in upregualting uPA secretion will enhance our 





















Alexandrova AY, Kopnin PB, Vasiliev JM, Kopnin BP (2006) ROS up-regulation 
mediates Ras-induced changes of cell morphology and motility. Exp Cell Res 312: 
2066-2073 
 
Alscher RG, Erturk N, Heath LS (2002) Role of superoxide dismutases (SODs) in 
controlling oxidative stress in plants. Journal of experimental botany 53: 1331-1341 
 
An JH, Kim JW, Jang SM, Kim CH, Kang EJ, Choi KH (2011) Gelsolin negatively 
regulates the activity of tumor suppressor p53 through their physical interaction in 
hepatocarcinoma HepG2 cells. Biochem Biophys Res Commun 412: 44-49 
 
Angers-Loustau A, Hering R, Werbowetski TE, Kaplan DR, Del Maestro RF (2004) 
SRC regulates actin dynamics and invasion of malignant glial cells in three 
dimensions. Mol Cancer Res 2: 595-605 
 
Antequera D, Vargas T, Ugalde C, Spuch C, Molina JA, Ferrer I, Bermejo-Pareja F, 
Carro E (2009) Cytoplasmic gelsolin increases mitochondrial activity and reduces 
Abeta burden in a mouse model of Alzheimer's disease. Neurobiology of disease 36: 
42-50 
 
Arora PD, Glogauer M, Kapus A, Kwiatkowski DJ, McCulloch CA (2004) Gelsolin 
mediates collagen phagocytosis through a rac-dependent step. Mol Biol Cell 15: 588-
599 
 
Arora PD, McCulloch CA (1996) Dependence of fibroblast migration on actin 
severing activity of gelsolin. J Biol Chem 271: 20516-20523 
 
Asch HL, Head K, Dong Y, Natoli F, Winston JS, Connolly JL, Asch BB (1996) 
Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res 
56: 4841-4845 
 
Azuma T, Koths K, Flanagan L, Kwiatkowski D (2000) Gelsolin in complex with 
phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic 
progression. J Biol Chem 275: 3761-3766 
 
Azuma T, Witke W, Stossel TP, Hartwig JH, Kwiatkowski DJ (1998) Gelsolin is a 
downstream effector of rac for fibroblast motility. EMBO J 17: 1362-1370 
 
Baldassarre M, Ayala I, Beznoussenko G, Giacchetti G, Machesky LM, Luini A, 
Buccione R (2006) Actin dynamics at sites of extracellular matrix degradation. Eur J 




Banci L, Bertini I, Cantini F, Kozyreva T, Massagni C, Palumaa P, Rubino JT, Zovo 
K (2012) Human superoxide dismutase 1 (hSOD1) maturation through interaction 
with human copper chaperone for SOD1 (hCCS). Proc Natl Acad Sci U S A 109: 
13555-13560 
 
Banci L, Bertini I, Cramaro F, Del Conte R, Viezzoli MS (2002) The solution 
structure of reduced dimeric copper zinc superoxide dismutase. The structural effects 
of dimerization. European journal of biochemistry / FEBS 269: 1905-1915 
 
Banno Y, Nakashima T, Kumada T, Ebisawa K, Nonomura Y, Nozawa Y (1992) 
Effects of gelsolin on human platelet cytosolic phosphoinositide-phospholipase C 
isozymes. J Biol Chem 267: 6488-6494 
 
Barbour A, Gotley DC (2003) Current concepts of tumour metastasis. Annals of the 
Academy of Medicine, Singapore 32: 176-184 
 
Barnett P, Arnold RS, Mezencev R, Chung LW, Zayzafoon M, Odero-Marah V 
(2011) Snail-mediated regulation of reactive oxygen species in ARCaP human 
prostate cancer cells. Biochem Biophys Res Commun 404: 34-39 
 
Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, 
Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM (2005) Targeting of urokinase 
plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- 
and insulin-like growth factor-I receptor-mediated migration and invasion and 
orthotopic tumor growth in mice. Cancer Res 65: 7775-7781 
 
Baum B, Settleman J, Quinlan MP (2008) Transitions between epithelial and 
mesenchymal states in development and disease. Semin Cell Dev Biol 19: 294-308 
 
Ben Mahdi MH, Andrieu V, Pasquier C (2000) Focal adhesion kinase regulation by 
oxidative stress in different cell types. IUBMB Life 50: 291-299 
 
Benhar M, Engelberg D, Levitzki A (2002) ROS, stress-activated kinases and stress 
signaling in cancer. EMBO Rep 3: 420-425 
 
Binker MG, Binker-Cosen AA, Richards D, Oliver B, Cosen-Binker LI (2009) EGF 
promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and 
activation of MMP-2. Biochem Biophys Res Commun 379: 445-450 
 
Boivin B, Yang M, Tonks NK (2010) Targeting the reversibly oxidized protein 
tyrosine phosphatase superfamily. Sci Signal 3: pl2 
 
Bostwick DG, Alexander EE, Singh R, Shan A, Qian J, Santella RM, Oberley LW, 
Yan T, Zhong W, Jiang X, Oberley TD (2000) Antioxidant enzyme expression and 
reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. 
Cancer 89: 123-134 
132 
 
Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM (2010) Molecular 
interactions in cancer cell metastasis. Acta Histochem 112: 3-25 
 
Brown DI, Griendling KK (2009) Nox proteins in signal transduction. Free Radic 
Biol Med 47: 1239-1253 
 
Burtnick LD, Koepf EK, Grimes J, Jones EY, Stuart DI, McLaughlin PJ, Robinson 
RC (1997) The crystal structure of plasma gelsolin: implications for actin severing, 
capping, and nucleation. Cell 90: 661-670 
 
Burtnick LD, Urosev D, Irobi E, Narayan K, Robinson RC (2004) Structure of the N-
terminal half of gelsolin bound to actin: roles in severing, apoptosis and FAF. EMBO 
J 23: 2713-2722 
 
Cadenas E, Davies KJ (2000) Mitochondrial free radical generation, oxidative stress, 
and aging. Free Radic Biol Med 29: 222-230 
 
Campbell PM, Der CJ (2004) Oncogenic Ras and its role in tumor cell invasion and 
metastasis. Seminars in cancer biology 14: 105-114 
 
Cannito S, Novo E, di Bonzo LV, Busletta C, Colombatto S, Parola M (2010) 
Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to 
implications in human health and disease. Antioxid Redox Signal 12: 1383-1430 
 
Carroll MC, Outten CE, Proescher JB, Rosenfeld L, Watson WH, Whitson LJ, Hart 
PJ, Jensen LT, Cizewski Culotta V (2006) The effects of glutaredoxin and copper 
activation pathways on the disulfide and stability of Cu,Zn superoxide dismutase. J 
Biol Chem 281: 28648-28656 
 
Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of 
cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572 
 
Chauhan V, Ji L, Chauhan A (2008) Anti-amyloidogenic, anti-oxidant and anti-
apoptotic role of gelsolin in Alzheimer's disease. Biogerontology 9: 381-389 
 
Chellaiah M, Fitzgerald C, Alvarez U, Hruska K (1998) c-Src is required for 
stimulation of gelsolin-associated phosphatidylinositol 3-kinase. J Biol Chem 273: 
11908-11916 
 
Chellaiah M, Hruska K (1996) Osteopontin stimulates gelsolin-associated 
phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase. Mol 




Chellaiah M, Kizer N, Silva M, Alvarez U, Kwiatkowski D, Hruska KA (2000) 
Gelsolin deficiency blocks podosome assembly and produces increased bone mass 
and strength. J Cell Biol 148: 665-678 
 
Chellaiah MA (2006) Regulation of podosomes by integrin alphavbeta3 and Rho 
GTPase-facilitated phosphoinositide signaling. Eur J Cell Biol 85: 311-317 
 
Chellaiah MA, Biswas RS, Yuen D, Alvarez UM, Hruska KA (2001) 
Phosphatidylinositol 3,4,5-trisphosphate directs association of Src homology 2-
containing signaling proteins with gelsolin. J Biol Chem 276: 47434-47444 
 
Chen P, Murphy-Ullrich JE, Wells A (1996) A role for gelsolin in actuating 
epidermal growth factor receptor-mediated cell motility. J Cell Biol 134: 689-698 
 
Chen WT (1989) Proteolytic activity of specialized surface protrusions formed at 
rosette contact sites of transformed cells. The Journal of experimental zoology 251: 
167-185 
 
Cheng G, Diebold BA, Hughes Y, Lambeth JD (2006) Nox1-dependent reactive 
oxygen generation is regulated by Rac1. J Biol Chem 281: 17718-17726 
 
Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, Raugei G, Symons M, 
Borrello S, Galeotti T, Ramponi G (2003) Reactive oxygen species as essential 
mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is 
required for cell adhesion. J Cell Biol 161: 933-944 
 
Chiu WT, Shen SC, Chow JM, Lin CW, Shia LT, Chen YC (2010) Contribution of 
reactive oxygen species to migration/invasion of human glioblastoma cells U87 via 
ERK-dependent COX-2/PGE(2) activation. Neurobiology of disease 37: 118-129 
 
Choe H, Burtnick LD, Mejillano M, Yin HL, Robinson RC, Choe S (2002) The 
calcium activation of gelsolin: insights from the 3A structure of the G4-G6/actin 
complex. Journal of molecular biology 324: 691-702 
 
Chou J, Stolz DB, Burke NA, Watkins SC, Wells A (2002) Distribution of gelsolin 
and phosphoinositol 4,5-bisphosphate in lamellipodia during EGF-induced motility. 
Int J Biochem Cell Biol 34: 776-790 
 
Clark ES, Weaver AM (2008) A new role for cortactin in invadopodia: regulation of 
protease secretion. Eur J Cell Biol 87: 581-590 
 
Clark ES, Whigham AS, Yarbrough WG, Weaver AM (2007) Cortactin is an 
essential regulator of matrix metalloproteinase secretion and extracellular matrix 




Clement MV, Stamenkovic I (1996) Superoxide anion is a natural inhibitor of FAS-
mediated cell death. EMBO J 15: 216-225 
 
Crowley J, Smith T, Fang Z, Takizawa N, Luna E (2009) Supervillin reorganizes the 
actin cytoskeleton and increases invadopodial efficiency. Mol Biol Cell 20: 948-962 
 
Cunningham CC, Stossel TP, Kwiatkowski DJ (1991) Enhanced motility in NIH 3T3 
fibroblasts that overexpress gelsolin. Science 251: 1233-1236 
 
Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI (2004) Matrix 
metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies 
poor prognosis colorectal cancers. Clin Cancer Res 10: 8229-8234 
 
Curran S, Murray GI (2000) Matrix metalloproteinases: molecular aspects of their 
roles in tumour invasion and metastasis. Eur J Cancer 36: 1621-1630 
 
D'Autréaux B, Toledano MB (2007) ROS as signalling molecules: mechanisms that 
generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8: 813-824 
 
DalleDonne I, Milzani A, Colombo R (1995) H2O2-treated actin: assembly and 
polymer interactions with cross-linking proteins. Biophys J 69: 2710-2719 
 
DalleDonne I, Milzani A, Colombo R (1999) The tert-butyl hydroperoxide-induced 
oxidation of actin Cys-374 is coupled with structural changes in distant regions of the 
protein. Biochemistry 38: 12471-12480 
 
De Corte V, Bruyneel E, Boucherie C, Mareel M, Vandekerckhove J, Gettemans J 
(2002) Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. 
EMBO J 21: 6781-6790 
 
 
den Hertog J, Ostman A, Böhmer FD (2008) Protein tyrosine phosphatases: 
regulatory mechanisms. FEBS J 275: 831-847 
 
Diaz B, Courtneidge SA (2012) Redox signaling at invasive microdomains in cancer 
cells. Free Radic Biol Med 52: 247-256 
 
Diaz B, Shani G, Pass I, Anderson D, Quintavalle M, Courtneidge SA (2009) Tks5-
dependent, nox-mediated generation of reactive oxygen species is necessary for 
invadopodia formation. Sci Signal 2: ra53 
 
Didion SP, Hathaway CA, Faraci FM (2001) Superoxide levels and function of 
cerebral blood vessels after inhibition of CuZn-SOD. American journal of physiology 
Heart and circulatory physiology 281: H1697-1703 
135 
 
Ditsch A, Wegner A (1994) Nucleation of actin polymerization by gelsolin. European 
journal of biochemistry / FEBS 224: 223-227 
 
Dong Y, Asch HL, Ying A, Asch BB (2002) Molecular mechanism of transcriptional 
repression of gelsolin in human breast cancer cells. Exp Cell Res 276: 328-336 
 
Dosaka-Akita H, Hommura F, Fujita H, Kinoshita I, Nishi M, Morikawa T, Katoh H, 
Kawakami Y, Kuzumaki N (1998) Frequent loss of gelsolin expression in non-small 
cell lung cancers of heavy smokers. Cancer Res 58: 322-327 
 
Duffy MJ (2004) The urokinase plasminogen activator system: role in malignancy. 
Current pharmaceutical design 10: 39-49 
 
Elchuri S, Oberley TD, Qi W, Eisenstein RS, Jackson Roberts L, Van Remmen H, 
Epstein CJ, Huang TT (2005) CuZnSOD deficiency leads to persistent and 
widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 24: 
367-380 
 
Endres M, Fink K, Zhu J, Stagliano NE, Bondada V, Geddes JW, Azuma T, Mattson 
MP, Kwiatkowski DJ, Moskowitz MA (1999) Neuroprotective effects of gelsolin 
during murine stroke. J Clin Invest 103: 347-354 
 
Ferri A, Fiorenzo P, Nencini M, Cozzolino M, Pesaresi MG, Valle C, Sepe S, Moreno 
S, Carri MT (2010) Glutaredoxin 2 prevents aggregation of mutant SOD1 in 
mitochondria and abolishes its toxicity. Human molecular genetics 19: 4529-4542 
 
Fiaschi T, Cozzi G, Raugei G, Formigli L, Ramponi G, Chiarugi P (2006) Redox 
regulation of beta-actin during integrin-mediated cell adhesion. The Journal of 
biological chemistry 281: 22983-22991 
 
Finkelstein M, Etkovitz N, Breitbart H (2010) Role and regulation of sperm gelsolin 
prior to fertilization. J Biol Chem 285: 39702-39709 
 
Fridovich I (1978) Superoxide radicals, superoxide dismutases and the aerobic 
lifestyle. Photochemistry and photobiology 28: 733-741 
 
Fridovich I (1995) Superoxide radical and superoxide dismutases. Annu Rev Biochem 
64: 97-112 
 
Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity 
and reciprocity. Cell 147: 992-1009 
 
Friedl P, Gilmour D (2009) Collective cell migration in morphogenesis, regeneration 
and cancer. Nat Rev Mol Cell Biol 10: 445-457 
136 
 
Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape 
mechanisms. Nat Rev Cancer 3: 362-374 
 
Furukawa Y, Torres AS, O'Halloran TV (2004) Oxygen-induced maturation of 
SOD1: a key role for disulfide formation by the copper chaperone CCS. EMBO J 23: 
2872-2881 
 
Gay F, Estornes Y, Saurin JC, Joly-Pharaboz MO, Friederich E, Scoazec JY, Abello J 
(2008) In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated 
during the transition from adenoma to carcinoma. Hum Pathol 39: 1420-1430 
 
Geng YJ, Azuma T, Tang JX, Hartwig JH, Muszynski M, Wu Q, Libby P, 
Kwiatkowski DJ (1998) Caspase-3-induced gelsolin fragmentation contributes to 
actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle 
cells exposed to proinflammatory cytokines. Eur J Cell Biol 77: 294-302 
 
Gianni D, Taulet N, DerMardirossian C, Bokoch GM (2010a) c-Src-mediated 
phosphorylation of NoxA1 and Tks4 induces the reactive oxygen species (ROS)-
dependent formation of functional invadopodia in human colon cancer cells. Mol Biol 
Cell 21: 4287-4298 
 
Gianni D, Taulet N, Zhang H, DerMardirossian C, Kister J, Martinez L, Roush WR, 
Brown SJ, Bokoch GM, Rosen H (2010b) A novel and specific NADPH oxidase-1 
(Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in 
human colon cancer cells. ACS chemical biology 5: 981-993 
 
Giridharan SS, Rohn JL, Naslavsky N, Caplan S (2012) Differential regulation of 
actin microfilaments by human MICAL proteins. J Cell Sci 
Gladyshev VN, Liu A, Novoselov SV, Krysan K, Sun QA, Kryukov VM, Kryukov 
GV, Lou MF (2001) Identification and characterization of a new mammalian 
glutaredoxin (thioltransferase), Grx2. J Biol Chem 276: 30374-30380 
 
Gloire G, Legrand-Poels S, Piette J (2006) NF-kappaB activation by reactive oxygen 
species: fifteen years later. Biochemical pharmacology 72: 1493-1505 
 
Glorieux C, Dejeans N, Sid B, Beck R, Calderon PB, Verrax J (2011) Catalase 
overexpression in mammary cancer cells leads to a less aggressive phenotype and an 
altered response to chemotherapy. Biochemical pharmacology 82: 1384-1390 
 
Granfeldt D, Dahlgren C (2001) An intact cytoskeleton is required for prolonged 
respiratory burst activity during neutrophil phagocytosis. Inflammation 25: 165-169 
 
Greijer AE, van der Groep P, Kemming D, Shvarts A, Semenza GL, Meijer GA, van 
de Wiel MA, Belien JA, van Diest PJ, van der Wall E (2005) Up-regulation of gene 
expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 
(HIF-1). J Pathol 206: 291-304 
137 
 
Guan JL (1997) Role of focal adhesion kinase in integrin signaling. Int J Biochem 
Cell Biol 29: 1085-1096 
 
Guarino M (2010) Src signaling in cancer invasion. J Cell Physiol 223: 14-26 
 
Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127: 
679-695 
 
Haga K, Fujita H, Nomoto M, Sazawa A, Nakagawa K, Harabayashi T, Shinohara N, 
Takimoto M, Nonomura K, Kuzumaki N (2004) Gelsolin gene silencing involving 
unusual hypersensitivities to dimethylsulfate and KMnO4 in vivo footprinting on its 
promoter region. International journal of cancer Journal international du cancer 
111: 873-880 
 
Halliwell B (1996) Antioxidants in human health and disease. Annual review of 
nutrition 16: 33-50 
 
Halliwell B (2006) Reactive species and antioxidants. Redox biology is a 
fundamental theme of aerobic life. Plant physiology 141: 312-322 
 
Halliwell B (2007) Oxidative stress and cancer: have we moved forward? The 
Biochemical journal 401: 1-11 
 
Han JW, Ahn SH, Park SH, Wang SY, Bae GU, Seo DW, Kwon HK, Hong S, Lee 
HY, Lee YW, Lee HW (2000) Apicidin, a histone deacetylase inhibitor, inhibits 
proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res 
60: 6068-6074 
 
Heikkila RE, Cabbat FS, Cohen G (1976) In vivo inhibition of superoxide dismutase 
in mice by diethyldithiocarbamate. J Biol Chem 251: 2182-2185 
 
Hjornevik LV, Fismen L, Young FM, Solstad T, Fladmark KE (2012) Nodularin 
Exposure Induces SOD1 Phosphorylation and Disrupts SOD1 Co-localization with 
Actin Filaments. Toxins 4: 1482-1499 
 
Hoshikawa Y, Kwon HJ, Yoshida M, Horinouchi S, Beppu T (1994) Trichostatin A 
induces morphological changes and gelsolin expression by inhibiting histone 
deacetylase in human carcinoma cell lines. Exp Cell Res 214: 189-197 
 
Hung RJ, Pak CW, Terman JR (2011) Direct redox regulation of F-actin assembly 
and disassembly by Mical. Science 334: 1710-1713 
Janmey PA, Stossel TP (1987) Modulation of gelsolin function by 




Ji L, Chauhan A, Chauhan V (2008) Cytoplasmic gelsolin in pheochromocytoma-12 
cells forms a complex with amyloid beta-protein. Neuroreport 19: 463-466 
Jones GE, Zicha D, Dunn GA, Blundell M, Thrasher A (2002) Restoration of 
podosomes and chemotaxis in Wiskott-Aldrich syndrome macrophages following 
induced expression of WASp. Int J Biochem Cell Biol 34: 806-815 
 
Kamata T (2009) Roles of Nox1 and other Nox isoforms in cancer development. 
Cancer Sci 100: 1382-1388 
 
Kang J, Pervaiz S (2012) Crosstalk between Bcl-2 family and Ras family small 
GTPases: potential cell fate regulation? Frontiers in oncology 2: 206 
 
Kassis J, Lauffenburger DA, Turner T, Wells A (2001) Tumor invasion as 
dysregulated cell motility. Seminars in cancer biology 11: 105-117 
 
Katsuyama M, Matsuno K, Yabe-Nishimura C (2012) Physiological roles of 
NOX/NADPH oxidase, the superoxide-generating enzyme. Journal of clinical 
biochemistry and nutrition 50: 9-22 
 
Khoi PN, Park JS, Kim NH, Jung YD (2012a) Nicotine stimulates urokinase-type 
plasminogen activator receptor expression and cell invasiveness through mitogen-
activated protein kinase and reactive oxygen species signaling in ECV304 endothelial 
cells. Toxicol Appl Pharmacol 259: 248-256 
 
Khoi PN, Park JS, Kim NH, Jung YD (2012b) Nicotine stimulates urokinase-type 
plasminogen activator receptor expression and cell invasiveness through mitogen-
activated protein kinase and reactive oxygen species signaling in ECV304 endothelial 
cells. Toxicol Appl Pharmacol 
 
Kim JH, Choi YK, Kwon HJ, Yang HK, Choi JH, Kim DY (2004) Downregulation of 
gelsolin and retinoic acid receptor beta expression in gastric cancer tissues through 
histone deacetylase 1. Journal of gastroenterology and hepatology 19: 218-224 
 
Kim JS, Bak EJ, Lee BC, Kim YS, Park JB, Choi IG (2011) Neuregulin induces 
HaCaT keratinocyte migration via Rac1-mediated NADPH-oxidase activation. J Cell 
Physiol 226: 3014-3021 
 
Kim JS, Huang TY, Bokoch GM (2009) Reactive oxygen species regulate a 
slingshot-cofilin activation pathway. Mol Biol Cell 20: 2650-2660 
 
Kim MH, Yoo HS, Kim MY, Jang HJ, Baek MK, Kim HR, Kim KK, Shin BA, Ahn 
BW, Jung YD (2007a) Helicobacter pylori stimulates urokinase plasminogen 
activator receptor expression and cell invasiveness through reactive oxygen species 




Kim MH, Yoo HS, Kim MY, Jang HJ, Baek MK, Kim HR, Kim KK, Shin BA, Ahn 
BW, Jung YD (2007b) Helicobacter pylori stimulates urokinase plasminogen 
activator receptor expression and cell invasiveness through reactive oxygen species 
and NF-kappaB signaling in human gastric carcinoma cells. Int J Mol Med 19: 689-
697 
 
Klampfer L, Swaby L, Huang J, Sasazuki T, Shirasawa S, Augenlicht L (2005) 
Oncogenic Ras increases sensitivity of colon cancer cells to 5-FU-induced apoptosis. 
Oncogene 24: 3932-3941 
 
Knapp LT, Klann E (2000) Superoxide-induced stimulation of protein kinase C via 
thiol modification and modulation of zinc content. J Biol Chem 275: 24136-24145 
 
Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, 
Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT (1997) Caspase-3-generated 
fragment of gelsolin: effector of morphological change in apoptosis. Science 278: 
294-298 
 
Koya R, Fujita H, Shimizu S, Ohtsu M, Takimoto M, Tsujimoto Y, Kuzumaki N 
(2000) Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss 
and cytochrome c release. J Biol Chem 275: 15343-15349 
 
Kozma R, Ahmed S, Best A, Lim L (1995) The Ras-related protein Cdc42Hs and 
bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 
3T3 fibroblasts. Mol Cell Biol 15: 1942-1952 
 
Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK (2008) Oxidative stress is 
inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 
68: 1777-1785 
 
Kusano H, Shimizu S, Koya R, Fujita H, Kamada S, Kuzumaki N, Tsujimoto Y 
(2000) Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial 
changes via closing VDAC. Oncogene 19: 4807-4814 
 
Kwiatkowski DJ (1999) Functions of gelsolin: motility, signaling, apoptosis, cancer. 
Curr Opin Cell Biol 11: 103-108 
 
Kwiatkowski DJ, Stossel TP, Orkin SH, Mole JE, Colten HR, Yin HL (1986) Plasma 
and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated 
actin-binding domain. Nature 323: 455-458 
 
Lai FP, Szczodrak M, Block J, Faix J, Breitsprecher D, Mannherz HG, Stradal TE, 
Dunn GA, Small JV, Rottner K (2008) Arp2/3 complex interactions and actin 
network turnover in lamellipodia. EMBO J 27: 982-992 
Leber MF, Efferth T (2009) Molecular principles of cancer invasion and metastasis 
(review). International journal of oncology 34: 881-895 
140 
 
Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T, Yu ZX, Ferrans VJ, Howard 
BH, Finkel T (1999a) Ras proteins induce senescence by altering the intracellular 
levels of reactive oxygen species. J Biol Chem 274: 7936-7940 
 
Lee HK, Driscoll D, Asch H, Asch B, Zhang PJ (1999b) Downregulated gelsolin 
expression in hyperplastic and neoplastic lesions of the prostate. The Prostate 40: 14-
19 
 
Lee KH, Kim SW, Kim JR (2009) Reactive oxygen species regulate urokinase 
plasminogen activator expression and cell invasion via mitogen-activated protein 
kinase pathways after treatment with hepatocyte growth factor in stomach cancer 
cells. J Exp Clin Cancer Res 28: 73 
 
Legrand C, Polette M, Tournier JM, de Bentzmann S, Huet E, Monteau M, Birembaut 
P (2001) uPA/plasmin system-mediated MMP-9 activation is implicated in bronchial 
epithelial cell migration. Exp Cell Res 264: 326-336 
 
Li A, Dawson JC, Forero-Vargas M, Spence HJ, Yu X, Konig I, Anderson K, 
Machesky LM (2010) The actin-bundling protein fascin stabilizes actin in 
invadopodia and potentiates protrusive invasion. Curr Biol 20: 339-345 
 
Li GH, Arora PD, Chen Y, McCulloch CA, Liu P (2012) Multifunctional roles of 
gelsolin in health and diseases. Medicinal research reviews 32: 999-1025 
 
Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura 
MP, Berger C, Chan PH, Wallace DC, Epstein CJ (1995) Dilated cardiomyopathy 
and neonatal lethality in mutant mice lacking manganese superoxide dismutase. 
Nature genetics 11: 376-381 
 
Liao CJ, Wu TI, Huang YH, Chang TC, Wang CS, Tsai MM, Hsu CY, Tsai MH, Lai 
CH, Lin KH (2011) Overexpression of gelsolin in human cervical carcinoma and its 
clinicopathological significance. Gynecologic oncology 120: 135-144 
 
Lijnen HR (2001) Elements of the fibrinolytic system. Ann N Y Acad Sci 936: 226-
236 
 
Litwin M, Mazur AJ, Nowak D, Mannherz HG, Malicka-Blaszkiewicz M (2009) 
Gelsolin in human colon adenocarcinoma cells with different metastatic potential. 
Acta biochimica Polonica 56: 739-743 
 
Litwin M, Nowak D, Mazur AJ, Baczynska D, Mannherz HG, Malicka-Blaszkiewicz 
M (2012) Gelsolin affects the migratory ability of human colon adenocarcinoma and 
melanoma cells. Life sciences 90: 851-861 
 
Lu M, Witke W, Kwiatkowski DJ, Kosik KS (1997) Delayed retraction of filopodia 
in gelsolin null mice. J Cell Biol 138: 1279-1287 
141 
 
Lukaszewicz-Zając M, Mroczko B, Szmitkowski M (2011) Gastric cancer - The role 
of matrix metalloproteinases in tumor progression. Clin Chim Acta 412: 1725-1730 
 
Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, 
Groom AC (1998) Multistep nature of metastatic inefficiency: dormancy of solitary 
cells after successful extravasation and limited survival of early micrometastases. The 
American journal of pathology 153: 865-873 
 
Machesky LM, Insall RH (1998) Scar1 and the related Wiskott-Aldrich syndrome 
protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr 
Biol 8: 1347-1356 
 
Machesky LM, Li A (2010) Fascin: Invasive filopodia promoting metastasis. 
Communicative & integrative biology 3: 263-270 
 
Maniatis NA, Harokopos V, Thanassopoulou A, Oikonomou N, Mersinias V, Witke 
W, Orfanos SE, Armaganidis A, Roussos C, Kotanidou A, Aidinis V (2009) A 
critical role for gelsolin in ventilator-induced lung injury. Am J Respir Cell Mol Biol 
41: 426-432 
 
Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R (1997) Platelet-derived growth 
factor-stimulated superoxide anion production modulates activation of transcription 
factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human 
aortic smooth muscle cells. Circulation 96: 2361-2367 
 
Maury CP (1991) Gelsolin-related amyloidosis. Identification of the amyloid protein 
in Finnish hereditary amyloidosis as a fragment of variant gelsolin. J Clin Invest 87: 
1195-1199 
 
McLaughlin PJ, Gooch JT, Mannherz HG, Weeds AG (1993) Structure of gelsolin 
segment 1-actin complex and the mechanism of filament severing. Nature 364: 685-
692 
 
Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 
6: 449-458 
 
Mellier G, Pervaiz S (2012) The three Rs along the TRAIL: resistance, re-
sensitization and reactive oxygen species (ROS). Free radical research 46: 996-1003 
 
Melov S, Doctrow SR, Schneider JA, Haberson J, Patel M, Coskun PE, Huffman K, 
Wallace DC, Malfroy B (2001) Lifespan extension and rescue of spongiform 
encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide 
dismutase-catalase mimetics. The Journal of neuroscience : the official journal of the 




Meyer T, Hart IR (1998) Mechanisms of tumour metastasis. Eur J Cancer 34: 214-
221 
 
Mielnicki LM, Ying AM, Head KL, Asch HL, Asch BB (1999) Epigenetic regulation 
of gelsolin expression in human breast cancer cells. Exp Cell Res 249: 161-176 
 
Milani P, Gagliardi S, Cova E, Cereda C (2011) SOD1 Transcriptional and 
Posttranscriptional Regulation and Its Potential Implications in ALS. Neurology 
research international 2011: 458427 
 
Miyano K, Ueno N, Takeya R, Sumimoto H (2006) Direct involvement of the small 
GTPase Rac in activation of the superoxide-producing NADPH oxidase Nox1. J Biol 
Chem 281: 21857-21868 
 
Mizuguchi K, Deane CM, Blundell TL, Johnson MS, Overington JP (1998) JOY: 
protein sequence-structure representation and analysis. Bioinformatics 14: 617-623 
 
Mohanam S, Chandrasekar N, Yanamandra N, Khawar S, Mirza F, Dinh DH, Olivero 
WC, Rao JS (2002) Modulation of invasive properties of human glioblastoma cells 
stably expressing amino-terminal fragment of urokinase-type plasminogen activator. 
Oncogene 21: 7824-7830 
 
Moldovan L, Irani K, Moldovan NI, Finkel T, Goldschmidt-Clermont PJ (1999) The 
actin cytoskeleton reorganization induced by Rac1 requires the production of 
superoxide. Antioxid Redox Signal 1: 29-43 
 
Moldovan L, Mythreye K, Goldschmidt-Clermont P, Satterwhite L (2006) Reactive 
oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and 
Rac1. Cardiovasc Res 71: 236-246 
 
Moriya S, Yanagihara K, Fujita H, Kuzumaki N (1994) Differential expression of 
hsp90, gelsolin and gst-pi in human gastric-carcinoma cell-lines. International 
journal of oncology 5: 1347-1351 
 
Mullauer L, Fujita H, Ishizaki A, Kuzumaki N (1993) Tumor-suppressive function of 
mutated gelsolin in ras-transformed cells. Oncogene 8: 2531-2536 
 
Myhre O, Andersen JM, Aarnes H, Fonnum F (2003) Evaluation of the probes 2',7'-
dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species 
formation. Biochemical pharmacology 65: 1575-1582 
 
Nelson KK, Melendez JA (2004) Mitochondrial redox control of matrix 




Ni XG, Zhou L, Wang GQ, Liu SM, Bai XF, Liu F, Peppelenbosch MP, Zhao P 
(2008) The ubiquitin-proteasome pathway mediates gelsolin protein downregulation 
in pancreatic cancer. Mol Med 14: 582-589 
 
Nishikawa M (2008) Reactive oxygen species in tumor metastasis. Cancer Lett 266: 
53-59 
 
Nishikawa M, Hashida M (2006) Inhibition of tumour metastasis by targeted delivery 
of antioxidant enzymes. Expert Opin Drug Deliv 3: 355-369 
 
Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, 
Yeh S, Miyamoto H, Shin M, Aozasa K, Okuyama A, Chang C (2003) Modulation of 
androgen receptor transactivation by gelsolin: a newly identified androgen receptor 
coregulator. Cancer Res 63: 4888-4894 
 
Nobes CD, Hall A (1995a) Rho, rac and cdc42 GTPases: regulators of actin 
structures, cell adhesion and motility. Biochem Soc Trans 23: 456-459 
 
Nobes CD, Hall A (1995b) Rho, rac, and cdc42 GTPases regulate the assembly of 
multimolecular focal complexes associated with actin stress fibers, lamellipodia, and 
filopodia. Cell 81: 53-62 
 
Nobes CD, Hall A (1999) Rho GTPases control polarity, protrusion, and adhesion 
during cell movement. J Cell Biol 144: 1235-1244 
 
Noske A, Denkert C, Schober H, Sers C, Zhumabayeva B, Weichert W, Dietel M, 
Wiechen K (2005) Loss of Gelsolin expression in human ovarian carcinomas. Eur J 
Cancer 41: 461-469 
 
Novo E, Parola M (2008) Redox mechanisms in hepatic chronic wound healing and 
fibrogenesis. Fibrogenesis Tissue Repair 1: 5 
 
Ohtsu M, Sakai N, Fujita H, Kashiwagi M, Gasa S, Shimizu S, Eguchi Y, Tsujimoto 
Y, Sakiyama Y, Kobayashi K, Kuzumaki N (1997) Inhibition of apoptosis by the 
actin-regulatory protein gelsolin. EMBO J 16: 4650-4656 
 
Oikonomou N, Thanasopoulou A, Tzouvelekis A, Harokopos V, Paparountas T, 
Nikitopoulou I, Witke W, Karameris A, Kotanidou A, Bouros D, Aidinis V (2009) 
Gelsolin expression is necessary for the development of modelled pulmonary 
inflammation and fibrosis. Thorax 64: 467-475 
 
Pelicano H, Lu W, Zhou Y, Zhang W, Chen Z, Hu Y, Huang P (2009) Mitochondrial 
dysfunction and reactive oxygen species imbalance promote breast cancer cell 




Pervaiz S, Clement M (2007) Superoxide anion: oncogenic reactive oxygen species? 
Int J Biochem Cell Biol 39: 1297-1304 
 
Pope B, Maciver S, Weeds A (1995) Localization of the calcium-sensitive actin 
monomer binding site in gelsolin to segment 4 and identification of calcium binding 
sites. Biochemistry 34: 1583-1588 
 
Price JT, Thompson EW (2002) Mechanisms of tumour invasion and metastasis: 
emerging targets for therapy. Expert Opin Ther Targets 6: 217-233 
 
Pyke C, Kristensen P, Ralfkiaer E, Grondahl-Hansen J, Eriksen J, Blasi F, Dano K 
(1991) Urokinase-type plasminogen activator is expressed in stromal cells and its 
receptor in cancer cells at invasive foci in human colon adenocarcinomas. The 
American journal of pathology 138: 1059-1067 
 
Qiao H, McMillan JR (2007) Gelsolin segment 5 inhibits HIV-induced T-cell 
apoptosis via Vpr-binding to VDAC. FEBS letters 581: 535-540 
 
Radwanska A, Litwin M, Nowak D, Baczynska D, Wegrowski Y, Maquart FX, 
Malicka-Blaszkiewicz M (2012) Overexpression of lumican affects the migration of 
human colon cancer cells through up-regulation of gelsolin and filamentous actin 
reorganization. Exp Cell Res 318: 2312-2323 
 
Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS (1996) Reactive 
oxygen species produced by macrophage-derived foam cells regulate the activity of 
vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque 
stability. J Clin Invest 98: 2572-2579 
 
Rao J, Seligson D, Visapaa H, Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun 
A, Palotie A (2002) Tissue microarray analysis of cytoskeletal actin-associated 
biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer 95: 1247-1257 
 
Ridley AJ (2011) Life at the leading edge. Cell 145: 1012-1022 
 
Robertson AK, Cross AR, Jones OT, Andrew PW (1990) The use of diphenylene 
iodonium, an inhibitor of NADPH oxidase, to investigate the antimicrobial action of 
human monocyte derived macrophages. Journal of immunological methods 133: 175-
179 
 
Royall JA, Ischiropoulos H (1993) Evaluation of 2',7'-dichlorofluorescin and 
dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured 
endothelial cells. Arch Biochem Biophys 302: 348-355 
 
Saari H, Sorsa T, Lindy O, Suomalainen K, Halinen S, Konttinen YT (1992) Reactive 
oxygen species as regulators of human neutrophil and fibroblast interstitial 
collagenases. Int J Tissue React 14: 113-120 
145 
 
Sahai E (2005) Mechanisms of cancer cell invasion. Current opinion in genetics & 
development 15: 87-96 
 
Salmeen A, Barford D (2005) Functions and mechanisms of redox regulation of 
cysteine-based phosphatases. Antioxid Redox Signal 7: 560-577 
 
San Martin A, Griendling KK (2010) Redox control of vascular smooth muscle 
migration. Antioxid Redox Signal 12: 625-640 
 
Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005) PatchDock and 
SymmDock: servers for rigid and symmetric docking. Nucleic acids research 33: 
W363-367 
 
Scott JA, Homcy CJ, Khaw BA, Rabito CA (1988) Quantitation of intracellular 
oxidation in a renal epithelial cell line. Free Radic Biol Med 4: 79-83 
 
Shibue T, Weinberg RA (2009) Integrin beta1-focal adhesion kinase signaling directs 
the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad 
Sci U S A 106: 10290-10295 
 
Shieh DB, Chen IW, Wei TY, Shao CY, Chang HJ, Chung CH, Wong TY, Jin YT 
(2006) Tissue expression of gelsolin in oral carcinogenesis progression and its 
clinicopathological implications. Oral oncology 42: 599-606 
 
Shieh DB, Godleski J, Herndon JE, 2nd, Azuma T, Mercer H, Sugarbaker DJ, 
Kwiatkowski DJ (1999) Cell motility as a prognostic factor in Stage I nonsmall cell 
lung carcinoma: the role of gelsolin expression. Cancer 85: 47-57 
 
Sies H (1997) Oxidative stress: oxidants and antioxidants. Experimental physiology 
82: 291-295 
 
Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL, Hayoz D (2004) Gelsolin 
superfamily proteins: key regulators of cellular functions. Cellular and molecular life 
sciences : CMLS 61: 2614-2623 
 
Spagnolo L, Toro I, D'Orazio M, O'Neill P, Pedersen JZ, Carugo O, Rotilio G, 
Battistoni A, Djinovic-Carugo K (2004) Unique features of the sodC-encoded 
superoxide dismutase from Mycobacterium tuberculosis, a fully functional copper-
containing enzyme lacking zinc in the active site. J Biol Chem 279: 33447-33455 
 
Spinardi L, Witke W (2007) Gelsolin and diseases. Sub-cellular biochemistry 45: 55-
69 
 
Steeg PS (2003) Metastasis suppressors alter the signal transduction of cancer cells. 
Nat Rev Cancer 3: 55-63 
146 
 
Sun HQ, Yamamoto M, Mejillano M, Yin HL (1999) Gelsolin, a multifunctional 
actin regulatory protein. J Biol Chem 274: 33179-33182 
 
Suzuki M, Kato M, Hanaka H, Izumi T, Morikawa A (2003) Actin assembly is a 
crucial factor for superoxide anion generation from adherent human eosinophils. The 
Journal of allergy and clinical immunology 112: 126-133 
 
Svineng G, Ravuri C, Rikardsen O, Huseby NE, Winberg JO (2008) The role of 
reactive oxygen species in integrin and matrix metalloproteinase expression and 
function. Connective tissue research 49: 197-202 
 
Syrovets T, Simmet T (2004) Novel aspects and new roles for the serine protease 
plasmin. Cellular and molecular life sciences : CMLS 61: 873-885 
 
Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide 
by human tumor cells. Cancer Res 51: 794-798 
 
Taddei ML, Parri M, Mello T, Catalano A, Levine AD, Raugei G, Ramponi G, 
Chiarugi P (2007) Integrin-mediated cell adhesion and spreading engage different 
sources of reactive oxygen species. Antioxid Redox Signal 9: 469-481 
 
Takamiya R, Takahashi M, Park YS, Tawara Y, Fujiwara N, Miyamoto Y, Gu J, 
Suzuki K, Taniguchi N (2005) Overexpression of mutated Cu,Zn-SOD in 
neuroblastoma cells results in cytoskeletal change. Am J Physiol Cell Physiol 288: 
C253-259 
 
Talmadge JE, Fidler IJ (2010) AACR centennial series: the biology of cancer 
metastasis: historical perspective. Cancer Res 70: 5649-5669 
 
Tanaka M, Mullauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, 
Shinohara N, Koyanagi T, Kuzumaki N (1995) Gelsolin: a candidate for suppressor 
of human bladder cancer. Cancer Res 55: 3228-3232 
 
Taniguchi T, Lemoine NR, Kakkar AK (1998) Urokinase receptor is a key player in 
tumour progression. Gut 43: 739-740 
 
Tellam R, Frieden C (1982) Cytochalasin D and platelet gelsolin accelerate actin 
polymer formation. A model for regulation of the extent of actin polymer formation 
in vivo. Biochemistry 21: 3207-3214 
 
Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev 
Cancer 2: 442-454 
 
Thiery JP (2003) Epithelial-mesenchymal transitions in development and pathologies. 




Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal 
transitions. Nat Rev Mol Cell Biol 7: 131-142 
 
Thompson CC, Ashcroft FJ, Patel S, Saraga G, Vimalachandran D, Prime W, 
Campbell F, Dodson A, Jenkins RE, Lemoine NR, Crnogorac-Jurcevic T, Yin HL, 
Costello E (2007) Pancreatic cancer cells overexpress gelsolin family-capping 
proteins, which contribute to their cell motility. Gut 56: 95-106 
 
Thor AD, Edgerton SM, Liu S, Moore DH, 2nd, Kwiatkowski DJ (2001) Gelsolin as 
a negative prognostic factor and effector of motility in erbB-2-positive epidermal 
growth factor receptor-positive breast cancers. Clin Cancer Res 7: 2415-2424 
 
Tina KG, Bhadra R, Srinivasan N (2007) PIC: Protein Interactions Calculator. 
Nucleic acids research 35: W473-476 
 
Tobar N, Villar V, Santibanez JF (2010a) ROS-NFkappaB mediates TGF-beta1-
induced expression of urokinase-type plasminogen activator, matrix 
metalloproteinase-9 and cell invasion. Molecular and cellular biochemistry 340: 195-
202 
 
Tobar N, Villar V, Santibanez JF (2010b) ROS-NFkappaB mediates TGF-beta1-
induced expression of urokinase-type plasminogen activator, matrix 
metalloproteinase-9 and cell invasion. Mol Cell Biochem 340: 195-202 
 
Tochhawng L, Deng S, Pervaiz S, Yap CT (2013) Redox regulation of cancer cell 
migration and invasion. Mitochondrion 13: 246-253 
 
Tran H, Maurer F, Nagamine Y (2003a) Stabilization of urokinase and urokinase 
receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by 
activated mitogen-activated protein kinase-activated protein kinase 2. Mol Cell Biol 
23: 7177-7188 
 
Tran H, Maurer F, Nagamine Y (2003b) Stabilization of urokinase and urokinase 
receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by 
activated mitogen-activated protein kinase-activated protein kinase 2. Mol Cell Biol 
23: 7177-7188 
 
Usatyuk PV, Romer LH, He D, Parinandi NL, Kleinberg ME, Zhan S, Jacobson JR, 
Dudek SM, Pendyala S, Garcia JG, Natarajan V (2007) Regulation of hyperoxia-
induced NADPH oxidase activation in human lung endothelial cells by the actin 
cytoskeleton and cortactin. J Biol Chem 282: 23284-23295 
 
Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving 
paradigms. Cell 147: 275-292 
148 
 
Van den Abbeele A, De Corte V, Van Impe K, Bruyneel E, Boucherie C, Bracke M, 
Vandekerckhove J, Gettemans J (2007) Downregulation of gelsolin family proteins 
counteracts cancer cell invasion in vitro. Cancer Lett 255: 57-70 
 
Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) 
GROMACS: fast, flexible, and free. Journal of computational chemistry 26: 1701-
1718 
 
Van Raamsdonk JM, Hekimi S (2012) Superoxide dismutase is dispensable for 
normal animal lifespan. Proc Natl Acad Sci U S A 109: 5785-5790 
 
Van Remmen H, Ikeno Y, Hamilton M, Pahlavani M, Wolf N, Thorpe SR, Alderson 
NL, Baynes JW, Epstein CJ, Huang TT, Nelson J, Strong R, Richardson A (2003) 
Life-long reduction in MnSOD activity results in increased DNA damage and higher 
incidence of cancer but does not accelerate aging. Physiological genomics 16: 29-37 
 
Vandekerckhove J, Bauw G, Vancompernolle K, Honore B, Celis J (1990) 
Comparative two-dimensional gel analysis and microsequencing identifies gelsolin as 
one of the most prominent downregulated markers of transformed human fibroblast 
and epithelial cells. J Cell Biol 111: 95-102 
 
Vassalli JD, Belin D (1987) Amiloride selectively inhibits the urokinase-type 
plasminogen activator. FEBS letters 214: 187-191 
 
Vouyiouklis DA, Brophy PJ (1997) A novel gelsolin isoform expressed by 
oligodendrocytes in the central nervous system. Journal of neurochemistry 69: 995-
1005 
 
Wang FS, Wang CJ, Chen YJ, Chang PR, Huang YT, Sun YC, Huang HC, Yang YJ, 
Yang KD (2004) Ras induction of superoxide activates ERK-dependent angiogenic 
transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated 
osteoblasts. J Biol Chem 279: 10331-10337 
 
Wang Y, Dang J, Liang X, Doe WF (1995) Amiloride modulates urokinase gene 
expression at both transcription and post-transcription levels in human colon cancer 
cells. Clin Exp Metastasis 13: 196-202 
 
Weaver AM (2006) Invadopodia: specialized cell structures for cancer invasion. Clin 
Exp Metastasis 23: 97-105 
 
Weigelt B, Peterse JL, van 't Veer LJ (2005) Breast cancer metastasis: markers and 
models. Nat Rev Cancer 5: 591-602 
 
Werner E, Werb Z (2002) Integrins engage mitochondrial function for signal 




Weydert CJ, Waugh TA, Ritchie JM, Iyer KS, Smith JL, Li L, Spitz DR, Oberley LW 
(2006) Overexpression of manganese or copper-zinc superoxide dismutase inhibits 
breast cancer growth. Free Radic Biol Med 41: 226-237 
 
Winston JS, Asch HL, Zhang PJ, Edge SB, Hyland A, Asch BB (2001) 
Downregulation of gelsolin correlates with the progression to breast carcinoma. 
Breast cancer research and treatment 65: 11-21 
 
Witke W, Sharpe AH, Hartwig JH, Azuma T, Stossel TP, Kwiatkowski DJ (1995) 
Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking 
gelsolin. Cell 81: 41-51 
 
Wu RF, Gu Y, Xu YC, Nwariaku FE, Terada LS (2003) Vascular endothelial growth 
factor causes translocation of p47phox to membrane ruffles through WAVE1. J Biol 
Chem 278: 36830-36840 
 
Wu WS (2006) The signaling mechanism of ROS in tumor progression. Cancer 
Metastasis Rev 25: 695-705 
 
Wu WS, Tsai RK, Chang CH, Wang S, Wu JR, Chang YX (2006) Reactive oxygen 
species mediated sustained activation of protein kinase C alpha and extracellular 
signal-regulated kinase for migration of human hepatoma cell Hepg2. Mol Cancer 
Res 4: 747-758 
 
Yamaguchi H, Condeelis J (2007) Regulation of the actin cytoskeleton in cancer cell 
migration and invasion. Biochim Biophys Acta 1773: 642-652 
 
Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, 
Eddy R, Miki H, Takenawa T, Condeelis J (2005) Molecular mechanisms of 
invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and 
cofilin. J Cell Biol 168: 441-452 
 
Yamaguchi H, Pixley F, Condeelis J (2006) Invadopodia and podosomes in tumor 
invasion. Eur J Cell Biol 85: 213-218 
 
Yap CT, Simpson TI, Pratt T, Price DJ, Maciver SK (2005) The motility of 
glioblastoma tumour cells is modulated by intracellular cofilin expression in a 
concentration-dependent manner. Cell Motil Cytoskeleton 60: 153-165 
 
Yilmaz M, Christofori G (2009) EMT, the cytoskeleton, and cancer cell invasion. 
Cancer Metastasis Rev 28: 15-33 
 
Yin HL, Kwiatkowski DJ, Mole JE, Cole FS (1984) Structure and biosynthesis of 




Yin HL, Stossel TP (1979) Control of cytoplasmic actin gel-sol transformation by 
gelsolin, a calcium-dependent regulatory protein. Nature 281: 583-586 
 
Yin HL, Stossel TP (1980) Purification and structural properties of gelsolin, a Ca2+-
activated regulatory protein of macrophages. J Biol Chem 255: 9490-9493 
 
Yin HL, Zaner KS, Stossel TP (1980) Ca2+ control of actin gelation. Interaction of 
gelsolin with actin filaments and regulation of actin gelation. J Biol Chem 255: 9494-
9500 
 
Yu X, Zech T, McDonald L, Gonzalez EG, Li A, Macpherson I, Schwarz JP, Spence 
H, Futo K, Timpson P, Nixon C, Ma Y, Anton IM, Visegrady B, Insall RH, Oien K, 
Blyth K, Norman JC, Machesky LM (2012) N-WASP coordinates the delivery and F-
actin-mediated capture of MT1-MMP at invasive pseudopods. J Cell Biol 199: 527-
544 
 
Zhan Y, He D, Newburger PE, Zhou GW (2004) p47(phox) PX domain of NADPH 
oxidase targets cell membrane via moesin-mediated association with the actin 
cytoskeleton. J Cell Biochem 92: 795-809 
 
Zhang F, Strom AL, Fukada K, Lee S, Hayward LJ, Zhu H (2007) Interaction 
between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the 
dynein complex. J Biol Chem 282: 16691-16699 
 
Zhang J, Sud S, Mizutani K, Gyetko MR, Pienta KJ (2011) Activation of urokinase 
plasminogen activator and its receptor axis is essential for macrophage infiltration in 
a prostate cancer mouse model. Neoplasia 13: 23-30 
 
Zhao X, Guan JL (2011) Focal adhesion kinase and its signaling pathways in cell 
migration and angiogenesis. Advanced drug delivery reviews 63: 610-615 
 
Zhao Y, Lyons CE, Jr., Xiao A, Templeton DJ, Sang QA, Brew K, Hussaini IM 
(2008) Urokinase directly activates matrix metalloproteinases-9: a potential role in 
glioblastoma invasion. Biochem Biophys Res Commun 369: 1215-1220 
 
Zhu H, Bannenberg GL, Moldeus P, Shertzer HG (1994) Oxidation pathways for the 
intracellular probe 2',7'-dichlorofluorescein. Archives of toxicology 68: 582-587 
 
Zhuge Y, Xu J (2001) Rac1 mediates type I collagen-dependent MMP-2 activation. 
role in cell invasion across collagen barrier. J Biol Chem 276: 16248-16256 
 
Zhuo J, Tan EH, Yan B, Tochhawng L, Jayapal M, Koh S, Tay HK, Maciver SK, 
Hooi SC, Salto-Tellez M, Kumar AP, Goh YC, Lim YC, Yap CT (2012) Gelsolin 
induces colorectal tumor cell invasion via modulation of the urokinase-type 























APPENDIX I (SUPPLEMENTARY DATA) 
In silico analysis of gelsolin and Cu/Zn SOD interaction  
(These data have been analysed and kindly provided by Dr Ganesan Pugalenthi, 
King Abdullah University of Science and Technology, Saudi Arabia) 
Aims 
1. To investigate whether gelsolin and Cu/Zn SOD can directly bind to 
each other  
2. To determine the stability of gelsolin-Cu/Zn SOD complex  
Docking 
To investigate whether gelsolin and Cu/Zn SOD are direct binding 
partners, docking was performed.  Crystal structures of gelsolin and Cu/Zn 
SOD were obtained from the protein database (PDB).  Gelsolin-SOD docking 
was then performed between pdb: 3FFN, chain A (gelsolin) and pdb: 1PU0 
Chain A (Cu/Zn SOD) using PatchDock (Schneidman-Duhovny et al., 2005).  
Briefly, PatchDock is a geometry-based molecular docking algorithm. It is 













To determine the stability of the docked gelsolin-Cu/Zn SOD complex, 
molecular dynamics simulations were performed under conditions that would 
mimic physiological conditions.  For molecular dynamics simulations the 
GROMACS version 4.5.3 with OPLS force field (Van Der Spoel et al., 2005) 
was employed.  The heterodimer model was placed in a cubic box with the 
box-edges at least 10 nm apart from the protein surface.  The system was 
solvated with Simple Point Charge (SPC216) water molecules and appropriate 
number of counterions were added in the box to neutralise the system. In order 
to remove the possible clashes between atoms, the energy minimisation was 
set to run for 50000 steps or until convergence to machine precision.  After 
energy minimisation, simulations were performed for 100 ps at constant 
temperature and pressure with periodic boundary conditions, particle-mesh 
Ewald summation, and a 2-fs time step to heat and equilibrate the system. 
Then the system was subjected to production MD simulations for 10 nano 
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seconds.  Structures were saved every 2 pico second for analysis.  The output 
files from the GROMACS 4.5.3 was analysed using XMGRACE software.  
The overall stability of the dimer was measured by estimating the following 
root mean square deviation (RMSD) of the molecule and its radius of gyration 
(Rg)  
Radius of gyration: Radius of gyration of a protein is a measure of its 
compactness. If a protein is stably folded, it will likely maintain a relatively 
steady value of Rg. If a protein unfolds, its Rg will change over time. 
Root Mean Square Displacement (RMSD): to evaluate the deviation of the 
structure from the original starting structure over the course of the simulation.  
Interactions were analysed (hydrogen bonds and hydrophobic forces) 
at the interface in each simulated structure.  Interaction between hydrophobic 
side chains are identified using a distance cutoff of 5 Angstrom between 
apolar groups in the apolar side chains (Tina et al., 2007).  The hydrogen 
bonds formed between subunits are identified using HBOND program which 
is a part of JOY suite (Mizuguchi et al., 1998).  The interactions that exist in at 
least 60% of the simulated structures were considered as dynamically stable 
and used for the interpretation of stability. 
Result and Discussion 
In section 4.6, we have shown that gelsolin co-immunoprecipitates 
with Cu/Zn SOD, however, it is unclear whether these two proteins directly 
bind to each other.  In order to predict the mode of interaction between 
gelsolin and Cu/Zn SOD, docking analysis using Patchdock followed by 
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molecular dynamic simulations were performed.  Docking between pdb: 
3FFN, chain A (gelsolin) and pdb: 1PU0 Chain A (Cu/Zn SOD) shows that 
gelsolin and Cu/Zn SOD are potential direct binding partners as shown in 
Appendix Figure 1.  Further analysis using Patchdock provide details of the 
interacting residues as well as the interaction type with the main chains and 
side chains involved in the interaction. Analysis of the residues involved in the 
interaction reveals that the C-terminal region of gelsolin is mostly likely the 
important region for its binding with Cu/Zn SOD.  Furthermore, to test the 
stability of the docked gelsolin-Cu/Zn SOD complex, molecular dynamics 
simulation that mimics physiological conditions was performed. Molecular 
dynamics simulation result show that the gelsolin-Cu/Zn SOD complex shows 
that the complex structure is intact up to 10 nano seconds (Appendix, Fig 
S1.2). Taking together, these results indicate that Gelsolin and Cu/Zn SOD can 
form a complex together and the complex thus formed is stable.  This finding 
ties in with our previous result (Section 4.4), that gelsolin suppresses the 
activity of Cu/Zn SOD.  If gelsolin-Cu/Zn SOD complex is maintained under 
physiological conditions, it is plausible that this interaction alters the activity 





Figure S1.1. 3-dimenstional structure of Gelsolin-Cu/Zn SOD complex 
obtained using PatchDock.  The green structure corresponds to gelsolin (pdb 







































































223  ASN  58  THR  Hbond-SS  95  
389  ASN  114  GLY  Hbond-SO  69  
403  SER  109  ASP  Hbond-SS  64  
662  MET  50  PHE  Hydrophobic  73  


































Figure S1.2. The radius of gyration of the complex structure of gelsolin-
Cu/Zn SOD measured upto 10 nano seconds.  The radius of gyration of a 
protein is a measure of its compactness.  If a protein is stably folded, it will 
likely maintain a relatively steady value of Rg.  If a protein unfolds, its Rg 
will change over time.  The above curve shows a steady value of Rg, 
indicating that stability of the gelsolin-Cu/Zn SOD complex structure is 









APPENDIX II (PREPARATION OF BUFFERS) 
CELL CULTURE MATERIALS 
McCoy’s 5A Medium (1L) 
1 bottle of McCoy’s 5A powder (M4892, Sigma-aldrich) 
2.2g NaHCO3,  
100mL Fetal Bovine Serum  
Top up to 900mL MiliQ water and sterile-filter through 0.22µm filter 
membrane. 
Dulbecco’s Modified Eagle Medium (DMEM) (1L) 
1 bottle of DMEM powder (D1152, Sigma-aldrich) 
3.7 NaHCO3,  
100mL Fetal Bovine Serum 
Top up to 900mL MiliQ water and sterile-filter through 0.22µm filter 
membrane. 
RPMI-1640 (1L)  
1 bottle of RPMI-1640 powder (R4130, Sigma-aldrich) 
2g NaHCO3, 
100mL Fetal Bovine Serum 











1X PBST (Wash solution) 
0.05% PBS-Tween  
WESTERN BLOT AND IMMUNOPRECIPITATION MATERIALS 
RIPA buffer 
50mL Tris-HCL pH 8.0 
150mM NaCl 
0.5% Sodium deoxycholate 
1% NP-40 
Modified RIPA buffer for IP 
5M Nacl 
1M Tris-HCL, pH 8.0 
0.5M EDTA 
1% Triton X-100 




5X SDS Gel loading buffer 
0.2M Tris-HCL pH 6.8,  
30% Glycerol, 
10% SDS  
0.05% Bromophenol blue) 
Resolving gel for SDS-PAGE 
Distilled water 
30% bis-acrylamide 




4% Stacking gel for SDS-PAGE 
Distilled water 
30% bis-acrylamide  
1M Tris (pH 6.8) 
10% SDS 
10% APS*  
TEMED 
SDS-PAGE running buffer (10Xstock) 





Transfer buffer for Sds-Page (10X stock)  
25mM Tris base, 
192mM Glycine 
0.025% SDS  
For 1x working solution, freshly add 20% ethanol. 
Phosphate Buffered Saline (PBS) (10X Stock, 1L) 
1.37M NaCl 
81mM Sodium phosphate dibase anhydrous Na2HPO4 
27.6mM Potassium chloride KCl 
14.7mM Potassium dihydrogen phosphate KH2PO4 
INVASION ASSAY MATERIALS 
Crystal Violet Stain 
0.2% Crystal Violet (w/v) 
0.9% NaCl 
10% ethanol 
ZYMOGRAPHIC ASSAY MATERIALS 
Wash Buffer 
2.5% Triton X-100 
20mM Tris-HCl, pH 8.0 
Incubation Buffer for uPA/Plasmin activity 




Coomassie Blue Stain 
0.1% Coomassie R-250 
40% Methanol 
10% Acetic acid 
Destain Solution 
10% Acetic acid 
30% Methanol 
MITOCHONDRIAL FRACTONATION BUFFER 
200mM mannitol 
68mM sucrose 
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